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Summary
The untargeted integration of foreign DNA into the mammalian cell genome, extensively
used in gene therapy and biotechnology, remains an incompletely understood process. It is
believed to be based on cellular DNA double strand break (DSB) repair machinery and to
involve two major steps: i) the formation of long gene arrays (concatemers), and ii) recom-
bination of the resulting concatemer with the genome. The main DSB repair pathways in
eukaryotes include non-homologous end-joining (NHEJ), homologous recombination (HR),
and microhomology-mediated end-joining (MMEJ). However, it is still not clear, which of
these pathways are responsible for transgene integration.
Here, we show that NHEJ is not the primary pathway used by mammalian cells in the
transgene integration process, while the components of the HR pathway seem to be impor-
tant for genomic integration but not concatemerization. Instead, concatemer formation
appears to be mediated by a subset of the MMEJ pathway, termed synthesis-dependent
MMEJ (SD-MMEJ). This mechanism also seems to be preferentially used for plasmid
integration into the genome, as confirmed by the analysis of plasmid-to-genome junction
sequences, which were found to display an SD-MMEJ pattern. Therefore, we propose the
existence of two distinct SD-MMEJ subpathways, relying on different subsets of enzymes.
One of these mechanisms appears to be responsible for concatemerization, while the other
mechanism, partially dependent in HR enzymes, seems to mediate recombination with the
genome.
Previous studies performed by our group suggested that matrix attachment regions
(MARs), which are epigenetic regulatory DNA elements that participate in the formation
of chromatin boundaries and augment transcription, may mediate increased plasmid inte-
gration into the genome of CHO cells by stimulating DNA recombination. In the present
work, we demonstrate that MAR-mediated plasmid integration results from the enhanced
SD-MMEJ pathway. Analysis of transgene integration loci and junction DNA sequences
validated the prevalent use of this pathway by the MAR elements to target plasmid DNA
into gene-rich areas of the CHO genome. We propose that this finding should in the future
help to engineer cells for improved recombinant protein production.
In addition to investigating the process of transgene integration, we designed recombina-
tion assays to better characterize the components of the MMEJ and SD-MMEJ pathways.
We also used CHO cells expressing cycle-sensitive reporter genes to demonstrate a potential
role of HR proteins in the cell cycle regulation.
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Résumé
L’intégration non ciblée d’ADN étranger dans le génome de cellules mammifères, largement
utilisée en thérapie génique et en biotechnologie, reste un processus peu compris. On pense
que ce type d’intégration est basé sur des mécanismes cellulaires de réparation des cassures
double brin (CDB) d’ADN et implique deux étapes principales: i) la formation de longues
molécules d’ADN constituées de multiples copies du transgène, et ii) la recombinaison
du concatémère avec le génome. Les principales voies de réparation des CDB chez les
eucaryotes sont la jonction d’extrémités non homologues (NHEJ), la recombinaison homo-
logue (HR) et la jonction d’extrémités médiée par microhomologie (MMEJ). Cependant, il
reste toujours des interrogations quant à savoir lesquelles de ces voies sont responsables de
l’intégration du transgène.
Ici, nous montrons que la NHEJ n’est pas la voie principalement utilisée par les cellules
de mammifères dans le processus d’intégration du transgène, tandis que des éléments de la
HR semblent être importants pour l’intégration génomique mais pas pour la concatéméri-
sation. Par contre, la formation de concatémères semble se faire par l’intermédiaire d’une
réparation par MMEJ dépendant de la synthèse d’ADN appelée SD-MMEJ. Ce mécanisme
apparaît également être préférentiellement utilisé pour l’intégration du plasmide dans
le génome, comme le confirme l’analyse des séquences des jonctions plasmide-génome,
qui révèlent un motif caractéristique de la SD-MMEJ. Par conséquent, nous proposons
l’existence de deux sous-voies de la SD-MMEJ distinctes, qui dépendent de différents
sous-ensembles d’enzymes. L’une d’entre elles serait responsable de concatémérisation,
tandis que l’autre, en partie dépendante des enzymes de la HR, jouerait un rôle dans la
recombinaison avec le génome.
Les études précédentes réalisées dans notre laboratoire ont suggéré que les MARs
(matrix attachment regions), qui sont des éléments épigénétiques de contrôle de l’ADN
qui participent à la formation des frontières de la chromatine et augmentent la transcrip-
tion, peuvent promouvoir l’intégration de plasmides dans le génome des cellules CHO en
stimulant la recombinaison d’ADN. Dans cette présente étude, nous avons pu montrer
que l’intégration du plasmide par l’intermédiaire des éléments MAR résulte de la voie
SD-MMEJ. L’analyse des loci d’intégration du transgène et des séquences des jonctions
ont validé l’utilisation de cette voie par les éléments MAR pour cibler l’ADN plasmidique
dans les régions du génome de CHO riches en gènes. Ces résultats pourraient aider dans
l’avenir à modifier des cellules pour améliorer la production de protéines recombinantes.
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En plus d’avoir étudié le processus d’intégration du transgène, nous avons conçu des
essais de recombinaison permettant de mieux caractériser les composants des voies MMEJ
et SD-MMEJ. Nous avons également démontré un rôle potentiel des protéines de HR dans
la régulation du cycle cellulaire à l’aide de cellules CHO exprimant des gènes rapporteurs
dépendant du cycle cellulaire.
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Chapter 1
Introduction
Integration of foreign DNA into the genome of eukaryotic cells is one of the most commonly
used methods in molecular biology. It permits to change the cell’s genetic material in
order to overexpress an exogenous protein. To achieve this, the DNA has to be delivered
inside the cell and then transported into the nucleus, where it can be incorporated into
the genome, for instance by using the cellular DNA repair machinery. Various techniques
used to deliver genes into the cells as well as the different DNA vectors will be described
in the first section of this chapter. The second section will review the different DNA repair
mechanisms existing in eukaryotic cells.
1.1 Gene delivery methods
To arrive in the cell nucleus and integrate, the transgene first needs to cross the cell and
nuclear membranes, and in case of plants or fungi also the cell wall. This process can
be facilitated by the use of many physical or chemical techniques, collectively termed
transfection, or by employing the natural ability of bacteria or viruses to infect eukaryotic
cells, referred to as transformation or transduction, respectively. Different methods of
transgene delivery can be used for different cell types and purposes. The main methods used
for gene transfer in plants are Agrobacterium-mediated transformation, electroporation,
particle bombardment, or direct microinjection into plant protoplasts (reviewed in [6,
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268]). The methods of choice for gene delivery into yeast cells include lithium acetate
transformation and electroporation (reviewed in [157]).
Animal cells, and more specifically mammalian cells which are the main focus of
this work, can be efficiently transfected by calcium phosphate precipitation, lipofection,
electroporation, microinjection, or viral transduction (reviewed in [161, 164]). Calcium
phosphate precipitation is one of the oldest and cost effective methods of mammalian
cell transfection [115]. It involves co-precipitation of DNA with calcium phosphate salts,
which enter the cells by endocytosis. Lipofection is currently one of the most popular, but
costly, methods of gene delivery into mammalian cells. It is based on the formation of
vesicles from positively charged lipids which encapsulate the negatively charged nucleic
acids and release it into the cell by fusing with its membrane [96].
The two most common physical methods of DNA transfer into mammalian cells are
microinjection and electroporation. In the first method a glass micropipette or needle is
used to introduce the DNA directly inside the cell [77]. This technique is used primarily
to inject DNA into oocytes to generate transgenic animals. In contrast to microinjection,
electroporation enables to introduce the transgene into a large numbers of cells. This later
method uses short electrical pulses, which disturb the cell membrane generating small
holes in the lipid bilayer enabling the DNA to enter into the cell [243].
Transduction, which uses the natural ability of viruses to infect animal cells, is probably
the most efficient method of gene delivery. This method is based on modified viral particles,
in which the viral DNA is partially replaced by the gene of interest. The most common
vectors, used in this, and other transfection methods, will be described in the following
sections.
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1.2 Methods of Transgene integration into the genome
1.2.1 Vectors
1.2.1.1 Viral vectors
Gene transfer using viral vectors relies on the ability of viruses to introduce their genome
into the nucleus of their host. Depending on the type and strain of the virus, the genetic
material either replicates to rapidly produce new particles, or integrates into the cell
genome as a provirus. This last feature is especially desirable from the point of view of
molecular biology. Viral vectors for gene delivery are constructed by removing the genes
responsible for the production of infectious viral particles. Instead they only contain the
minimal set of genes necessary for encapsidation of the genetic material and sequences
necessary for genomic integration (reviewed in [344]). These replication defective viral
particles carrying the gene of interest are produced in special packaging cell lines, which
express the missing viral genes necessary for the assembly of fully functional virions
[214]. This enables the transgene-carrying viruses to enter the target cells and integrate
their cargo into the genome, but prevents them from producing more infectious particles.
However, this procedure also significantly extends the vector preparation time.
The most common types of viruses used for the production of viral vectors include
adenoviruses, adeno-associated viruses (AAV), Herpes simplex virus (HSV-1), lentiviruses
and retroviruses [11, 338]). The first experiments with viral gene transfer were performed
using adenoviruses [322]. These viruses have a double-stranded DNA (dsDNA) genome,
which does not integrate into the genome of the host, but can remain in form of episomes
in non-dividing cells. However, cells that divide, gradually loose the transgene, which
constitutes a major drawback for biotechnology. Adenoviruses have also proven to be
highly immunogenic, and therefore are also not the preferred vector choice for gene ther-
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apy. These defects can be overcome by the use of AAVs, which not only integrate their
genetic material, but also do it in a very specific locus on human chromosome 19 [283].
However, they can only carry a cargo of up to 4 kb, which makes them impractical for
large transgenes. Large cargo (up to 50 kb) can be delivered by vectors based on HSV-1
[213]. However, this virus does not integrate its genetic material into the genome.
RNA viruses – retro- and lentiviruses mediate very efficient gene integration in mam-
malian cells. However, to do so, they first need to convert their genetic material into
DNA using a viral reverse-transcriptase. Retroviruses are only able to infect dividing cells
and were shown to preferentially integrate their genome near transcription start sites,
increasing the risk of gene-inactivation or oncogenic transformation [37]. Lentiviruses very
efficiently infect dividing and non-dividing cells, and tend to integrate away from cellular
promoters, making them a better choice than retroviruses for most applications [52].
Although viral vectors are very effective in delivering genes into mammalian cells, they
have many limitations. Apart from aforementioned limited cargo size, risk of insertional
mutagenesis and immunogenicity, they also entail high production costs and lengthy
preparation procedures. Moreover, the use of viral vectors in recombinant protein produc-
tion carries the risk of contaminating the therapeutic protein with viral particles. These
disadvantages make viral vectors less attractive from the point of view of biotechnology
and gene therapy. Therefore, many efforts are directed towards the development and
improvement of non-viral vectors.
1.2.1.2 Transposon vectors
Transposons, also called "jumping genes", belong to naturally occurring mobile genetic
elements that constitute around 45% of human genome, some of which can change their
genomic positions (reviewed in [114, 140]). They generally only encode a minimal set
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of genes necessary for their own transposition. Depending on the mechanism they use,
transposons can be divided into two classes: retrotransposons and DNA transposons
[352]. The first class resembles retroviruses in their mode of action, except that they
lack the ability to produce infectious particles. They use a copy-and-paste mechanism of
transposition, which involves an RNA-intermediate generated with the transposon-encoded
reverse transcriptase.
Class II DNA transposons use a cut-and-paste mechanism, and generally encode a
transposase protein flanked by inverted terminal repeats (ITRs), which serve as transposase
binding sites and are necessary for transposition. This class of transposable elements
was used to create gene transfer vectors by replacing the transposase gene with a gene
of interest and providing the transposase in trans (on a separate plasmid or RNA, or
as protein). This two-component system limits the transposon from being excised from
a primary insertion site, as the expression of transposase is gradually lost with time.
The two most commonly used transposon-based systems in mammalian cells, modified
from salmon and moth transposons, were gracefully named Sleeping Beauty and Piggy
Back, respectively [124, 139]. Although transposons were reported to integrate non-
randomly, with a preference for TA and TTAA nucleotides [140, 366], the ability to deliver
large transgene sizes, low production costs and lack of infectious potential, give them an
advantage over viral vectors.
1.2.1.3 Plasmid vectors
Certainly the most common type of vectors used for transgene delivery into eukaryotic
cells are plasmids - circular DNA molecules of bacterial origin. Ease and low costs of
manipulation, large insert sizes, as well as the existence of constantly growing molecular
cloning techniques makes them very powerful gene delivery tools for molecular biology.
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Plasmids can be easily delivered into the cells using one of the methods described
previously (section 1.1). After reaching the nucleus, plasmids can recombine with the
genome in a random place, likely taking an advantage of a break in a chromosome. This
process is thought to be mediated by the cellular DNA repair machinery, which joins
the plasmid with the repaired fragment of the chromosomal DNA. Unlike viruses and
transposons, which typically integrate only one copy of the gene per genomic locus, plasmid
vectors often integrate in many copies [116, 167, 249]. This is thought to result from a
two-step integration process [167]. In this model the plasmid molecules first join together
forming long gene arrays, termed concatemers, which subsequently recombine with the
cellular genome in a single genomic locus (Fig.1.1).
1.   concatemerization
2.  recombination 
     with the genome
vectors
genome
Figure 1.1: The model of the two-step plasmid integration process
While random transgene integration is relatively efficient, the major disadvantage of this
method is the lack of control over the transgene integration site, which may lead to
insertional mutagenesis or silencing of the gene of interest. Therefore, many alternative
gene delivery systems have been developed to tackle this problem.
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1.2.2 Site specific integration techniques
All the previously described vectors integrate into the genome in a more or less random
fashion. As mentioned previously this is a disadvantage, as it may lead to inactivation
of cellular genes or activation of proto-oncogenes. It may also result in lack of transgene
expression, if the integration takes place in non-permissive heterochromatin. The following
paragraphs describe the different approaches aimed at gaining control over the integration
site choice, to potentially improve safety and efficiency of the transgene integration process.
1.2.2.1 Site-specific recombinases (Cre/LoxP, Flp/FRT, φC31/att)
Site-specific recombinases are enzymes which catalyze the recombination of specific DNA
sequences, through strand cleavage, exchange and ligation (reviewed in [33, 99]). These
recombinases recognize only very specific target sites composed of two inverted palindromic
repeats separated by a spacer sequence, where the DNA cleavage occurs. Depending on the
presence of one or two of these sites, as well as their relative orientation, the recombinases
can mediate integration, excision, inversion or exchange of a DNA fragment.
The most common site-specific recombination systems are based on recombinases termed
Cre (causes recombination), Flp (“flip”) and φC31. Cre, isolated from from bacteriophage
P1, recognizes 34bp target sites called loxP (“locus of crossover in phage P1”) [286]. The
Flp recombinase, derived from a 2µ S. cerevisiae plasmid, specifically recognizes 48 bp FRT
(Flp recombinase recognition target) sites [113]. The target sites of both enzymes are not
altered by the recombination process, which means that recombination can occur again in
the same locus, potentially leading to the excision of freshly inserted transgene. This can
be circumvented by using heterotypic and incompatible recognition target sites. The φC31
integrase, isolated from a Streptomyces phage φC31, mediates recombination between
att (attachment) sites - attB (donor) and attP (acceptor). This process is irreversible, as
7
recombination results in the formation of fusion sequences termed attL and attR, which
are no longer recognized by the recombinase [134, 302].
Site-specific recombinases are typically used to introduce the gene of interest into
the mammalian genome by way of recombinase-mediated cassette exchange (RMCE)
(reviewed in [102, 331]). In this technique a cassette with the recombinase target sites is
first randomly integrated into the genome in a single copy. This acceptor cassette can then
be used by the recombinases to insert a transgene flanked by the same set of recognition
sites. This method is most often used to generate transgenic mice. Although it enables
to precisely control the transgene integration process, it requires the pre-introduction of
recombinase target sites using other techniques, as these sequences are not present in
mammalian genomes. This is often requires very laborious, time consuming screening
procedures, which is the greatest limitation of this technique.
1.2.2.2 Recombinant nucleases (ZFN, TALENs, CRISPR/Cas)
A novel approach to targeted integration came with the development of recombinant
nucleases: zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases
(TALENs) and clustered regulatory interspaced short palindromic repeat (CRISPR)/Cas-
based RNA-guided DNA endonucleases (reviewed in [98, 271]). All these systems are
based on a simple idea to introduce a single- or double-stranded break in a chosen place
in the genome, which is subsequently repaired by the cellular DNA repair mechanisms.
Since error-prone, potentially mutagenic mechanisms are thought to repair the majority of
DNA breaks in higher eukaryotes, this approach was successfully used for gene knock-out.
Alternatively, these systems can be used for transgene integration. This can be achieved
by providing a donor plasmid containing flanking sequences homologous to the targeted
locus, which stimulates DNA recombination by homology-directed repair mechanisms.
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Both ZFNs and TALENs are composed of sequence-specific DNA-binding domain
(DBD) and a non-specific nuclease domain, typically the FokI restriction endonuclease.
The ZFN DBDs are derived from zinc-finger proteins, while in TALENs they are based on
transcription activator-like effector (TALE) proteins [98, 314, 334]. In both systems the
DNA-binding region is made up of several zinc-finger or TALE modules linked together.
Each module recognizes 3 bp (in ZFNs) or 1 bp (in TALENs) from the target locus.
By using different combinations of modules the DBDs can be customized to recognize a
wide variety of sequences. The active enzyme is a dimer of two monomers targeting the
sequences flanking the FokI cleavage site.
A recently developed CRISPR/Cas system is based on a bacterial defense mechanism
against foreign DNA [210]. It consists of a guide RNA, which recognizes a specific DNA
target sequence, and a Cas nuclease which cleaves it. By designing a specific guide RNA
the system can be easily engineered to cut most target sequences. This makes it easier and
more affordable than the ZFNs and TALENs. However, its specificity and the potential
for off-target effects still need to be fully assessed.
1.3 Limitations of stable transgenesis
None of the methods of gene delivery and integration fully ensure efficient and long
term transgene expression in all cells having received the transgene. Regardless of the
delivery type, the gene of interest becomes a part of the cellular genome upon integration,
where it can be influenced by the surrounding genes, regulatory elements and changes of
the chromatin structure. This phenomenon, collectively termed the position effect, can
result in transgene silencing, due to heterochromatin spreading, or decreased expression
caused by the neighboring repressor elements. To protect the transgene against negative
position effects and stabilize its expression, epigenetic regulatory elements are often
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incorporated into the vectors. These elements may act as insulators, i.e. protect the
transgene from the effects of cellular enhancers or repressors, or as chromatin boundaries,
i.e. prevent the spreading of heterochromatin into the transgene integration site. Among
such DNA elements are Insulators, Locus Control Regions (LCRs), STabilizing Anti-
Repressor (STAR) elements, Ubiquitous chromatin opening elements (UCOEs) and Matrix
Attachment Regions (MARs). The first four groups have been characterized and reviewed
by others [173, 209]. The properties of MARs, which are the main focus of this work, will
be described in detail in the following section.
1.4 Matrix attachment regions
MARs were first identified in 1984 as chromatin fragments which co-purified with nuclear
proteins after endonuclease digestion of the genomic DNA [57, 228]. They were subse-
quently termed matrix- or scaffold-attachment regions (MARs or SARs), for their ability
to anchor the chromatin to the nuclear matrix, a putative network of protein fibers thought
to constitute the inner skeleton of the cell nucleus.
MARs are highly AT-rich (above 65%), non-coding sequences of variable length, and
often contain topoisomerase II cleavage sites [105]. While they have no obvious consen-
sus sequence, MAR-containing DNA fragments were shown to possess common physical
properties, like curvature, deeper DNA major groove and wider minor groove, and a high
potential for unwinding, unpairing and denaturing the double helix [29, 90, 110, 131, 262].
However, all these features likely result from the high content of AT base pairs in these
elements. Although there seem to be no strong sequence similarities between different
MARs described so far, they appear to be evolutionarily conserved [58]. They have
been identified in the flanking regions of many genes, e.g. chicken lysozyme and human
interferon β [30, 258], as well as in intergenic regions and introns.
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In biotechnology, MARs are best known for their beneficial role in sustaining transgene
expression [5]. One of their most attractive properties from a biotechnological point of
view is their proposed function of insulators, i.e. borders between active and inactive
chromatin domains, which may enable them to prevent gene silencing [106, 125]. This
MAR feature increased the interest in these elements in the field of genetic engineering, as
many studies have shown that an addition of a MAR element in a vector containing a
transgene results in increased and more stable transgene expression [111, 209, 377].
Upon their discovery, MARs were proposed to play a role in the organization of chro-
matin into higher-order structures by dividing chromosomes into functionally independent
50–200 kb loop domains [105, 215]. Later studies showed that MARs may directly bind to
many proteins involved in chromatin organization, e.g. special (A+T)-rich binding protein
1 (SATB1), CTCF, and SWI/SNF (mating type switching and sucrose non-fermenting)
complex [38, 273, 376]. Many of these proteins also function as transcription factors,
which suggested a role for MAR elements in the regulation of gene expression [10, 101].
MARs were also proposed to contribute to the initiation of DNA replication [71, 259].
Recently, the data from our group also implicated these elements in the process of DNA
recombination [110, 111, 116]. All this evidence suggests that MAR elements are not only
important for chromatin organization within the nucleus, but may also participate in the
regulation of essential cellular processes like transcription, replication and DNA repair.
1.5 DNA repair
1.5.1 DNA damage response and cell cycle regulation
All living organisms are constantly exposed to numerous factors causing DNA damage,
which poses a serious threat to the integrity of the cell genome. DNA damage can lead
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to cellular senescence or cell death, if left unrepaired, or to various types of mutations if
misrepaired. To counteract DNA damage, cells activate a network of DNA repair and
signaling pathways, collectively termed the DNA damage response (DDR) [65, 129, 132,
145, 200]. The role of the DDR is to sense DNA damage, initiate its repair through one of
many specialized pathways, and if necessary, arrest cell cycle progression to allow time
for the repair to be completed. Cells possess many DNA repair pathways, responsible for
repairing different types of DNA lesions. The most important of these pathways operating
in eukaryotic cells will be described later in this chapter.
Some types of DNA damage, e.g. chemically modified or mismatched nucleotides, can
be repaired rapidly, without activating the DDR. However, more complicated lesions, like
DNA interstrand crosslinks or single- and double-stranded breaks (SSBs, DSBs), which
require more time to be processed, stimulate DNA damage signaling leading to cell cycle
delay or arrest.
Upon SSB formation, the exposed single-stranded DNA (ssDNA) is rapidly recognized
and bound by replication protein A (RPA), which in turn leads to the activation of the
primary transducer kinase - ataxia telangiectasia and Rad3-related (ATR) [238]. The first
sensor of DSBs, the Mre11/Rad50/Nbs1 (MRN) complex, activates ataxia telangiectasia
mutated (ATM), another key protein kinase in the DDR network [294, 296]. ATR and
ATM are responsible for the phosphorylation of cell cycle checkpoint kinases 1 and 2
(CHK1 and CHK2), respectively. These kinases spread the DDR signal throughout the
nucleus by phosphorylating many other effector proteins. This ultimately results in the
inactivation of the cell-division cycle 25 (CDC25) phosphatase and in the activation of
the tumor suppressor p53 [208, 332]. Inactivation of CDC25, the phosphatase controlling
entry into mitosis, results in a rapid cell cycle arrest. Phosphorylated p53 activates the
transcription of its target genes, most notably a cyclin-dependent kinase inhibitor p21,
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which induces a persistent G1 phase arrest [74] (Fig.1.2).
ATM also phosphorylates many downstream DNA repair and cell cycle factors, including
histone H2AX, mediator of DNA-damage checkpoint 1 (MDC1), p53-binding protein 1
(53BP1) and breast cancer susceptibility protein 1 (BRCA1) [183, 296]. Activated MDC1
participates in the amplification of the DDR signal by recruiting more ATM molecules
to the DNA damage site [202]. Phosphorylated 53BP1 and Brca1 activate the non-
homologous end-joining (NHEJ) and homologous recombination (HR) DSB repair pathways,
respectively [132]. The phosphorylation of histone H2AX (γH2AX) induces global changes
in the chromatin structure leading to further recruitment of DNA repair proteins to
the sites of damage [93]. This accumulation of repair factors results in the formation
of microscopically-visible nuclear foci. When DSBs are repaired, dephosphorylation of
γH2AX and loss of nuclear foci suppresses the DDR machinery, leading to the progression
of the normal cell cycle. A failure to repair the damage results in persistent DDR signaling
and triggers apoptosis [145].
1.5.2 DNA damage repair pathways
Cells evolved many different repair mechanisms against the DNA damage to which the
genome is exposed every day. In case of simple chemical modifications of nucleotides, e.g.
spontaneous addition of a methyl group (alkylation), the damage can usually be reversed
by a single enzyme [289]. However, to repair more complex types of DNA damage cells
possess specialized enzymatic pathways often involving many components.
1.5.2.1 Base excision repair (BER)
The base excision repair (BER) pathway is used to correct relatively minor damage to DNA
bases, resulting from oxidation, deamination, or alkylation (reviewed in [78, 166, 170]).
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Figure 1.2: The ATM pathway in response to DSBs (from [64]).
The process is initiated by a DNA glycosylase, an enzyme which recognizes the damaged
base and removes it by cleaving the N-glycosylic bond between the base and the sugar
backbone [191]. Up to date, 11 different glycosylases were identified in mammals, each
recognizing a specific base modification. The resulting apurinic/apyrimidinic (AP) site
is processed by an AP endonuclease, which cuts the phosphodiester bond 5’ to the AP
site, and a phosphodiesterase, which cleaves the sugar-phosphate backbone, leading to the
removal of the suger backbone (reviewed in [166]). Alternatively, an enzyme with the AP
lyase activity, e.g. polymerase β, directly removes the sugar backbone overriding the need
for the AP endonuclease [303]. Finally the remaining gap is filled by a DNA polymerase
and sealed by a ligase.
Depending on the extent of damage, BER can proceed through one of the two sub-
pathways, called the short- or long-patch BER. In short-patch repair only the damaged
nucleotide is replaced by DNA polymerase β, a BER-specific member of the Pol X family,
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which typically inserts single nucleotides (reviewed in [364]). In contrast, long-patch BER
is mediated by DNA replication enzymes – proliferating cell nuclear antigen (PCNA) and
the highly processive Pol B family DNA polymerases -  and δ [310].
In the final step of BER, the remaining nick is sealed by DNA Ligase I or by the Ligase
III/Xrcc1 complex [324]. Ligase I, which also plays a role in DNA replication, is thought
to participate primarily in long-patch repair. Ligase III seems to be more important for
short-patch BER. Yeast, which lack the homolog of mammalian DNA Ligase III as well as
equivalents of polymerase β and Xrcc1, seem to rely mainly on long-patch repair (reviewed
in [159]).
1.5.2.2 Nucleotide excision repair (NER)
In contrast to BER, which removes modified bases, nucleotide excision repair (NER) is
responsible for the repair of large helix-distorting DNA lesions, e.g. pyrimidine dimers,
intrastrand crosslinks or bulky chemical adducts (reviewed in [153, 216, 287]). This type
of damage is primarily induced by UV light and some chemotherapeutic agents. NER pos-
sesses a set of multifunctional enzymes that recognize a wide variety of damage. Common
features of the NER substrates are bulkiness and propensity to destabilize the DNA helix.
Depending on how the damaged nucleotides are recognized, NER can be divided into
two sub-pathways: global genome NER (GG-NER) or transcription-coupled NER (TC-
NER) [109, 123]. In GG-NER two damage-recognition factors, the xeroderma pigmentosum
complementation group C (XPC)-RAD23B dimer and the UV-damaged DNA-binding pro-
tein (UV-DDB), scan the entire genome for helix deformations [312]. TC-NER occurs only
during transcription when RNA polymerase II is stalled by a damaged nucleotide in the
template DNA. This process does not require the XPC-RAD23B and UV-DDB complexes,
instead it relies on many TC-NER specific factors, including Cockayne syndrome proteins
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A and B (CSA and CSB) [95].
The remaining steps of the repair process are the same for both sub-pathways. After
the initial recognition of the damage, the core NER complex assembles from transcrip-
tion factor II H (TFIIH) and the xeroderma pigmentosum B, D, A, and G (XPB, XPD,
XPA, and XPG) proteins [89]. RPA also participates in the complex by binding to the
undamaged ssDNA strand. Finally the XPF/Ercc1 complex is recruited to the damage
site, which leads to the cleavage 5’ and 3’ to the lesion by XPF and XPG respectively,
resulting in the removal of a 22-30 nucleotide DNA fragment [17, 298]. The new strand is
synthesized by DNA polymerases  or δ, together with PCNA, or DNA polymerase κ, one
of the translesion synthesis (TLS) polymerases [247]. In the last step, the nick is sealed by
Ligase I or the Ligase III/Xrcc1 complex [232, 247].
The diseases caused by the deficiency in NER enzymes are Xeroderma pigmento-
sum, characterized by high sensitivity to sunlight and development of skin cancers, and
Cockayne’s syndrome, which results in premature ageing [54].
1.5.2.3 Mismatch repair (MMR)
The two repair mechanisms described in the previous sections are responsible for removing
nucleotides that have an incorrect chemical structure. However, they are unable to recognize
normal nucleotides incorrectly inserted during replication. A mechanism capable of doing
this is termed mismatch repair (MMR). MMR detects non-Watson-Crick base pairs and
insertion/deletion loops (IDLs), typically resulting from DNA polymerase slippage during
the replication of a microsatellite repeats. To prevent mutations in the daughter DNA,
this type of damage needs to be repaired already during replication.
MMR is a highly conserved mechanism found in most living organisms (reviewed in
[59, 15, 149, 255]). The first MMR enzyme, Mutator S (MutS) was discovered in E. coli
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[311]. Later MutS homologs (MSHs) were also identified in eukaryotes.
In mammals, the MMR process starts with the recognition of the mismatched bases by
the MutSα heterodimer, composed of MSH2 and MSH6 [135] (Fig. 1.3). IDL recognition
is thought to be mediated by a MutSβ complex, comprising MSH2 and MSH3 [250].
Following damage recognition MutS recruits the next MMR-specific complex: MutLα,
a heterodimer of bacterial MutL homolog 1 (MLH1) and mismatch repair endonuclease
PMS2 [265]. The MutS-MutL complex then moves along the DNA, until the nearest
nick in the dsDNA, e.g. a gap between two Okazaki fragments bound by PCNA. This
leads to the recruitment of exonuclease 1 (Exo1), which removes part of the nicked strand
surrounding the mismatch [327]. The resulting ssDNA is coated by RPA, and the new
strand is synthesized by DNA polymerase δ [199]. Finally the nick is sealed by DNA
Ligase I [382].
The defects in MMR enzymes were linked to cancer predisposition. One of the diseases
caused by mutations in MMR genes is Lynch syndrome (hereditary nonpolyposis colorectal
cancer; HNPCC), a condition characterized by early-onset cancer of the colon and other
organs [251].
1.5.2.4 Interstrand crosslink (ICL) repair
In addition to base damage, many mutagenic chemicals also cause the formation of DNA
interstrand crosslinks (ICLs), lesions where two nucleotides from complementary DNA
strands are covalently bound. This type of damage prevents DNA strand separation causing
problems during replication, leading to replication fork stalling, and during transcription.
This is especially detrimental for rapidly dividing cells. For this reason many cross-linking
agents, like cisplatin, mitomycin C, psoralen and nitrogen mustards, are used in cancer
chemotherapy [70]. ICLs may also be caused by some endogenous metabolic products, e.g.
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Figure 1.3: The mismatch repair pathway (from [15]).
aldehydes or nitric oxide.
In the S phase, replication fork stalling at ICLs leads to the activation of the Fanconi
anemia (FA) pathway. This process was named after a disease first described in 1927
by a Swiss pediatrician Guido Fanconi [188]. FA is characterized by genomic instability,
cancer predisposition, and hypersensitivity to DNA cross-linking agents (reviewed in
[53, 162, 342]). Genes important for ICL repair were first identified in patients suffering
from this condition.
The repair process starts when replication forks converge at the ICL, which covalently
links the two DNA strands (Fig.1.4). This leads to the recruitment of Fanconi anemia
complementation group M (FANCM) protein, which forms a complex with FA-associated
protein 24 kDa (FAAP24) and histone fold protein 1 (MHF1) [51, 223, 365]. Upon ICL
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recognition, the FANCM/FAAP24/MHF1 complex activates ATR signaling as well as the
downstream FA repair factors, which together form the FA core complex. The FA core
complex, composed of FANCA, -B, -C, -E, -F, -G, -L, and -M, has a ubiquitin E3 Ligase
activity [104, 222]. Its role is the monoubiquitination of FANCD2 and FANCI, which is
a key event in the ICL repair. The activated FANCD2-FANCI heterodimer recruits the
nucleases, which cut one of the DNA strands on both sides of the ICL. Among the candidate
enzymes generating the incision are Fanconi anemia-associated nuclease 1 (FAN1) and
FANCP (SLX4) [165, 207]. As a result of the incisions, termed ICL unhooking, one of the
DNA strands is left with the cross-linked nucleotides. TLS polymerases, REV1 or Pol ζ,
synthesize a complementary strand bypassing the lesion [130]. Finally the unhooked ICL
is removed by the NER pathway, described previously. The other DNA strand, containing
a double stranded break (DSB), is repaired by homologous recombination (HR) using the
TLS- and NER-repaired strand as a template [142, 69]. The HR pathway will be described
in more detail in a later section.
1.5.2.5 Translesion synthesis (TLS)
During replication, when DNA is unwound at replication forks, repairing DNA lesions
through excision may lead to DNA breaks and loss of chromosome fragments. To prevent
this, the damaged strand is first replicated to restore dsDNA. This is achieved by translesion
synthesis (TLS), mediated by specialized DNA polymerases, which have the ability to
bypass damaged DNA bases. The polymerases implicated in this process are the Y family
enzymes: polymerase η, κ, ι and Rev1, as well as the B family polymerase ζ (reviewed in
[130, 281]).
TLS polymerases have a special structure, which enables them to insert nucleotides
opposite chemically modified or distorted bases. This however renders them more error-
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Figure 1.4: The ICL repair pathway (from [107]).
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prone compared to the high fidelity replication polymerases (i.e.  and δ). Therefore, their
use is confined to the damage site to prevent mutagenesis. However, TLS polymerases are
crucial for bypassing UV-induced lesions like DNA intrastrand crosslinks, oxidized bases
or guanine N2 adducts, which block the progression of replication enzymes [130]. They
also participate in the repair of ICLs, together with the FA pathway, as well as in filling-in
abasic sites during BER and NER, all of which were described in the previous sections.
In addition to the main TLS enzymes, eukaryotes also possess other error-prone
polymerases which are capable of translesion synthesis. These enzymes, belonging to
the A and X families, are involved in a variety of DNA repair processes. The X family
polymerases - µ and λ, both capable of TLS, are used mainly during non-homologous end-
joining (NHEJ) repair of double stranded breaks (DSBs) [49, 91]. The A-family polymerase
θ was shown to participate in BER and recently also in the microhomology-mediated
end-joining (MMEJ) of DSBs [45, 47, 160, 218, 369, 372].
1.5.2.6 Single strand break repair (SSBR)
Single stranded breaks (SSBs) are a type of damage where only one of the two DNA
strands is severed. These types of lesions usually result from the loss of a single nucleotide
in one of the two DNA strands and are accompanied by modifications at the ends of the
broken strand. SSBs can occur directly, e.g. due to reactive oxygen species (ROS) attack
on the sugar backbone or as a result of abortive topoisomerase I activity (reviewed in
[41, 79]). However, they can also arise indirectly, as intermediates during NER, BER or
ICL repair. The most common source of SSBs are ROS, which leave 3’-phosphate and
3’-phosphoglycolate termini. Before these breaks can be repaired, DNA ends need to be
restored to contain 3’-OH and 5’-phosphate groups, which are suitable targets for DNA
polymerase and ligase.
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The initial step of SSB repair involves break recognition by poly (ADP-ribose) polymerase-
1 (PARP1), a key SSBR enzyme [87, 348]. PARP1 recruitment to SSBs leads to its
activation and to that of its downstream factors by their poly(ADP)ribosylation, i.e. by
the transfer of several ADP-ribose groups from NAD+ to these target proteins [42]. The
main target of PARP1 is X-ray repair cross-complementing protein 1 (Xrcc1) [87, 231].
Xrcc1 serves as a docking molecule for the SSBR factors responsible for the restoration of 5’
phosphate and 3’ OH termini. Depending on the type of modification, different enzymes are
used. Among them are polynucleotide kinase/phosphatase (PNKP), which processes ROS-
induced SSBs, while Aprataxin (APTX) and tyrosyl DNA phosphodiesterase 1 (TDP1)
process breaks resulting from abortive ligase and topoisomerase 1 activity (reviewed in
[40]). Xrcc1 also recruits DNA polymerase β, which removes the 5’ sugar remaining after
the activity of the AP endonuclease 1 [303, 364]. After the modifications are removed
from DNA ends, the gap is filled and ligated by BER enzymes. This most often involves
DNA polymerase β, which inserts single nucleotides. However, when longer fragments
need to be replaced long patch BER polymerases δ or  take over. The final step of SSBR
is carried out by Ligase III (in complex with Xrcc1) or Ligase I (stimulated by PCNA),
the first one being used in the short- and the latter in the long-patch repair [39, 324].
1.5.2.7 Double strand break repair (DSBR)
Probably the most deleterious type of DNA damage are double stranded breaks (DSBs).
DSBs are types of DNA lesions where both strands of the DNA helix are severed due
to chemical agents, reactive oxygen species or ionizing radiation (reviewed in [121, 129,
144, 155]). They can also occur spontaneusly during cellular processes like replication,
meiosis, V(D)J recombination or class-switch recombination. DSBs can be particularly
harmful for the cells if unrepaired, leading to cell death, or to various types of mutations
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if misrepaired. The two major pathways responsible for DSB repair in mammalian cells
are non-homologous end-joining (NHEJ) and homologous recombination (HR) (Fig.1.5).
A third group of DSB repair pathways, thought to function when the two main repair
mechanisms are impaired, was collectively termed microhomology-mediated end joining
(MMEJ). The choice of the repair pathway is made depending on the type of DSB and
the phase of the cell cycle.
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Figure 1.5: The pathways of DSB repair in higher eukaryotes. Description of the pathways,
abbreviations and references are given in the text.
1.5.2.7.1 Non-homologous end joining (NHEJ)
Non-homologous end joining (NHEJ) appears to be the major mechanism responsible
for DSB repair in higher eukaryotes. NHEJ operates throughout the entire cell cycle,
although it becomes less important in the late S phase and G2 phase, when homologous
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recombination is also used [230]. The components of this pathway were first characterized
in Chinese hamster ovary (CHO) cells sensitive to ionizing radiation (reviewed in [147]).
Apart from its role in the repair of radiation-induced breaks, NHEJ is also responsible for
the repair of naturally arising DSBs. Among the cellular processes requiring NHEJ are
V(D)J recombination, a process of antigen receptor gene rearrangement in primary immune
cells, and class-switch recombination (CSR), a process of immunoglobulin heavy-chain
(IgH) constant region gene rearrangement in mature B cells (reviewed in [306]).
In contrast to the other DSB repair pathways, NHEJ repairs broken ends without any
need for sequence homology. It is able to very quickly and efficiently repair ends which
require a simple ligation step, like blunt or cohesive ends [301]. However, when the ends
are non-cohesive, additional processing is needed, rendering the process slower and more
error-prone. In addition, more complex breaks, which require extensive processing, may
be better substrates for other DSB repair pathways.
The initial step of NHEJ involves the Ku heterodimer (Ku70 and Ku80), which
recognizes and binds to the broken DNA ends. Ku proteins were first identified by using
autoantibodies from a patient with an autoimmune disease (polymyositis-scleroderma)
and termed Ku after the first two letters of the patient’s name [227]. Eukaryotic Ku is a
dimer of two peptides: Ku70 (XRCC6) and Ku80 (XRCC5), which form a ring structure
around the two broken extremities of the DNA helix [343].
DNA-bound Ku dimers serve as docking sites for the DNA-dependent protein kinase
catalytic subunit (DNA-PKcs), which together with Ku forms the DNA-PK holoenzyme
[147]. The DNA-PKcs molecules from the two sides of the break interact forming a bridge
between the two ends [172]. This interaction is thought to trigger their catalytic activity
leading to their autophosphorylation as well as to the phosphorylation of other targets,
e.g. the Artemis nuclease [205, 305]. Although the exact role of the DNA-PKcs subunit is
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still unclear, its kinase activity seems to be required for effective NHEJ [242].
Following DNA-PKcs activation other NHEJ factors are also recruited to the break site.
These include the Artemis nuclease, DNA polymerases µ and λ and finally the Xlf and
Xrcc4-Ligase IV complex [241]. Artemis and the polymerases µ and λ, participate in the
processing of non-ligatable DSBs, by removing secondary structures (e.g. hairpins generated
during V(D)J recombination [205]) and filling-in the gaps between non-complementary
ends [253].
In the final step of NHEJ the two ends are joined by the Xrcc4-Ligase IV complex [63].
Ligase IV contains a catalytic domain at the N terminus and two BRCT domains in the
C-terminal part [349]. Xrcc4 binds to Ligase IV between the BRCT domains stabilizing
the complex [117]. Although Xrcc4 does not seem to have an enzymatic function, its
presence is necessary for the activity of the complex. An additional factor, termed Xlf
(Cernunnos) also participates in the ligation step [3, 35]. While its exact function is not
entirely clear, it has been reported to stimulate the activity of the Xrcc4-Ligase IV dimer
[329].
Additional factors, including 53BP1 and the MRN complex participating in the DNA
damage response signaling, were proposed to modulate the NHEJ pathway [230, 345, 361].
53BP1 has been identified as one of the proteins binding to the tumor suppressor protein
p53, hence the name [141]. It is one of the first factors recruited to the site of the DNA
break, forming so called nuclear foci, which colocalize with phosphorylated H2AX (γH2AX)
[269]. In addition to its role in mediating the DNA damage response and checkpoint
signaling, 53BP1 was shown to promote repair through NHEJ by inhibiting DNA end
resection, a process generating long ssDNA tails, which are poor NHEJ substrates [383].
It was also proposed to participate in keeping the two sides of the break in close proximity,
thus facilitating the ligation [80]. The MRN complex (MRX in yeast), composed of Mre11,
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Rad50 and Nbs1 (homolog of yeast Xrs2), participates in the earliest steps of DSB sensing
as well as in the transmission of the signal to the checkpoint signaling and DNA repair
pathways (reviewed in [67, 174]). MRN was shown to participate in the choice of the
DSB repair pathway by regulating the DNA end resection step [237, 285]. It has been
hypothesized that in the late S and G2 phase MRN, together with other factors, stimulates
end resection, reducing the efficiency of NHEJ, while in G1 it prevents extensive resection,
promoting NHEJ [82].
1.5.2.7.2 Homologous recombination (HR)
Homologous recombination (HR) is regarded as the most accurate mechanism used by
eukaryotic cells to repair DSBs. It is the main DSB repair pathway in yeast [304]. In
higher eukaryotes it occurs almost exclusively at the end of the S-phase and in G2-phase
of the cell cycle, when the genetic material is already replicated and homologous template
DNA is abundant [278]. This form of recombination is also important during meiosis, e.g.
in the process of crossing-over between homologous chromosomes, in the final steps of
interstrand crosslink (ICL) repair, and at collapsed replication forks [282, 69, 319].
The main initial steps of HR upon DSB detection include: 1) resection of 5’ DNA ends
to create 3’ ssDNA tails, 2) coating of the ssDNA end with the Rad51 recombinase, 3)
invasion of the coated strand into a homologous DNA molecule and formation of a D-loop,
a joint molecule between the broken DNA and the repair template, and 4) extension
of the 3’ end of the invading strand by a DNA polymerase. Once these first steps are
completed the process proceeds through one of the two possible sub-pathways: DSBR or
synthesis-dependent strand annealing (SDSA) [240, 319]. The DSBR mechanism involves
the formation of two Holliday junctions (HJs), which after resolution give rise to either
cross-over or non-crossover products. In the SDSA pathway repair occurs without the
formation of HJs. Instead the D-loop dissociates and the newly synthesized strand anneals
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to the second broken end. This is followed by DNA synthesis and ligation, likely mediated
by the DNA replication enzymes - polymerase δ and Ligase I [112, 211]. This process,
resulting in non-crossover products and gene conversion, appears to be the most common
type of HR repair in mammalian cells [150].
Unlike NHEJ, HR requires extensive 5’ to 3’ DNA end resection. As mentioned in the
previous section, this step is mediated by the MRN complex. However, since MRN does
not possess the 5’-3’ exonuclease activity, additional factors are required to catalyze this
reaction. One of the key factors cooperating with MRN is the carboxy-terminal binding
protein (CtBP)-interacting protein (CtIP) [285, 370]. CtIP is a homologue of S. cerevisiae
Sae2, which together with the MRX complex mediates DNA end processing in yeast [55].
After the initial resection by MRN and CtIP, more extensive DNA resection is carried
out by exonuclease 1 (Exo1) aided by the Bloom syndrome (BLM) helicase and the Dna2
nuclease [226, 246, 245]. In a recently proposed bidirectional model of end resection, the
MRN/CtIP complex first creates a nick upstream of the DSB and catalyzes 3’-5’ resection
towards the break [43, 103]. Next, Exo1/Dna2 extend the resection in the 5’ to 3’ direction.
The long 3’ ssDNA tails generated in the resection process are rapidly bound by the
ssDNA-binding RPA [313]. In subsequent steps, RPA is displaced by the Rad51 recombinase
[19]. Rad51 is a homologue of E.coli RecA protein, the first identified recombinase and
an essential component of bacterial DNA repair. In mice, the disruption of the Rad51
gene leads to early embryonic lethality, emphasizing its cardinal role in mammalian HR
[330]. Like RecA, Rad51 binds ssDNA ends forming long helical nucleoprotein filaments
[19, 22]. The DNA-bound Rad51 searches for sequence homology along the dsDNA and
finally mediates pairing between the two complementary strands.
The search for sequence homology and pairing is aided by a collection of other proteins,
including Rad54/Rad54B and the five Rad51 paralogs: Rad51B, Rad51C, Rad51D, and
27
X-ray repair cross-complementing 2 and 3 (Xrcc2 and Xrcc3) [217, 317]. Among the factors
involved in this process are also Rad52 and the breast cancer susceptibility proteins 1 and
2 (Brca1 and Brca2) [146, 233, 272]. Mutations in Brca1 and Brca2, undoubtedly among
the best known HR genes, are widely associated with predisposition to breast and ovarian
cancers [97, 175, 224, 239, 357].
Rad54 is a dsDNA-specific ATPase which binds directly to Rad51 and stimulates the
ATP-dependent translocation of the Rad51 nucleofilament along the DNA duplex in search
of homology [126]. Rad54 was also shown to stimulate the Rad51-mediated formation of
the D loop [256]. A paralog of Rad54, named Rad54B, was also identified [219]. Both
proteins have similar biological functions, suggesting that Rad54B may serve as backup in
case of Rad54 absence [350].
The Rad51 paralogs have limited homology to the Rad51 and to each other (approx.
20-30%) and likely originated from a series of duplication events of the Rad51 gene [190].
They form two types of complexes, which act at different stages of the HR pathway
[197, 217]. One of the complexes, termed BCDX2, comprises Rad51B, Rad51C, Rad51D
and Xrcc2. It was proposed to take part in the formation and/or stabilization of the
Rad51-DNA filament. The second complex, composed of Rad51C and Xrcc3 (CX3), seems
to play a role in Holliday junction branch migration and resolution.
Rad52 in yeast plays the role of a mediator between the DSB and the recombination
machinery by delivering Rad51 to ssDNA ends [252]. Until recently, mammalian Rad52
homolog did not seem to have a similar mediator function. Instead, another protein –
Brca2, was believed to play this role [194]. Brca2 is a large protein with several BRC
domains, which serve to bind Rad51. Its main function is Rad51 delivery and loading
onto the ssDNA tails [68]. However, it was also proposed to prevent Rad51 binding to
dsDNA and to help in RPA displacement (reviewed in [148]). While in mammals Brca2
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seems to be the key factor responsible for Rad51 nucleofilament assembly, Rad52 was also
recently reported to play a role in this process [92]. This suggested the existence of two
separate pathways, one utilizing Rad52 as a mediator like in yeast, the other relying on
Brca2. In the absence of a functional Brca2, Rad52 may take over its function, explaining
why Rad52 inactivation is synthetically lethal in Brca2 null background. The other breast
cancer susceptibility gene, Brca1, is also required for functional HR. Brca1 was reported
to function as a heterodimer with Bard1, a protein necessary for Brca1 stability [151, 358].
The Brca1/Bard1 dimer is thought to play a role in the regulation of the choice between HR
and NHEJ, similarly to 53BP1 (reviewed in [48]). Although the molecular mechanism of its
action is unclear, Brca1 was proposed to stimulate HR by counteracting the anti-resection
activity of 53BP1 [36].
Apart from repairing DSBs arising during the mitotic cell cycle, HR also plays a
very important role in meiotic recombination, a process that permits to correctly align
and segregate homologous chromosomes during meiosis. In the first stage of this process
Spo11, a topoisomerase-related protein, introduces DSBs along the chromosomes [158].
Subsequent DNA end processing is identical to that of regular HR. However, the resulting
ssDNA tails are bound by two recombinases: Rad51 and Dmc1. Dmc1 is a meiosis-specific
paralog of Rad51 [26]. Both proteins share over 50% sequence identity, suggesting that the
Dmc1 gene was generated by duplication of the Rad51 gene early in eukaryotic evolution
[190]. Unlike Rad51 mutants, Dmc1 knock-out mice are viable, but adult animals are
sterile, underlining the essential role of Dmc1 in meiosis [260]. Both Rad51 and Dmc1
play a role in formation of nucleoprotein filament and homology search during meiotic
recombination. However, Rad51 was shown to play only an accessory function, while Dmc1
is absolutely crucial for this process [56]. The remaining steps of meiotic recombination
resemble those of mitotic HR, although there is a higher frequency of cross-over products
29
than that observed in mitosis, due to the more frequent use of the DSBR pathway [8].
1.5.2.7.3 Microhomology mediated end-joining (MMEJ)
It is becoming increasingly clear that NHEJ and HR are not the only mechanisms of DSB
repair in eukaryotic cells. Over the past 20 years, many groups reported the existence of
alternative repair pathways, which come into play when the two main repair processes are
absent or dysfunctional. This third group of still poorly characterized DSB repair pathways
was collectively termed microhomology-mediated end joining (MMEJ), also referred to as
alternative or backup NHEJ (alt-NHEJ or B-NHEJ) [12, 28, 73, 83, 108, 248, 254]. Here
the term MMEJ will be used to emphasize the characteristic feature of this pathway, i.e.
the use of 5-25 bp microhomologies during the alignment of broken DNA strands before
joining [221].
MMEJ occurs throughout the cell cycle and is independent of core NHEJ and HR
factors [28, 184, 204, 372]. However, it was reported to share resection steps with HR,
indicating that it may partially rely on HR enzymes [72, 83, 184, 204, 328]. Indeed, MMEJ
initiation was shown to require MRN and CtIP [204, 374]. Other factors that have been
proposed to participate in MMEJ include PARP1, the Ligase III/ Xrcc1 complex, Ligase I,
DNA polymerase θ, DNA polymerase δ, and the ERCC1/XPF complex [12, 184, 204, 372].
However, this is unlikely to be an exhaustive list of implicated proteins.
It has been suggested that in the absence of other DNA-end binding proteins (like Ku
or Rad51) the DSBs are recognized by PARP1 which then initiates their repair through
MMEJ [221]. The repair process, similarly to HR, starts with 5’ to 3’ end resection,
which exposes short regions of homology on each side of the break. This processing step
is mediated by the MRN/CtIP complex [229]. The complementary regions, present in
the 3’ ssDNA fragments, pair together and the non-complementary segments (’flaps’) are
removed [372]. The ERCC1/XPF complex was proposed to be responsible for mediating
30
flap removal [2, 204]. Gaps (if any) are then filled in by a polymerase (e.g. DNA polymerase
θ or δ) and breaks joined by the Ligase I or Ligase III/Xrcc1 complex [184, 372].
In the absence of immediate microhomology regions at the DNA ends, which is often
the case, a more distant fragment of the repaired molecule can be copied using a low
fidelity DNA polymerase (e.g. polymerase θ). This duplicated region then participates in
the alignment of DNA ends, which results in an insertion in the created junction, termed a
templated insert. This more complex variant of microhomology-mediated repair has been
termed synthesis-dependent MMEJ (SD-MMEJ) [372].
MMEJ is an error-prone and highly mutagenic mechanism, due to large deletions
of genomic sequence characteristic of this pathway. While it seems that the use of this
mechanism is limited in normal cells, it was shown to be very active in many types of
cancer [323]. Indeed, cancer cells were shown to preferentially use this pathway of DSB
repair, likely due to deficiency in the main repair mechanisms [23]. This may potentially
make MMEJ a therapeutic target for treatment of cancers resistant to current therapies.
Although MMEJ is generally regarded as an alternative DSB repair pathway, it was
recently shown to play a role in class switch recombination and V(D)J joining, which are
processes previously thought to rely exclusively on NHEJ [28, 108]. This suggests that
this mechanism may be more than a backup pathway. It is also possible that some DSBs,
e.g. incompatible overhangs, which are poor NHEJ and/or HR targets, might be more
efficiently repaired by MMEJ [380]. This opens the possibility that this repair pathway
may play a more important role than initially suspected.
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Chapter 2
Aim of the thesis
Untargeted integration of plasmid DNA into the mammalian cell genome is a process
widely used in molecular biology and biotechnology, for instance to produce cells expressing
recombinant proteins. However, it is relatively inefficient and still remains incompletely
understood. While it was proposed to be mediated by DSB repair mechanisms, such as
NHEJ, HR or MMEJ, which of these pathways may be primarily responsible for this
process has remained unclear. A better knowledge of the molecular basis of spontaneous
plasmid integration may help to make this process more efficient and less time consuming,
facilitating its use in gene therapy and biotechnology. It may also allow to decrease
the unwanted non-specific integration of exogenous DNA, facilitating genome editing.
Therefore, one of the main goals of this study was to identify and characterize the
mechanisms primarily responsible for foreign DNA integration into the mammalian cell
genome.
Previous studies performed in our group demonstrated that MAR elements can stimulate
integration of plasmid DNA into the CHO genome [111, 110]. In addition, we observed that
successive transfections with MAR-containing vectors resulted in a very high increase of
transgene expression, possibly due to enhanced recombination between individual plasmid
copies leading to the formation of long concatemers [116]. Together these observations
led to the hypothesis that MAR elements could play a role in transgene integration by
33
stimulating DNA recombination. Here, we further explored this connection between MARs
and the DNA recombination machinery to determine which DNA repair pathway may be
activated by these elements.
In addition to investigating the role of DSB repair pathways in transgene integration,
we also sought to better understand these DNA recombination mechanisms and their link
to the cell cycle. Therefore, we designed recombination assays to study the function of
different variants of the MMEJ pathway, and we constructed cell cycle-sensitive reporter
CHO cells to investigate the potential role of DNA repair proteins in the cell cycle
regulation.
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Chapter 3
The analysis of two CHO mutants deficient in the
activity of Rad51D and DNA-PKcs reveals additional
defects in DNA repair gene expression
This chapter includes data generated by Mélanie Grandjean and Samuel Neuenschwander.
Mélanie Grandjean performed experiments represented on Fig.3.2 and published in: Grand-
jean, M., Girod, P.-A., Calabrese, D., Kostyrko, K., Wicht, M., Yerly, F., Mazza, C.,
Beckmann, J.S., Martinet, D., Mermod, N. High-level transgene expression by homologous
recombination-mediated gene transfer. Nucleic Acids Res. 2011 Aug; 39(15):e104.
Samuel Neuenschwander performed the RNA-seq data analysis (Fig.3.5,3.6; Table 3S1,3S2).
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3.1 Abstract
Chinese hamster cell lines sensitive to ionizing radiation and DNA damaging agents have
been used for many years to characterize the components of the DNA double strand break
(DSB) repair machinery in mammalian cells. Here, we used two such mutant cell lines,
deficient in the activity of DNA-PKcs, and important non-homologous end-joining (NHEJ)
enzyme, or Rad51D, one of the homologous recombination (HR) factors, to study the
connection between DSB repair and matrix attachment regions (MARs). MARs are DNA
elements proposed to play a role in chromatin organization, transcription and replication.
Previous work from our group also suggested that MARs stimulate foreign DNA integration
into the genome of Chinese hamster ovary (CHO) cells, opening the possibility that they
may play a role in DNA recombination. Here, we showed that MAR-mediated transgene
integration is enhanced in the DNA-PKcs mutant, but impaired in Rad51D-deficient cells.
This suggested that MAR elements require a functional HR pathway for efficient transgene
integration. However, the use of another Chinese hamster cell line, deficient in the activity
of an important HR factor - Brca2, failed to support this hypothesis. Therefore, we
performed whole transcriptome sequencing of the two CHO cell lines, which revealed
differences in the expression of other DSB repair genes. We conclude that these mutant
cell lines are not the best system to study DNA recombination and repair, and that other,
more controllable tools should be used instead.
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3.2 Introduction
Random genomic transgene integration is a problem in gene therapy and biotechnology,
as it can lead to gene silencing, mutagenesis or inefficient expression of the target gene.
Possible solutions to these problems include the use of strong or inducible promoters, gene
targeting, or flanking the target gene with matrix attachment regions (MARs). MARs are
polymorphic sequences in eukaryotic chromosomes that were first described in 1984, and
termed scaffold-attachment regions (SARs), for their ability to anchor the chromatin to
the nuclear matrix or scaffold. Upon their discovery, MARs were proposed to play a role
in the organization of chromatin into higher-order structures by dividing chromosomes
into functionally independent domains [215]. Later studies also showed that they may
act as insulators, i.e. borders between active and inactive chromatin, and can be used to
shield genes from silencing [106, 125]. Due to this property they have been successfully
used for many years in biotechnology to sustain and stabilize recombinant gene expression
[5, 106, 163, 377]. Apart from their role in chromatin organization, MARs were also
proposed to participate in DNA replication and regulation of gene expression [5, 71, 259].
Studies from our group also suggested that MARs stimulate transgene integration, opening
the possibility that they may play a role in DNA recombination [111, 110].
In eukaryotic cells, transgene integration requires cellular factors and it is believed to
be triggered by DNA double stranded breaks (DSBs). The two major pathways responsible
for DSB-repair in eukaryotic cells are non-homologous end-joining (NHEJ) and homologous
recombination (HR). These pathways were characterized largely due to the use of cell lines
sensitive to ionizing radiation or DNA-damaging chemical agents. Most of these cells were
derived from Chinese hamster and were found to be deficient in HR or NHEJ components.
Here, we used some of these Chinese hamster cell lines to study the possible link
between the MAR elements and DSB repair mechanisms. We first employed two Chinese
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hamster ovary (CHO) mutants defective in the activity of DNA-PKcs and Rad51D,
factors important for NHEJ and HR, respectively, and analyzed transgene integration and
expression in these cells in the presence or absence of the human MAR 1-68, previously
identified by our group [110]. These experiments demonstrated that MAR-mediated
transgene integration was enhanced in the absence of DNA-PKcs, suggesting that MARs
may promote integration by stimulating a mechanism alternative to NHEJ. In contrast,
plasmid integration was largely impaired in the absence of Rad51D, indicating that a
homology-dependent mechanism may be implicated in this process.
In parallel, we also used a different Chinese hamster mutant deficient in Brca2, another
important HR factor. In contrast to Rad51D-deficient cells, transgene integration and
expression was not abolished in these cells and instead was significantly increased compared
to the control cells. This led us to investigate further the Rad51D and DNA-PKcs mutant
cell lines. Plasmid recombination assays performed in these HR- and NHEJ-deficient cells
failed to demonstrate a defect in HR and NHEJ activities, respectively. In addition, whole
transcriptome sequencing of these cells revealed additional defects in the expression of
several DNA repair genes. Therefore, we conclude that these two mutant cell lines are not
a reliable system to study DNA recombination and that observations made in these, and
likely many other, mutant cell lines should be treated with reserve. We propose that a
different, more reliable system should be used to study the role of MAR elements in DNA
recombination.
3.3 Materials and Methods
Vectors
The control GFP vector (pGEGFP) contains the SV40 early promoter, enhancer and
vector backbone from pGL3 (Promega) driving the expression of the eGFP gene from
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pEGFP-N1 (Clontech). The vector containing the human MAR 1-68 (p1-68-SV40EGFP)
has been created by inserting the MAR into the pGEGFP upstream of the SV40 early
promoter. The pGL3-CMV-DsRed vector was created by inserting into the pGL3-basic
(Promega) the DsRed gene, together with the CMV promoter and enhancer, coming from
pCMV-DsRed (Clontech). The HR and NHEJ reporter plasmids were kindly provided by
V. Gorbunova (University of Rochester, New York, USA). Their construction has been
described in detail elsewhere [212, 291].
Cell culture
Wild type CHO AA8 cells, mutant V3.3 [27] and 51D1 cells [128] were cultivated
in DMEM/F-12+GlutaMAXTM with 10% fetal bovine serum (Gibco, Invitrogen) and
antibiotic-antimycotic solution (Sigma-Aldrich, #A5955). The same medium was used
for Chinese hamster Brca2-deficient VC8 cells and Brca2-complemented VC8-Brca2 cells
[169].
Transfections
Transfections were performed using Lipofectamine 2000 (Invitrogen) or Fugene 6 (Promega),
according to the manufacturer’s instructions. Transfection efficiency was monitored by
fluorescence microscopy (Carl Zeiss Microscope Axio Observer.A1). Stably transfected
cells expressing GFP were obtained by cotransfection of the pGEGFP or p1-68-SV40EGFP
vectors with the resistance plasmid pSVpuro (Clontech) using Lipofectamine 2000 (Invitro-
gen). After two weeks of selection with 5 µg/ml puromycin cells were analyzed by FACS.
FACS analysis
For fluorescence-activated cell sorting (FACS) cells were harvested 24h following trans-
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fection or after 2 weeks of selection, and resuspended in PBS with 2% FBS (Gibco,
Invitrogen). Fluorescence acquisition was performed on the FACScalibur flow cytometer
(Becton Dickinson) or the CyAn ADP Analyzer (Beckman Coulter) and data was analyzed
using the FlowJo software (Tree Star).
Recombination assays
For HR and NHEJ recombination transient assays, cells were transfected with HR or
NHEJ reporter plasmids digested with I-SceI, and with the pGL3-CMV-dsRed plasmid
to normalize for transfection efficiency, using Fugene 6 (Promega). The pGEGFP vec-
tor was transfected in parallel as a positive control of GFP expression. Expression of
GFP and DsRed was monitored by fluorescence microscopy (Carl Zeiss Microscope Axio
Observer.A1) and analyzed by FACS. GFP repair efciency was calculated as a ratio of
GFP-positive cells over the number of dsRed-positive cells.
PCR and quantitative PCR
To determine transgene copy number total genomic DNA was isolated from cells using
the DNeasy purification kit (Qiagen). For quantitative PCR (qPCR), 6 ng of genomic
DNA were analyzed using the SYBR Green I Master kit for the Light Cycler 480 ma-
chine (Roche) using primers EGFP-2F (AGCAAAGACCCCAACGAGAA) and EGFP-2R
(GGCGGCGGTCACGAA). The beta-2-microglobulin (B2M) CHO gene was used as
a normalization control using primers B2M_F (ACCACTCTGAAGGAGCCCA) and
B2M_R (GGAAGCTCTATCTGTGTCAA). The number of integrated GFP copies was
calculated using the B2M gene as a reference, as described previously [257].
To determine the presence of the Rad51D and DNA-PKcs transcripts in 51D1 and V3-3
cells, respectively, total RNA was isolated from cells using the NucleoSpin R© RNA II kit
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(Macherey-Nagel) and cDNA was generated using First-Strand cDNA Synthesis Kit (GE
Healthcare). The full CDS of hamster Rad51D was amplified using primers CgR51D_F
(AAACCATGGAAACATGGGCGTGCTCAGGG) and CgR51D_R (AAATCTAGAG-
CATCATGTCTGTTTGGCAG). The final 1kb of hamster DNA-PKcs CDS was amplified
using primers DNA-PKcs_F (GTGTCATGCCCATGACCT) and DNA-PKcs_R (TTA-
CATCCAAGGCTCCCA). The same primers were used for Sanger sequencing of this
fragment of DNA-PKcs mRNA.
Transcriptome sequencing (RNAseq)
For RNA sequencing total RNA was isolated from AA8, V3-3 and 51D1 cells using the
NucleoSpin R© RNA II kit (Macherey-Nagel). Libraries were prepared and sequenced
by paired-end sequencing using the Illumina technology by the Genomic Technologies
Facility of the University of Lausanne. Transcriptome analysis was performed by the
Vital-IT computer facility at the Swiss institute of Bioinformatics in Lausanne. The reads
where mapped to the annotation derived from CHO-K1 (CriGri_1.0, GCF_000223135.1)
allowing for max. 2 mismatches using Bowtie [177]. The number of reads mapping on
each transcript were counted and then compared among the conditions using DESeq [7],
the calculated p-values were adjusted for multiple testing with the Benjamini-Hochberg
procedure [20].
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3.4 Results
3.4.1 Transgene integration is impaired in Rad51D-deficient cells,
and increased in DNA-PKcs mutant in the presence of the
MAR
To study the role of MAR elements in DNA recombination we used two CHO mutants,
the V3-3 and 51D1 cells [27, 128, 351]. The 51D1 cell line was generated by knock-out of
exon 4 in the gene coding for Rad51D, one of the Rad51 paralogs important for HR. We
confirmed the absence of the full Rad51D transcript in 51D1 cells by PCR (Fig.3.1A). The
second cell line, V3-3, was reported to be deficient in the activity of DNA-PKcs, an enzyme
indispensable for NHEJ. These cells were obtained by EMS (Ethyl methanesulfonate)
mutagenesis and still express the DNA-PKcs mRNA (Fig.3.1B). However, they were
reported to contain a nonsense mutation in one of the DNA-PKcs alleles which gives rise
to a truncated protein [264]. Sequencing results confirmed that half of the DNA-PKcs
transcripts present in V3-3 cells contain a CAA to TAA mutation, potentially resulting in
a protein lacking 104 amino acids at the C-terminus (Fig.3.1C).
We transfected these cells with a GFP expression vector containing a human MAR 1-68
or a MAR-devoid control, and analyzed the integration and expression of these plasmids.
Stable GFP expression from the control plasmid was similar in the wild-type parental
cells (AA8) and the DNA-PKcs V3-3 mutant (Fig.3.2A). However, the Rad51D-deficient
51D1 cells showed a decrease in survival upon antibiotic selection as well as diminished
GFP fluorescence. The number of integrated transgene copies correlated well with GFP
fluorescence, showing a similar decrease in cells lacking Rad51D (Fig.3.2B). Taken together,
these results suggested that NHEJ may not be responsible for transgene integration, while
the lack of a functional HR, may negatively influence this process.
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Figure 3.1: Analysis of Rad51D and DNA-PKcs transcripts in 51D1 and V3-3 cells.
A) PCR of the Rad51D CDS (1015 bp) in RNA extracts from AA8, V3-3, 51D1 and CHO-K1
(K1) cells. CgRad51D from CHO-K1 cloned into a pSV40 vector served as positive control (c+).
B) PCR of the final 1013 bp from the DNA-PKcs CDS in CHO cell extracts. C) Fragment of the
DNA-PKcs CDS sequencing result from the V3-3 cells. Forward sequencing reaction in green,
reverse in red. Results were aligned to CgDNA-PKcs (ref: XM_003509456.1).
The presence of the MAR resulted in a 3-fold increase in GFP integration and
expression in wild type cells, confirming previous observations. Interestingly, in the NHEJ
mutant this effect was enhanced, resulting in a 5- to 6-fold increase in GFP integration and
expression when compared to AA8 cells transfected with the vector without the MAR. We
therefore hypothesized that in the absence functional NHEJ, an alternative repair pathway
may cooperate with the MAR to mediate very high transgene integration. In contrast, the
presence of the MAR did not improve GFP expression or integration in 51D1 cells. Also
in this case the number of antibiotic-resistant colonies remained very low. We therefore
concluded that the MAR element may mediate transgene integration, which becomes
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AB
Figure 3.2: MAR-mediated transgene integration and expression is enhanced in
V3-3 cells and abolished in 51D1 cells. Parental CHO cells (AA8) and mutants deficient
in DNA-PKcs (V3.3) or Rad51D (51D1) were transfected with a pSV40-GFP (GFP) or the same
plasmid with the MAR 1-68 (MARGFP). A) Relative mean GFP fluorescence, B) relative GFP
transgene copy number. Bars represent mean fold change over the AA8 cells transfected with
pSV40-GFP, s.e.m. error bars, n≥5. Asterisks indicate significant differences; (*) p<0.05, (**)
p<0.01, unpaired Student’s t-test. Data are from Mélanie Grandjean [116].
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more efficient in the absence of NHEJ. This effect was almost completely abolished in HR
deficient cells, suggesting that this pathway may be important for transgene integration in
CHO cells.
3.4.2 Lack of Brca2 affects expression from genome integrated
plasmids
We subsequently tested the involvement of the MAR in DNA recombination and its
impact on transgene integration in another HR mutant – the Brca2-deficient VC8 cell line
[169, 340]. The VC8 cells were derived from Chinese hamster lung fibroblast cell line V79
by ENU (N-ethyl-N-nitrosourea) mutagenesis. They were later found to contain premature
termination mutations in both alleles of the Brca2 gene [353].
Surprisingly, the lack of functional Brca2 did not affect GFP expression or integration
(Fig.3.3A,B). In addition, in the presence of the MAR 1-68, Brca2 deficiency very signifi-
cantly increased expression, indicating that this defect in HR may not impair transgene
genomic integration and expression but rather enhance it. Furthermore, the presence
of the MAR in the plasmid resulted in higher transgene expression both in cells lacking
Brca2 and Brca2-complemented (approx. 17-20 fold). This increase was much higher than
ever observed with MAR 1-68 in any of the other CHO cell lines. Interestingly, GFP
fluorescence in Brca2-deficient cells transfected with the MAR-containing plasmid was
2-fold higher than in cells expressing Brca2, despite the lack of significant difference in the
number of integrated GFP copies between the two cell lines. Instead, GFP expression per
gene copy was significantly increased in this condition (Fig.3.3C). This may suggest that
the absence of Brca2 does not affect the MAR-mediated increase in transgene integration,
but that it may possibly direct the transgenes to more favorable genomic loci, improving
their expression. Taken together it seems that the absence of Brca2, an important HR
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component, does not impair transgene integration. Moreover, lack of this protein seems to
have a beneficial effect on the integration and expression of the transgene. These results
were in contrast with the experiments performed in Rad51D-deficient cells. Therefore, we
next tested the efficiency of HR and NHEJ in the 51D1 and V3-3 CHO mutants and we
performed their whole transcriptome analysis to assess if the expression of DSB repair
genes is altered in these cells.
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Figure 3.3: Effect of Brca2-deficiency on plasmid genomic integration and expres-
sion. Brca2-deficient (-Brca2) and complemented (+Brca2) cells were transfected with a
pSV40-GFP (GFP) or the same plasmid with the MAR 1-68 (MAR). Results are shown as
fold increase over the data obtained from Brca2-complemented cells transfected with the GFP
plasmid without the MAR. Mean of 4 experiments. Asterisks indicate significant differences
between the MAR sample and the corresponding GFP control or between the two MAR samples;
(*) p<0.05, (**) p<0.01, unpaired Student’s t-test. A) mean GFP fluorescence, B) GFP copy
number, and C) fluorescence per GFP copy.
3.4.3 CHO 51D1 and V3-3 mutant cells are not fully deficient
in HR and NHEJ activities
To verify the activity of DSB repair pathways in CHO cells, we used two plasmid assays
based on the reconstitution of a functional GFP gene from two non-functional fragments
by either HR or NHEJ (Fig.3S1A,B) [212, 291]. Digestion of the two vectors with the
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I-SceI enzyme creates breaks imitating naturally occurring DSBs, which in case of the
NHEJ reporter can be repaired by end-joining, yielding GFP expression. The HR cassette
can produce a functional GFP only through inter- or intramolecular gene conversion, i.e.
non-crossover and non-reciprocal gene exchange, which is the most frequent form of HR
repair in mammals [150]. Without DNA cleavage and repair, the original cassettes do not
express GFP.
In wild type AA8 cells, both reporters yielded GFP positive cells, although the frequency
of GFP reconstitution through NHEJ was 3-fold higher than through HR, reflecting the
predominance of NHEJ over HR in mammals (Fig.3S2). The frequency of HR was increased
in the V3-3 mutant, albeit not significantly (Fig.3.4A). Surprisingly, we observed no change
in HR in 51D1 cells. The efficiency of NHEJ was only slightly decreased in DNA-PKcs-
deficient cells, and remained unaffected in the Rad51D mutant (Fig.3.4B). These results
suggested that the 51D1 and V3-3 cells may not be fully deficient in HR and NHEJ
activities, respectively. We thus hypothesized that the cells may possess secondary or
compensatory mutations, which alter their recombination propensity, and/or that they
may be mutated in other DNA repair pathways. Therefore, we proceeded to analyze the
full transcriptome of these cell lines by whole RNA sequencing (RNAseq).
3.4.4 Genes mutated in 51D1 and V3-3 cells show decreased
expression
We first compared the expression profiles of the two genes mutated in 51D1 and V3-3 cells
using the parental AA8 cells as a reference. In 51D1 cells we observed a significant, over
70% reduction of the Rad51D mRNA compared to the wild type cells (Fig.3.5A, Table
3S1). A small number of detected hits matching Rad51D mRNA likely represents the
sequencing reads mapping to the truncated transcript. Indeed, a marked reduction in the
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Figure 3.4: HR and NHEJ-mediated DSB repair in AA8, V3-3 and 51D1 cells. Bars
represent mean fold change over AA8 cells transfected with A) the HR reporter, B) the NHEJ
reporter. Mean of 3 experiments, s.e.m. error bars. Statistical signicance between the V3-3 or
51D1 cells and the AA8 cells was determined by unpaired Student’s t-test, significance level
p<0.05, ns – not significant.
transcript coverage was observed in the region corresponding to the exon 4.
In the V3-3 cell line we also observed a 50% reduction in the DNA-PKcs transcript
level (Fig.3.5B, Table 3S1). Since an intact DNA-PKcs allele is still present in these
cells, this decrease may result from partial degradation of the transcripts containing the
premature stop codon due to nonsense-mediated mRNA decay [34]. The detailed analysis
of the sequences mapping to the V3-3 DNA-PKcs mRNA revealed two nonsense mutations
at positions 10 135 and 12 082 present in half of the transcripts (Fig.3.5C,D). The second
mutation confirmed our previous sequencing analysis and reports published by others. The
earlier mutation, giving rise to a protein lacking 748 amino acids at the C-terminus, has
not been reported previously to our knowledge. However, we were unable to determine
whether these two mutations, potentially yielding truncated proteins, are on the same or
two different DNA-PKcs alleles.
These results further confirm that the the 51D1 cells are deficient in Rad51D. They
also demonstrate that DNA-PKcs expression is decreased in V3-3 cells. However, since
these mutations did not seem to significantly affect the DSB repair properties of these
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Figure 3.5: Rad51D and DNA-PKcs transcripts mapping coverage. A) Mapping of
the RNAseq reads from AA8, V3-3 and 51D1 cells to the Rad51D transcript (XM_003495801.1).
Yellow bar – Rad51D CDS, red bar - exon 4 knocked-out in the 51D1 cells. B) Mapping of the
RNAseq reads from AA8, V3-3 and 51D1 cells to the DNA-PKcs transcript (XM_003509456.1).
Red arrows point to nonsense mutations at positions 10 135 and 12 082 shown in detail in C)
and D). Analysis from Samuel Neuenschwander (SIB).
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cells, we decided to look at the expression of other repair genes to identify candidates that
could potentially compensate for the genetic defects in these cells.
3.4.5 51D1 cells are potentially deficient in interstrand crosslink
repair
We subsequently analyzed the expression of other DSB repair genes in 51D1 cells. Only
the level of Rad52 mRNA was decreased compared to the control AA8 cells, albeit not
significantly (Fig.3.6A, Table 3S1). However, we also observed a 30-60% increase in
expression of several HR genes, most notably MDC1, Rad51, Nbs1, Xrcc2 and Xrcc3,
as well as some genes attributed to other DNA repair pathways, e.g. Xrcc1, PARP1.
Increased transcription of these genes, notably Rad51 and the other Rad51 paralogs -
Xrcc2 and Xrcc3, could indicate that some of these factors may compensate for the lack of
Rad51D in the HR pathway.
The 51D1 cells were shown to be very sensitive to γ-irradiation and UV light [128].
We also observed that they divided much slower than the AA8 or V3-3 cells, and were
sensitive to transfection and antibiotic selection procedures (data not shown). Since the
mutation in Rad51D does not seem to affect HR-mediated repair in these cells, we reasoned
that altered expression of another gene may be responsible for their poor viability. We
therefore examined all the genes that were significantly downregulated in the 51D1 cells
compared to the other two cell lines (Table 3S2). Apart from Rad51D, we found significant
decrease in expression of many genes important for embryogenesis, neuronal development
or keratinocyte differentiation. However, all these factors are likely not essential for the
survival of cultured cells. Interestingly, we also observed an over 10-fold decrease in the
expression of Fanconi anemia complementation group L (Fancl), the E3 ubiquitin ligase
crucial for the Fanconi anemia (FA) pathway. The FA pathway is responsible for the
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removal of DNA interstrand crosslinks (ICLs), lesions where two nucleotides from opposing
DNA strands are covalently bound together. This type of damage prevents DNA strand
separation and therefore is especially harmful during replication and transcription. It has
been estimated that mammalian cells encounter on average 10 ICLs per day [118]. While
this may not appear to be a large number, it was shown that as little as 17-40 ICLs can
be lethal for repair-deficient cells [179]. Therefore, a lack of an essential component of
FA pathway may make these cells very susceptible to damage. Since the HR pathway
is important for the downstream steps of ICL repair, the combined Fancl and Rad51D-
deficiency may have a synergistic effect, potentially explaining the genetic instability and
low viability of these cells.
3.4.6 Genes involved in alternative DSB repair pathways show
higher expression in V3-3 cells
The lack of one functional DNA-PKcs allele was shown to strongly influence NHEJ-
mediated DSB repair and V(D)J recombination in V3-3 cells [27]. However, we only
observed a small decrease in NHEJ events as assessed by the GFP-reconstitution plasmid
assay. Since this assay was designed to tolerate a wide range of insertions and deletions
[212], we hypothesized that it likely detects repair events resulting from classical NHEJ as
well as alternative end-joining, also referred to as alternative NHEJ or microhomology-
mediated end-joining (MMEJ). Since this pathway was reported to be more active in
NHEJ-deficient cells [28, 72, 75, 152, 186], we hypothesized that the efficient GFP repair
in V3-3 cells could be due to MMEJ. Indeed, we observed an up to 2-fold increase in
the expression of several genes reported to play a role in MMEJ, e.g. Ercc1, Xrcc1,
Ligase III, PARP1, Pold3, Nbs1 (Fig.3.6B, Table 3S1). While these differences were not
statistically significant, they seem to be in line with previous studies reporting elevated
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Figure 3.6: Relative expression of DSB repair genes in 51D1 and V3-3 cells. Bars
represent the number of RNAseq reads mapping to the DSB repair gene transcripts relative to
the number of corresponding reads from AA8 cells. A) 51D1 cells, B) V3-3 cells. Data from
Samuel Neuenschwander (SIB).
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use of microhomology in these cells [335, 50], a hallmark of the MMEJ pathway [221]. In
conclusion, it seemed that while the V3-3 cells lack the activity of DNA-PKcs, they may
be proficient in DSB repair via the MMEJ pathway.
3.5 Discussion
Matrix attachment regions are often employed in biotechnology to prevent silencing of the
gene of interest and to stabilize its expression in mammalian cells. Our previous study
suggested that a human MAR 1-68 may also stimulate plasmid integration into the cellular
genome, potentially by cooperating with the DNA repair machinery [110]. Here, we used
different Chinese hamster cell mutants deficient in the components of two DSB repair
pathways - HR and NHEJ, to explore this possibility.
The experiments using Rad51D- and DNA-PKcs-deficient CHO cells suggested that
MAR-mediated plasmid integration may require a pathway alternative to NHEJ, as the
inactivation of this mechanism increased the integration and expression of MAR-containing
plasmids. Conversely, a defect in Rad51D, one of the factors implicated in HR, nearly
abolished transgene integration and expression as well as decreased the survival of stably
transfected cells. This suggested that the process of transgene integration in CHO cells may
be homology-dependent. Surprisingly, transgene expression in a different, Brca2-deficient
cell line was higher than in control cells, both in the presence and absence of the MAR.
In cells transfected with GFP only, this increase resulted from an elevated number of
integrated gene copies, whereas in the presence of the MAR the increased expression
could not be explained by higher copy numbers. This suggested that in the absence of
Brca2, the MAR rather than further increasing the number of transgenes that integrate,
may direct them to more favorable genomic loci. These results are in contrast with those
obtained in with Rad51D-deficient cells, which suggested that some of these cells may
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contain additional genetic defects.
CHO cell lines deficient in various recombination factors have been used for many
years to study the DNA repair processes in mammalian cells. However, most of these cells
were generated before high throughput sequencing technologies were developed, thus the
underlying mutations remain largely unknown. Furthermore, secondary or compensatory
mutations that improve culture growth have been proposed to occur, possibly affecting the
recombination propensity of these cell lines [340]. We hypothesized that the CHO cell lines
used in our study may have acquired mutations that restored their ability to efficiently
repair DSBs. To test this hypothesis we employed two widely used GFP-reconstitution
assays based on the reconstruction of a functional GFP gene through either NHEJ or HR.
Surprisingly, little differences in recombination frequencies were observed between the two
mutant cell lines and the parental cells. This suggested that these cells may not be fully
deficient in HR or NHEJ activities, contain complementing mutations, and possess very
active alternative DSB repair pathways.
To address this question we performed whole transcriptome sequencing of these cells
and analyzed their DSB repair gene expression. While the two previously described
mutations were apparent in these cells, we also observed additional differences in gene
expression between the two mutants and the parental cell line. The 51D1 cells, in addition
to the Rad51D mutation, showed a significant decrease in the expression of Fancl, a crucial
factor in the FA pathway. Both functional FA and HR pathways are needed for efficient
ICL repair. Therefore, ICL repair in 51D1 cells may be severely compromised due to the
deficiency in the components of both pathways. In line with this, 51D1 cells complemented
with wild type Rad51D remain more sensitive to cross-linking agents than the parental
AA8 cells [195]. This double defect in ICL and DSB repair may account for the extreme
sensitivity of these cells.
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The V3-3 cells proved to contain two nonsense mutations in at least one allele of the
the DNA-PKcs gene, likely rendering them defective in the NHEJ-mediated DSB repair.
However, we also observed an increase in the expression of genes implicated in the MMEJ
pathway. This, taken together with the lack of apparent end-joining defect, suggested that
this pathway compensates for NHEJ deficiency in these cells. This conclusion is supported
by other studies that reported very efficient DNA end-joining in cells with dysfunctional
NHEJ [28, 152, 186, 244].
In conclusion, we uncovered previously unknown defects in two widely used recombination-
deficient CHO cell lines. These results indicated that the mutant cell lines may not be
the most reliable model to study DNA repair, and they highlighted the need for a more
controllable system to study these processes.
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3.6 Supplementary materials
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Figure 3S1: GFP-reconstitution reporter cassettes for detection of NHEJ and HR.
A) The NHEJ reporter contains a GFP sequence disrupted by the intron from the rat Pem1 gene
containing an adenoviral exon, which becomes inserted into the GFP mRNA after the intron
is spliced out. Digestion with I-SceI removes the adenoviral exon and generates a DSB with
incompatible ends, which can be repaired by NHEJ leading to the restoration of a functional
GFP gene. B) The HR vector is construced similarly to the NHEJ reporter, but the first GFP
fragment contains a 22nt deletion and two I-SceI restriction sites used to generate a DSB with
incompatible ends. The GFP gene is followed by a copy of the first fragment lacking an ATG,
which can be used as a templete to repair the GFP gene through intramolecular or intermolecular
gene conversion. Components of each cassette are depicted on the legend at the right. Modified
from [212]
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Figure 3S2: The efficiency of HR and NHEJ-mediated DSB repair in AA8, V3-3
and 51D1 cells. Bars represent mean fold change over the cells transfected with the pGEGFP
plasmid (GFP) in each cell line. Mean of 3 experiments, s.e.m. error bars. The V3-3 and
51D1 cells transfected with the HR assay (HR) and the NHEJ assay (NHEJ) were compared to
the corresponding samples from AA8 cells. Statistical significance was determined by unpaired
Student’s t-test, significance level p<0.05, ns – not significant.
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Table 3S1: DSB repair gene expression in AA8, V3-3 and 51D1 cells. Analysis from
Samuel Neuenschwander.
 
Gene name Count 51D1 Count AA8 Count V33 Padj 51D1/AA8 Padj 51D1/V33 Padj V33/AA8 
DNA-PKcs 24090 32496 14710 1 1 0.274314865 
53BP1 26324 28488 23994 1 1 1 
Ku70 25072 23120 20716 1 1 1 
Ku80 12218 12816 14248 1 1 1 
DNA ligase IV 1850 2044 3530 1 0.850517258 1 
Xrcc4 1052 982 1012 1 1 1 
MDC1 16504 12512 12866 1 1 1 
Cyclin D1 22060 13848 14772 1 1 1 
Bard1 4662 3828 3466 1 1 1 
Brca1 96778 93154 45498 1 0.312618836 0.397143498 
Brca2 15778 20052 16982 1 1 1 
Rad51 10782 7990 9452 1 1 1 
Rad51B 1888 1792 1880 1 1 1 
Rad51C 888 1142 1046 1 1 1 
Rad51D 3188 10722 14784 0.012142075 0.000213137 1 
Rad52 6506 11484 5628 0.768426467 1 0.48511229 
Rad54 variant 2 5542 4938 5220 1 1 1 
Rad54 variant 1 5718 4958 5218 1 1 1 
Xrcc2 854 572 880 1 1 1 
Xrcc3 286 196 250 1 1 1 
Xrcc1 14880 9472 16990 1 1 1 
CtIP 17732 20196 18932 1 1 1 
Mre11 23626 19742 27912 1 1 1 
Nbs1 6594 4428 7312 1 1 1 
Rad50 17516 19606 18232 1 1 1 
Bach1/Brip1 12226 9178 13492 1 1 1 
Ercc1 19240 15620 32884 1 0.950873953 0.752269087 
Ligase I 25502 20452 24636 1 1 1 
Ligase III variant 1 5550 5126 7234 1 1 1 
Ligase III variant 2 7048 6604 9314 1 1 1 
Ligase III variant 3 5998 5684 8090 1 1 1 
PARP1 57968 37706 52906 1 1 1 
Polymerase theta 3304 3212 3264 1 1 1 
Wrn 14534 18162 14200 1 1 1 
Xpf/Ercc4 2444 3428 3180 1 1 1 
POLD3 15714 11930 15752 1 1 1 
MSH2 17442 17668 15780 1 1 1 
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Table 3S2: Genes significantly downregulated in 51D1 cells compared to AA8 and
V3-3 cell lines. Analysis from Samuel Neuenschwander.
Gene name Count 51D1 Count AA8 Count V3-3 Padj 51D1/AA8 Padj 51D1/V3-3 Padj V3-3/AA8 
Hox-C8 90 4308 1678 0.000000000 0.000000368 0.23 
Sprr2h 2068 15694 6890 0.000000630 0.016909143 0.25 
Serpinf1 778 10464 4918 0.000000000 0.000040094 0.41 
Ugt1a1 946 10618 5702 0.000000005 0.000045381 0.72 
PTPRZ1 2446 14114 7812 0.000028140 0.022222446 0.77 
aquaporin-1 3466 14964 30480 0.000792297 0.000000007 0.86 
Hox-C10 466 11032 7020 0.000000000 0.000000000 1 
Lama3 3796 40600 26816 0.000000002 0.000000299 1 
Tcf7l1 896 4252 6432 0.001102082 0.000003690 1 
Fancl 406 4838 3190 0.000000020 0.000019269 1 
Myo1d 1298 4544 7850 0.016114493 0.000019369 1 
Hox-C6 104 1012 1334 0.000417922 0.000045896 1 
Rad51D 3188 10722 14784 0.012142075 0.000213137 1 
Slc1a4 2226 8142 9972 0.006535173 0.000515255 1 
U2AF1 60 538 790 0.014007224 0.001381771 1 
Tgfbr3 11586 33764 36982 0.032033409 0.010243412 1 
Medag 22338 73420 70024 0.009552403 0.011007031 1 
Itm2b 9040 34144 26446 0.002423083 0.026543681 1 
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Chapter 4
MAR-mediated transgene integration involves the
SD-MMEJ DNA repair pathway
This chapter is based on a manuscript in preparation entitled "MAR-mediated transgene
integration into permissive chromatin and efficient expression involve an SD-MMEJ-like
DNA repair pathway" by Kostyrko, K., Neuenschwander, S., Junier, T., Regamey, A.,
Iseli, C., Schmid-Siegert, E., Bosshard, S., Majocchi, S., Girod, P.A., Xenarios, I., Mermod,
N.
59
4.1 Abstract
Untargeted integration of foreign DNA vectors into mammalian cell genomes is extensively
used in gene therapy and biotechnology, but it remains a poorly understood and relatively
inefficient process. The formation of vector concatemeric arrays and their genomic integra-
tion are commonly believed to involve DNA double strand break (DSB) repair pathways
such as non-homologous end-joining (NHEJ) or homologous recombination (HR), but
whether these pathways might mediate plasmid integration has remained unclear. Here,
we silenced essential DSB repair genes in Chinese hamster ovary (CHO) cells and found
that the lack of NHEJ activities did not affect integration or expression, while the silencing
of HR factors enhanced plasmid concatemer formation and stable expression. Genomic
integration of plasmids was inhibited by the silencing of specific HR proteins mediating
homology search and of DNA synthesis-dependent microhomology-mediated end-joining
(SD-MMEJ) activities. Analysis of transgene integration loci and junction DNA sequences
validated the prevalent use of an SD-MMEJ pathway for transgene integration within
gene-rich areas of the CHO genome, an effect shared with DNA elements that activate
transgene integration and expression. These findings should lead to an approach mediating
significantly improved gene transfer efficacy.
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4.2 Introduction
Spontaneous integration of non-viral DNA vectors such as plasmids into the eukaryotic cell
genome is a widely exploited process in gene therapy and biotechnology. Its molecular basis
however, remains incompletely understood. It is believed to rely on cellular DNA-repair
mechanisms, as it is favored and likely triggered by the presence of free DNA ends in the
vector resembling double stranded breaks (DSBs). The two major pathways responsible for
DSB repair in eukaryotic cells are non-homologous end-joining (NHEJ) and homologous
recombination (HR) [121, 144, 155]. NHEJ, active throughout the entire cell cycle, is a
fast mechanism, which efficiently joins DNA ends with little DNA end processing. In
contrast, HR is a slow, multi-step process requiring resection of one of the two DNA
strands and a homologous template for repair. Because of this requirement for homology,
HR is traditionally regarded as an error-free pathway [25, 120]. A third group of DSB
repair pathways, thought to function when the main repair mechanisms are impaired, are
collectively termed microhomology-mediated end joining (MMEJ). MMEJ is a still poorly
characterized family of pathways, also referred to as alternative or backup end-joining
[12, 28, 73, 83, 108, 248, 254]. The MMEJ mechanisms require short (2-25 nt) homologies
to align broken DNA strands before joining. Another hallmark of this process is the
occurrence of large deletions and, less frequently, insertions of sequences copied from other
parts of the genome, termed templated inserts [204, 225]. MMEJ was also reported to
share DNA strand resection with HR, implying that it may partially rely on HR enzymes
[72, 83, 184, 204, 328].
Plasmid integration into the genome of eukaryotic cells is an overall inefficient process,
occurring in a minor proportion of cells that take up the exogenous DNA. It was shown
to involve two major steps: i) recombination between vector molecules to form multiple
transgene arrays termed concatemers, and ii) the recombination of the resulting concatemers
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into the genome, usually at a single or at few chromosomal loci [94, 116, 167]. The
type of DSB repair pathway that is responsible for transgene concatemerization remains
currently unclear. In mammalian cells, this process was attributed to an HR mechanism
[94, 356], while NHEJ appeared to be involved in zebrafish embryos and rice [66, 167].
In addition, some studies suggest that alternative pathways may also play a role in the
joining of extrachromosomal DNA ends [203]. Similarly, the mechanism mediating the
final recombination of the transgene with the genome remains to be fully identified. NHEJ
is considered to mediate the majority of integration events in eukaryotic cells, while HR
may be responsible for a smaller proportion (reviewed in [339, 359]). However, there is
evidence that defects in HR strongly impair integration [201, 309], whereas other reports
implicated distinct pathways in this process [136, 225].
In previous studies, we reported that plasmid integration is enhanced by the presence
of matrix attachment regions (MARs), which are epigenetic regulatory DNA elements
that participate in the formation of chromatin boundaries and augment transcription
[101, 110, 116, 209]. MARs are thus widely used in biotechnology to sustain elevated
transgene expression, as well as to prevent epigenetic silencing effects by blocking the
propagation of heterochromatin [5, 125, 163, 377]. Their action to increase plasmid genomic
integration and copy number suggested that a positive effect of recombination mechanisms
may be an additional mechanism by which MARs improve transgene expression [110, 116].
We speculated that it involved an HR-related pathway, as transgene integration was
impaired in CHO cells mutated in Rad51D, one of its components, while it was increased
in cells deficient in an essential NHEJ enzyme. However, these observations based on
incompletely characterized mutant cell lines did not allow the characterization of the
mechanism by which plasmids integrate into the genome and how MAR elements may act
to increase this process. Thus, in this study, we first sought to identify the pathway(s)
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responsible for the integration of MAR containing or devoid plasmids into the genome of
CHO cells.
Using a knock-down approach, we show that a subset of alternative repair mechanisms,
termed synthesis-dependent MMEJ (SD-MMEJ), may be preferentially used by mammalian
cell lines for the spontaneous integration of foreign DNA into their genome. This finding
was confirmed by the characterization of plasmid-to-genome junction sequences, which
were found to display an SD-MMEJ pattern. Finally, we show that by stimulating this
mechanism, MAR elements mediate very efficient transgene integration into potentially
permissive chromatin loci, and that the inhibition of competing recombination pathways
can be used to significantly improve transgene expression.
4.3 Materials and Methods
Plasmids and siRNA
The MAR-devoid pGEGFP, MAR 1-68-containing p1-68-GFP, and pGL3-CMV-DsRed
expression vectors were described previously [116]. The HR and NHEJ reporter plasmids
were kindly provided by V. Gorbunova (University of Rochester, New York, USA) [212].
Small interfering RNA duplexes, specifically designed to target the CHO cell homologs of
the recombination proteins listed in Tables 4S1 and 4S2, were designed and provided by
Microsynth AG (Balgach, Switzerland). Three RNA duplexes were designed per mRNA to
increase the probability of successful knock-down. Three negative (non-targeting) siRNAs
were also designed as controls.
Cell culture
Adherent CHO DG44 cells [333] were cultivated in DMEM/F-12+GlutaMAXTM supple-
mented with 1x HT and 10% fetal bovine serum (Gibco, Invitrogen, Carlsbad, CA), and
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with the antibiotic-antimycotic solution (Sigma-Aldrich, St Louis, MO, #A5955). Sus-
pension adapted CHOK1 derived cells were cultured in SFM4CHO (HyCloneTM) medium
supplemented with 8mM L-Glutamine (PAA Laboratories GmbH, Austria) and HT (Gibco,
Invitrogen, Carlsbad, CA).
Recombination assays
For HR and NHEJ recombination transient assays, adherent CHO cells were transfected
with HR or NHEJ reporter plasmids digested with I-SceI, and with the pGL3-CMV-dsRed
plasmid to normalize for transfection efficiency, using Fugene 6 according to manufacturer’s
instructions (Promega, Madison, WI). The pSV40-GFP vector (pGEGFP) was transfected
in parallel as a positive control of GFP expression.
For siRNA-mediated knock-downs of recombination proteins, adherent cells were trans-
fected with equimolar mixes of three mRNA-specific or control siRNA duplexes at a final
concentration of 50nM using Lipofectamine RNAiMAX, according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA), using siRNAs against the genes described in
Tables 4S1 and 4S2. After two days, the siRNA-treated cells were re-transfected with
pGEGFP or p1-68-GFP and a puromycin resistance plasmid (pSVpuro) using Lipofec-
tamine 2000 (Invitrogen, Carlsbad, CA). Puromycin (5 µg/ml) was added to the culture
medium 24h after transfection, and stably transfected cells were selected for 2 weeks.
Puromycin-resistant colonies were stained with 0.2% methylene blue and quantified using
ImageJ (U.S. National Institutes of Health, Bethesda, Maryland, USA). GFP expression
was analyzed by cytofluorometry using a fluorescence-activated cell sorter (FACS) (CyAn
flow cytometer, Beckman Coulter), whereas aliquots of each sample were used for genomic
DNA extraction.
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Transgene copy number determination and quantitative PCR
To analyze the transgene genomic integration sites and copy number, total genomic DNA
was isolated from cells using the DNeasy purification kit (Qiagen, Hilden, Germany). For
quantitative PCR (qPCR), 6 ng of genomic DNA were analyzed using the SYBR Green I
Master kit for the Light Cycler 480 machine (Roche, CA) using AGCAAAGACCCCAAC-
GAGAA and GGCGGCGGTCACGAA as GFP-specific primers. The beta-2-microglobulin
(B2M) CHO gene was amplified as a normalization control using ACCACTCTGAAG-
GAGCCCA and GGAAGCTCTATCTGTGTCAA as primers. The number of integrated
transgene (GFP) copies was calculated using the B2M gene as a reference, as previously
described [257].
Characterization of transgene integration sites
The genome and transcriptome of the suspension-adapted parental CHO K1 cells was
determined by a combination of genomic shotgun and mate-pair sequencing using the
Illumina technology, performed by Fasteris SA (Plan-Les-Ouates, Switzerland), and by the
Pacific Biosystem technology at the Next Generation Sequencing Facility of the University
of Lausanne. Genome assembly was performed in the Vital-IT computer facility at the
Swiss institute of Bioinformatics Lausanne branch. The expressed coding sequences were
annotated using the publicly available Annotation Release 101 of the Chinese hamster
genome assembly (CriGri_1.0, GCF_000223135.1) [362].
For identification of plasmid integration sites in polyclonal populations, CHO K1 cells were
electroporated with the pGEGFP or p1-68-GFP plasmids and the pSVpuro plasmid using
the Neon transfection system (Invitrogen, Carlsbad, CA). After 3 weeks of puromycin
selection total genomic DNA was isolated from polyclonal cells using the Genomic-tip
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G/20 kit (Qiagen, Hilden, Germany). The DNA was sequenced using the Single Molecule
Real-Time (SMRT) technology (Pacific Biosciences, Menlo Park, CA) at the Next Gen-
eration Sequencing Facility of the University of Lausanne. CHO cells transfected with
p1-68-GFP were sequenced using 20 SMRT cells, and those transfected with pGEGFP
required the use of 60 SMRT cells to obtain the same number of integration site sequences.
Transgene integration sites were identified by a custom identification pipeline. PacBio
filtered subreads were obtained using the tool DEXTRACTOR (Myers, unpublished) using
the standard settings. Plasmid sequences were identified in PacBio filtered subreads with
the help of the alignment tool BLASR [46]. A raw score of at least -500 was chosen as
cut-off based on results using PacBio reads from untransfected CHO cells. Flanking regions
of matching plasmid sequences were extracted and mapped onto the CHO-K1 genome
using BLASR. 14 CHO genomic integration sites were identified per sample. 2 sets of 14
different, randomly-picked genomic scaffolds of the same length (+/-10%) as the sample
scaffolds were selected as controls. The Annotation Release 101 of the Chinese hamster
genome assembly (CriGri_1.0, GCF_000223135.1) was used to identify the CHO genes in
the vicinity of the integration sites. The presence of genes near the plasmid integration
position in each of the identified scaffolds was compared with an analogous position on a
corresponding control scaffold. An exact binomial test was used to calculate statistical
significance between these datasets. Based on this analysis integration within 5kb from an
open reading frame (ORF) was considered intragenic, whereas integration within 35 kb
from an ORF was defined as gene-proximal.
Suspension-adapted CHO K1 cells were stably transfected with plasmid vectors containing
the human MAR X-29 and encoding the light and heavy chains of the trastuzumab and
infliximab therapeutic antibodies, as previously described [181]. Clones expressing the
highest amount of the recombinant proteins were selected for whole genome sequencing
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(Illumina). Integration sites were first predicted by the in silico identification of paired
reads displaying linked plasmid and genomic sequences, and the predicted junctions were
subsequently validated by PCR amplification and Sanger sequencing. Identification of
CHO genes near the plasmid integration sites was performed as described for the polyclonal
populations.
Fluorescence in situ hybridization
Preparation of metaphase chromosomes and fluorescence in situ hybridization (FISH) were
described previously [76]. FISH probes were prepared by nick translation of plasmids used
to generate the clones in the presence of Orange 552 dUTP according to the manufacturer’s
protocol (Enzo Life Sciences, Farming dale, NY). The chromosomes were counterstained
with DAPI (VECTASHIELD R© Mounting Medium, Vector) and observed using a 63x oil
immersion objective on an Axio Observer.A1 microscope (Zeiss).
4.4 Results
4.4.1 Plasmid integration does not rely on NHEJ or the canon-
ical HR pathway
To assess the possible implication of NHEJ and HR in plasmid concatemer formation and
spontaneous integration into the cell genome, we silenced the components of these major
DSB repair pathways in CHO cells using short interfering RNA (siRNA) (Fig.1.5, Table
4S1). Efficient reduction of the target mRNA and/or protein levels by siRNA transfection
was validated experimentally, to insure decreased mRNA levels of at least 2-fold (Fig.4S1).
When assessed by western blotting, the Ku70, 53BP1, Rad51, and Rad51D proteins were
essentially undetectable in cells treated with their cognate siRNAs, whereas they were not
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significantly altered by the control siRNAs (Fig.4S2). We therefore concluded that the
studied recombination proteins were efficiently down-regulated in siRNA-treated cells.
To evaluate if the knock-down of these activities may affect DSB repair and recom-
bination mechanisms, we used previously described HR and NHEJ fluorescent reporter
assays, based on the repair of transiently transfected plasmids having a I-SceI-induced
DSB in the GFP coding sequence [212, 291]. These assays enable to evaluate the efficiency
of extrachromosomal break repair by monitoring the restoration of GFP expression, and
thereby may provide an estimation of the involvement of the HR and NHEJ pathways in
plasmid concatemer formation. We observed that DSB repair of the HR reporter plasmid
was significantly impaired by the knock-down of the Rad51 HR protein, whereas it was
rather increased in cells treated with siRNAs targeting NHEJ factors (Fig.4S3A). This
indicated that this HR protein may contribute to the repair of DSBs in episomal plasmids.
In contrast, the occurrence of restored GFP expression by an NHEJ mechanism was not
altered in any of the siRNA-treated cells (Fig.4S3B). Given the near-complete knock-down
of critical components of the NHEJ repair mechanism such as Ku70, these results implied
that NHEJ is not prominently used to rejoin plasmid DSBs in CHO cells.
The recombination mechanisms involved in plasmid concatemer formation and genomic
integration were further assessed by co-transfecting the siRNA-treated cells with plas-
mids carrying the GFP reporter and a puromycin resistance gene. Cells having stably
integrated the plasmids into their genome were selected by culture in the presence of the
antibiotic. Analysis of the average number of integrated GFP copies in antibiotic-resistant
polyclonal populations was used to assess the efficiency of the concatemerization process.
Quantification of puromycin-resistant colonies was performed to estimate the percentage
of cells which had successfully integrated transgenes into their genome, as a measure of
the overall efficiency of the integration process. The level of GFP expression was measured
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to assess plasmid expression per transgene copy, as an estimation of the integration of
plasmids within transcription permissive or non-permissive areas of the cell genome.
The genomic integration and expression of the GFP plasmid were not significantly
inhibited by the down regulation of NHEJ activities such as DNA-PKcs, Ligase IV or
Xrcc4, nor did it alter the number of antibiotic resistant colonies or expression per trans-
gene copy (Fig.4.1A-D). This indicated that NHEJ activities are not limiting for plasmid
concatemerization and integration within the CHO cell genome. Rather, the plasmid
copy number was increased by the down regulation of 53BP1, suggesting that NHEJ may
compete with a recombination pathway mediating plasmid concatemerization (Fig.4.1B).
Stable GFP expression and/or transgene copy numbers were significantly increased
by the knock-down of HR proteins, notably MDC1, Rad51, Rad52, Rad54, and Brca1
(Fig.4.1A,B). The knockdown of these proteins had overall little effect on gene expres-
sion when normalized to transgene copy, indicating that increased expression upon HR
activity knockdown resulted mostly from an increased copy number rather than from the
preferential integration of plasmids into transcription-permissive chromatin (Fig.4.1C).
These observations indicated that HR activities may oppose a mechanism that mediates
plasmid concatemerization prior to genomic integration. However, the knock-down of
MDC1, Rad51 and Rad51C strongly decreased the number of puromycin resistant colonies
(Fig.4.1D), indicating that these components of the HR pathway may be required for
transgene integration. Interestingly, the frequency of genomic integration was not affected
by the knock-down of other components of HR, such as Rad52, Rad54 or Brca1, despite
their effect on transgene integration and expression. These findings implied that proteins
mediating DNA homology search of the HR DNA repair pathways are required for genomic
integration, but that later-acting HR proteins are not involved, suggesting the occurrence
of non-canonical HR-related integration mechanisms.
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Figure 4.1: Effect of HR and NHEJ components knock-down on plasmid genomic
integration and expression. CHO cells were treated with siRNAs against the indicated HR
and NHEJ factors, as referenced in Table 4S1, and the cells were re-transfected with a GFP
expression plasmid and with a puromycin resistance vector. Puromycin-resistant polyclonal cell
populations were selected and used to assess the average GFP fluorescence (A), GFP transgene
copy number (B) and GFP expression per transgene copy (C), whereas the frequency of genomic
integration events was assessed by quantifying the occurrence of puromycin-resistant colonies
(D). Values represent mean fold change over control cells not treated with siRNAs (mock),
and error bars represent s.e.m, n≥3. Asterisks indicate significant differences between the
siRNA-treated sample and mock control, (*) p<0.05, (**) p<0.01; unpaired Student’s t-test with
Benjamini-Hochberg correction.
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4.4.2 MMEJ-type mechanism seems to mediate plasmid con-
catemerization and genomic integration
Given that neither the NHEJ nor the canonical HR pathway may be involved in plasmid
concatemerization prior to genomic integration, we thus hypothesized that plasmid con-
catemer formation may be mediated by a mechanism which is suppressed by the main DSB
repair pathways in untreated cells. We speculated that this could involve MMEJ-related
mechanisms that were recently reported to function in eukaryotic cells with impaired
NHEJ and/or HR, but that may share some early events with the HR pathway, such as
the 5’ strand resection (Fig.1.5) [72, 75, 204]. Thus, we next proceeded to knock-down
proteins proposed to participate in MMEJ pathways (Table 4S2).
In most cases, depletion of MMEJ proteins had little effect on plasmid integration or
expression, possibly because this pathway may be masked by the main repair mechanisms,
especially in the absence of induced DNA damage, as was the case here. Nevertheless, we
did observe some decrease of GFP expression and copy number upon the knock down of
the SD-MMEJ protein DNA polymerase θ (Pol theta) (Fig.4.2A,B). This suggested that
the plasmid concatemerization process may be DNA synthesis-dependent. Interestingly,
we observed an increase in transgene expression and copy number upon the knock-down
of DNA Ligase I (Fig.4.2B), whereas genomic integration of the plasmids was inhibited
(Fig.4.2C). A recent study suggested the existence of two branches of the MMEJ-related
alternative end-joining pathways, one of which may depend on Ligase I whereas the other
would require Ligase III (Fig.1.5) [248, 254]. Upon Ligase I knock-down, the Ligase
III-dependent branch should prevail, which may favor plasmid concatemer formation and
thereby mediate the observed increase of the transgene copy number. In contrast, the
Ligase I knock-down may suppress the other MMEJ-related pathway, thereby preventing
genomic integration of the plasmids. Taken together, the results pointed to a Ligase III-
71
and DNA polymerase θ-dependent mechanism playing a role in plasmid concatemerization,
whereas MDC1, Rad51 and Rad51C may be involved in a Ligase I-dependent pathway
mediating genomic integration.
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Figure 4.2: Effect of MMEJ components knock-down on plasmid genomic integra-
tion and expression. CHO cells were treated with siRNAs against the indicated MMEJ genes
and processed as described in the legend to Fig. 4.1 and in Table 4S2. The average GFP
fluorescence (A), GFP transgene copy number (B), and frequency of genomic integration events
(D) were assessed and represented as in Fig. 4.1 (n≥3).
4.4.3 Plasmid concatemerization relies on an SD-MMEJ path-
way involving DNA polymerase θ and Ligase III
To directly assess whether an MMEJ-related mechanism may mediate plasmid end-joining,
we constructed a MMEJ-specific GFP reporter assay based on analogous principles as for
the HR and NHEJ reporter plasmids used previously. The vector, based on a previously
described reporter sequence [347], contains two 9 nt microhomology sequences bracketing
an I-SceI site which may be used to restore a functional GFP via a MMEJ pathway
(Table 4S3). Upon transfection, the I-SceI-digested vector yielded approximately 50% of
fluorescent CHO cells having successfully reconstituted a functional GFP coding sequence,
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from which circularized plasmids were rescued and sequenced. Interestingly, we observed
that the 9 nt homology was used to restore the functional GFP through MMEJ in only 1
out of the 12 analyzed junctions (Table 4S3, junction 1). Instead, the majority of analyzed
sequences resembled the recently proposed mechanism termed synthesis dependent (SD)-
MMEJ [372]. This pathway is thought to use a non-processive DNA polymerase such
DNA polymerase θ to copy short homologous sequences (2-9 bp) from a different part of
the repaired molecule, which can then be used to pair with the other protruding single
strand [371, 372]. As a result, the junction sequence consists of a short duplication (direct
or inverted) of a sequence found nearby on the repaired DNA fragment. In the remaining
11 cases there was no significant microhomology at the fused sequences, as required by the
MMEJ mechanism, but we identified the direct or inverted repeat sequence which may have
served as template for the DNA synthesis of SD-MMEJ, either upstream or downstream of
the junction (Table 4S3 junctions 2-12). We also concluded that the repaired junctions did
not result from an NHEJ mechanism, as we observed large deletions indicating extensive
DNA end processing, which is not commonly observed in this latter end-joining mechanism.
We therefore concluded that plasmid concatemerization relies mostly on an SD-MMEJ
pathway involving the activities of DNA polymerase θ and Ligase III, and that the simple
MMEJ mechanism is seldom used.
4.4.4 MAR elements promote plasmid integration by stimulat-
ing the SD-MMEJ pathways
We have previously shown that transgene integration in CHO cells is enhanced 3-4 fold in
the presence of matrix attachment regions (MARs), which are DNA elements thought to
be responsible for the formation of chromatin domain boundaries [110, 209]. The action
of MARs to increase both the number of transgene copies as well as the frequency of
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genomic integration events has been previously ascribed to HR-related mechanisms [116].
However, which HR-related recombination mechanism may be activated by MAR elements
has remained elusive, as subsequent whole transcriptome sequencing analysis of the mutant
CHO cell lines used in this prior study revealed alterations in the expression of a number
of DNA repair genes (data not shown).
Thus, to unambiguously identify the recombination mechanism activated by such
elements, we combined the addition of the human MAR 1-68 in the GFP vector with
the siRNA knock down approach used earlier. As shown in previous studies, inclusion of
the human MAR 1-68 in the GFP plasmid enhanced GFP expression and copy number
by approximately 6-fold and 3-fold, respectively, when compared to the MAR-devoid
control plasmid (Fig.4.3A,B). This indicated that the MAR acted to activate the plasmid
concatemerization mechanism, whereas it concomitantly increased expression per gene
copy (Fig.4.3C). The presence of the MAR also increased around 2-fold the proportion of
cells having recombined the transgenes into their genome (Fig.4.3D), indicating that it
also activates the transgene integration process.
In the presence of the MAR, the silencing of NHEJ factors had no effect on transgene
expression or copy number, as before (Fig.4.3A,B). In contrast, the knock-down of many HR
and cell cycle control factors yielded very high transgene expression, but without increasing
further the transgene copy number. Consistently, we observed a significant enhancement
of expression per gene copy upon the knock-down of most HR factors (Fig.4.3C). A strong
inhibition of the frequency of plasmid genomic integration was again noted upon the
knock-down of MDC1 and especially Rad51 in the presence of the MAR (Fig.4.3D). Taken
together, these results indicated that the presence of the MAR and Rad51 inhibition
acted synergistically to promote transgene integration into expression-permissive portions
of the genome by a less prominent DNA repair pathway. We therefore speculated that
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the MAR may act to promote a MMEJ-related pathway that directs transgenes into
expression-favoring chromatin structures.
In the presence of the MAR, the knock-down of MMEJ factors had mostly similar
effects on GFP expression and copy number as observed earlier for the MAR devoid
plasmid, with a decrease upon the knock-down of DNA polymerase θ, and an increase in
the absence of Ligase I (Fig.4.3A,B). However, the presence of the MAR element seemed to
compensate for the effect of Ligase I down-regulation on transgene genomic integration, by
dampening the significant inhibition resulting from the lack of this ligase on the integration
of the MAR-devoid plasmid (Fig.4.3C,D). Taken together, these findings suggested that
the MAR may act to increase the frequency of genomic integration events by promoting
the use of the Ligase I-dependent integration pathway. Overall, we concluded that the
MAR element may activate both concatemerization and genomic integration processes by
stimulating SD-MMEJ related recombination pathways, and that the MAR and SD-MMEJ
pathways may concur to favor integration into expression-permissive genomic loci.
4.4.5 MAR elements and the SD-MMEJ pathway direct trans-
genes into gene-rich chromatin regions
To further assess which of the alternative recombination pathways may mediate favorable
genomic integration events, we analyzed the genomic integration loci and the DNA sequence
of the genome-plasmid junctions. This was performed on three CHO clones transfected
with immunoglobulin expression vectors containing a MAR element, and selected for stable
expression of these therapeutic proteins at high levels. To do so, we sequenced the genome
of the parental CHO-K1 cell line, as well as those of the three clones, and we devised a
software to identify linked DNA sequence reads pertaining either to the plasmid or to
the CHO genome. 6 integration sites in one clone (BS01) and 2 in each of the remaining
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Figure 4.3: Effect of a MAR element and recombination gene knock-down on plas-
mid genomic integration and expression. The effect of the inclusion of a MAR element
on A) stable transgene expression, B) GFP transgene copy number, C) GFP expression per
transgene copy, and D) the frequency of genomic integration events, were assessed as described
for Fig.4.1 and 4.2, except that siRNA-treated cells were re-transfected with the MAR-GFP, or
with the MAR-devoid GFP expression construct, as indicated, and with the puromycin resistance
vector (n≥3).
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two clones (BS03 and Cp33/64), as predicted by the bioinformatics software, were PCR
amplified from the cell genomes, which allowed the experimental validation of their junction
DNA sequences. The occurrence of the predicted number of plasmid integration loci was
also validated by FISH analysis for two of the analyzed clones (Fig.4S4).
From the 5 integration sites where both sides of the genomic junction sequence were
validated experimentally, 2 had large deletions (913bp in BS01 and 320bp in Cp33/64), as
expected from MMEJ-related mechanisms (Table 4S4, and Fig.4S5). In 5 of the 15 validated
junctions, we noted the presence of short (1-3 bp) or long (60-100 bp) templated inserts, as
may be explained by the involvement of a DNA polymerase such as DNA Polymerase θ in
the repair process, pointing to the synthesis-dependent mechanism (Fig.4S6). All analyzed
junction sequences fitted well to the SD-MMEJ model, whereas 3 junctions covered pre-
existing microhomologies extending over 2 nucleotides and thus could be explained equally
well by a simple MMEJ mechanism. Interestingly, we found no integration sites that could
be easily explained by HR. Although NHEJ cannot be fully excluded, as it does not require
homology, the SD-MMEJ mechanism seems more likely due to the presence of extended
deletions and templated inserts in the junctions, and because no junction lacking any
type of microhomology was observed. Overall, these results confirmed that the genomic
integration of MAR-containing plasmids predominantly involves the SD-MMEJ pathway.
The majority of integration sites (8/10) at annotated loci were found within or nearby
expressed genes (7 out of 8; Table 4S4), whereas only 2 were intergenic. We concluded
that most integration events had occurred in expressed chromatin or in the vicinity a
transcriptionally active genomic region. These results further suggested that the MAR-
containing plasmids may preferably integrate within, or in the close proximity of, expressed
CHO genes, providing an explanation for the proposed preferred integration of the MAR-
containing vectors into permissive chromatin structures. To further assess whether this
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indeed resulted from the presence of a MAR element in the immunoglobulin expression
vectors or from the selection of clones having well-expressed transgenes, we determined and
compared the integration loci of the MAR-containing or -devoid GFP expression vectors.
Analysis of the integration sites identified from the whole genome sequencing of
polyclonal CHO populations revealed that, in the presence of the MAR, plasmids often
integrated into the gene-rich areas of the genome (10/14 loci) (Table 4S5, Fig.4S7). This
result was significantly different from random (p=0.05), suggesting that the MAR may
stimulate genomic integration into chromatin regions potentially beneficial for transgene
expression. This effect was further increased when analyzing monoclonal populations of
cells selected to express the transgenes at very high levels, which displayed integration
sites at even closer proximity to CHO genes (Fig.4S7B). This finding implied that the
MAR and proximity to a CHO gene both acted to mediate higher transgene expression.
In the cells transfected with the MAR-devoid plasmid, integration in the vicinity of genes
was less frequent (8/14). Furthermore, it should be noted that these cells required 3-fold
more sequencing reads to identify the same number of integration loci as obtained from
the cells transfected with the MAR, suggesting that genomic integration events were less
frequent without the MAR element. Interestingly, we observed that the integration sites of
the MAR-devoid plasmids were more often located in or within 5kb of cellular genes (7/14
sites), which was significantly more frequent than expected by chance (p=0.02). Moreover,
all of these genes were found to be expressed in the parental CHO cells (Table 4S5, Fig.4S8),
suggesting that in order to survive antibiotic selection in the absence of the MAR, the
cells need to integrate the transgenes into transcriptionally active chromatin regions. This
may readily explain the strong decrease in cell surviving selection upon the knock-down of
Rad51, as this protein was recently reported to be primarily responsible for repairing DSBs
occurring in transcriptionally active chromatin [13]. In contrast, addition of the MAR
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into the plasmid seemed to alleviate this need to integrate into transcribed genes, as only
half of the genes in the vicinity of the integration sites were found to be expressed. This
suggested that the MAR itself may ensure high expression of the transgene, likely due to
its previously reported transcription-enhancing properties [1, 101]. Taken together, these
results suggested that MAR elements may promote transgene integration into gene-rich
chromatin regions by stimulating a Ligase I-dependent SD-MMEJ mechanism.
4.5 Discussion
Eukaryotic cells developed many defense mechanisms to detect and repair DNA double
stranded breaks, one of the most dangerous types of DNA damage. The two canonical
pathways responsible for DSB repair are HR and NHEJ. However, recent evidence has
indicated that these two mechanisms may not be sufficient to repair all the DSBs that arise
in cells, and that several alternative pathways, collectively termed MMEJ or alt-NHEJ, also
exist in eukaryotic cells [108, 328]. These processes are often obscured by the main repair
mechanisms, which may predominate in normal cells. Furthermore, their components
are still poorly characterized and there is no simple assay to specifically detect these
alternative mechanisms, rendering their study difficult. However, they are now attracting
increasing attention, notably in oncology, since these ’illegitimate’ recombination pathways
may be involved in tumor progression and resistance to therapy, as they were shown to
be more prevalent in tumor cells or cell lines defective in the main DSB repair pathways
[23, 323]. They were also identified as a major cause of chromosomal rearrangements
leading to cancer formation [138, 299, 381].
Here, we found that NHEJ and HR are not the main pathways responsible for non-
specific recombination, which may be required for the integration of exogenous DNA in the
genome of CHO cells. Rather, we found that the absence of many HR factors significantly
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augmented plasmid concatemerization, as indicated by the increased number of integrated
transgene copies, implying that HR proteins may compete with one or several other DSB
repair pathways that more efficiently mediate plasmid concatemer formation. In contrast,
specific HR proteins such as the homology-searching Rad51 were required for efficient
transgene recombination with the genome, whereas the silencing of other HR proteins did
not affect genomic integration. This suggested that another mechanism, which is distinct
from the canonical NHEJ or HR pathways but may nevertheless require DNA homology,
was mediating plasmid genomic integration.
Consistently, the knock-down of several genes involved in the SD-MMEJ pathway was
found to alter plasmid genomic integration. This conclusion was also supported by the
finding that the majority of rejoined plasmid extremities displayed microhomology patterns
characteristic of the SD-MMEJ mechanism, as proposed by Yu and McVey [372]. Indeed,
both plasmid-to-plasmid and plasmid-to-genome fusion sequences were also present as
direct or inverted repeats near the junction, and templated inserts occurred occasionally at
the junctions. However, the knock down of specific SD-MMEJ activities had distinct effects
on plasmid concatemer formation and on genomic integration, implying the occurrence
of multiple SD-MMEJ pathways. Taken together, our results imply that concatemer
formation and integration of MAR-devoid plasmids are mediated by different sets of
proteins that may belong to distinct branches of the SD-MMEJ pathways, as proposed
in Figure 4.4. One of the SD-MMEJ pathways, which may rely on polymerase θ and
Ligase III, appears to mediate plasmid concatemerization. This conclusion is supported
by the finding that the knock-down of the components of the HR and of the alternative
SD-MMEJ repair pathways, such as Rad genes and Ligase I, increased the number of
integrated transgene copies, whereas the silencing of DNA polymerase θ decreased it. The
other SD-MMEJ pathway, which may involve the activity of Ligase I, appears to mediate
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the recombination of plasmid concatemer with the genome, as indicated by the finding
that the lack of Ligase I nearly abolished genomic integration.
Interestingly, we observed that the knock down of Rad51 had very similar effects as
the silencing of Ligase I, implying that they contribute to the same pathway mediating
genomic integration of exogenous DNA. The mechanism mediating microhomology search
of the SD-MMEJ pathway remains mostly uncharacterized, but it may involve DSB repair
components that are common to other mechanisms, such as Rad51. In this model, the
Ligase I-dependent SD-MMEJ pathway may lie downstream of the search for a homologous
DNA strand by Rad51, as in the canonical HR pathway (Fig.4.4). However, the lack of
extended sequence similarities may preclude the productive cooperation of Rad51 with
its associated paralog proteins, preventing extended strand invasion and the successful
completion of the HR pathway. End-joining would then rather be performed by the Ligase
I-dependent SD-MMEJ salvage repair pathway, as it only requires short homology regions,
which may be shared by the plasmid and the cell genome. When such microhomologous
sequences are not available, they may be provided by an adaptor DNA stretch copied
from nearby plasmid or genome sequences, leading to the insertion of a templated insert
separating the joined sequences (Fig.4S6). We hypothesize that the enzyme involved in the
synthesis of the templated insert may be DNA polymerase δ, which together with Ligase I
participates in DNA replication and long patch base excision repair (BER) [85, 310]. This
polymerase has been recently implicated in an alternative mechanism of one-ended DSB
repair involving the use of microhomologies and characterized by the similar presence of
templated inserts at repaired junctions [60]. Interestingly, this latter mechanism, while
distinct from HR, also seemed to depend on Rad51.
The proposed existence of two parallel SD-MMEJ repair pathways, with only one
requiring Rad51, points to mechanistic differences. The use of the DNA polymerase
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θ in the Ligase III-mediated pathway may readily explain the lack of requirement for
Rad51, as this low-fidelity translesion DNA polymerase was previously associated with the
annealing of long microhomologous sequences by a Rad51-independent mechanism [47].
Consistent with this, polymerase θ was recently shown to play a role in an alternative
end-joining pathway competing with the Rad51-mediated DSB repair [45]. Conversely,
DNA polymerase δ is a high fidelity polymerase that does not easily switch base pairing
with the replicated DNA template, as it is held at the replication fork by the proliferating
cell nuclear antigen (PCNA) protein. Thus, it may need prior pairing of the DNA strand to
be extended with a nearby repeated sequence by homology searching and strand invasion
proteins such as Rad51, explaining the need for this HR protein in the Ligase I-dependent
SD-MMEJ branch.
Inclusion of a MAR element also increased plasmid concatemerization, suggesting
that it may act to activate the preferential processing of the plasmid ends by the Ligase
III-dependent SD-MMEJ mechanism. Consistently, the knock-down of competing HR
activities did not increase further the copy number of integrated MAR-containing plasmids.
In addition, the presence of the MAR increased genomic integration and it dampened the
inhibitory effect of Ligase I down regulation, whereas it did not abolish the requirement
for Rad51. This finding is consistent with a preferential use of the Ligase I-dependent
SD-MMEJ mechanism by the MAR-containing plasmid for genomic integration.
The molecular mechanism by which MAR elements can promote recombination by
SD-MMEJ mechanisms still remains unknown. MARs contain AT-rich cores which possess
a high potential to denature the double helix [29, 31, 90, 262], which may be prone to
DNA strand invasion. In addition, they were shown to contain topoisomerase II cleavage
sites, suggesting that they may be hot spots of DNA breakage and repair [307]. Finally,
MARs were associated with so-called fragile sites, which are regions of chromosomes with
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Figure 4.4: Revised model of the major eukaryotic DSB repair pathways. A novel
model describing the possible interplay of the NHEJ, HR, MMEJ and two distinct SD-MMEJ
pathways involved in the repair of DSBs in CHO cells is depicted, as modified from Fig.1.5.
Whereas NHEJ proceeds through a ligation step without the need for sequence homology or
DNA end-processing, HR involves extensive DNA 5’ end exonuclease processing (resection), and
it requires a homologous DNA template to complete DSB repair (DSBR) or synthesis-dependent
strand annealing (SDSA). Alternative DSB repair pathways such as MMEJ or the DNA synthesis-
dependent SD-MMEJ, may share the DNA end-resection machinery with HR. These alternative
pathways use short regions of homology (microhomology) to align DNA ends before repair by
flap removal, DNA synthesis and ligation. Whereas the MMEJ pathway utilises pre-exisiting
microhomologies, SD-MMEJ requires a DNA polymerase to amplify the microhomology from a
more distant region of the DNA. Although the junction sequences resulting from both SD-MMEJ
branches are similar, the Ligase I-dependent SD-MMEJ branch requires the homology-searching
Rad51 protein, and it may provide a fallback mechanism when an extensive region of homology
is not available. Activities that may initiate MMEJ and Ligase III-dependent SD-MMEJ remain
to be identified, but the presence or not of a microhomology sequence allowing the pairing of the
3’ protruding strand may dictate the choice between these two pathways.
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high tendency to breakage [143, 267, 316]. Consistently, these sites have been previously
reported to be preferred targets of plasmid integration [270].
MAR elements were also proposed to contribute to the initiation of replication in
mammalian somatic cells [71], and they were also associated with episomal DNA replication
[259], suggesting that the DNA replication machinery might preferentially associate at
or close to MARs. Among the factors participating in replication, several were shown
to be also involved in MMEJ-related mechanisms (e.g. Pold3, Ligase I). Furthermore,
these pathways were reported to be most active during the S phase, suggesting that
they may be one of the the primary mechanisms used for the repair of DSBs arising
during DNA replication [328]. Thus, MAR elements may be preferential sequences of
SD-MMEJ initiation, which would explain their action to increase end-joining by this repair
mechanism. MAR elements are also known to associate with nuclear matrix components
such as SMARCAL1, a SWI/SNF family protein involved in gene expression regulation,
DNA repair and stalled replication fork stabilization [273, 375]. However, whether the
ATP-dependent strand-annealing helicase activity of SMARCAL1 might contribute to the
SD-MMEJ mechanism has remained unexplored, as yet. Thus, additional experiments
will be required to elucidate the possible interaction of MAR elements with components of
the SD-MMEJ repair machinery.
Here, we identify the SD-MMEJ pathway as one of the primary mechanisms driving
exogenous DNA integration in the genome of mammalian CHO cells. We also propose
the existence of two distinct SD-MMEJ subpathways, relying on different subsets of
enzymes. One of these mechanisms, dependent on Ligase III and polymerase θ, seems
to be responsible for plasmid concatemerization. The other pathway, relying on Ligase I,
polymerase δ and HR strand-invasion enzymes, seems to mediate plasmid recombination
with the genome. Moreover, we propose that MAR elements may be able to stimulate
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this latter mechanism to preferentially target plasmid DNA into potentially advantageous,
gene-rich regions of the genome. This knowledge should in the future help to engineer
cells for highly efficient recombinant protein production.
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Figure 4S1: The effect of the siRNA on recombination protein mRNA level. Total
mRNA was extracted from CHO DG44 cells transfected with three negative control siRNAs
(siNeg) or with specific siRNAs targeting the indicated gene. The mRNA level fo the target
was quantified by qPCR (following mRNA conversion to cDNA). Values were normalized to the
target mRNA levels determined from cells transfected with the control siRNAs.
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Figure 4S2: The effect of the siRNA knock-down of recombination proteins on the
protein level. CHO cells were transfected with control (siNeg) or recombination protein-
targeting siRNAs as for Fig.4S1, or left untreated (mock). Total cell extracts were resolved on
SDS-PAGE gel, followed by immunoblotting using apropriate antibodies. Antibodies against
house-keeping genes (GAPDH, β-catenin, Tubulin) were used as loading controls. Immunoblotting
for A) Ku70, B) Rad51, C) 53BP1, and D) Rad51D.
m
oc
k
si
N
eg
si
K
u7
0
si
K
u8
0
si
D
N
A
-P
K
cs
si
Li
gI
V
si
Xr
cc
4
si
53
B
P1
si
M
D
C
1
si
R
ad
51
si
R
ad
51
B
si
R
ad
51
C
si
R
ad
51
D
si
Xr
cc
2
si
Xr
cc
3
si
R
ad
52
si
R
ad
54
si
Li
ga
se
 I
R
el
at
iv
e 
nu
m
be
r o
f G
FP
+ 
ce
lls
0.0
0.5
1.0
1.5
2.0
HR episomal assay
**
A
m
oc
k
si
N
eg
si
K
u7
0
si
K
u8
0
si
D
N
A
-P
K
cs
si
Li
gI
V
si
Xr
cc
4
si
53
B
P1
si
M
D
C
1
si
R
ad
51
si
R
ad
51
B
si
R
ad
51
C
si
R
ad
51
D
si
Xr
cc
2
si
Xr
cc
3
si
R
ad
52
si
R
ad
54
si
Li
ga
se
 I
R
el
at
iv
e 
nu
m
be
r o
f G
FP
+ 
ce
lls
0.0
0.5
1.0
1.5
2.0
NHEJ episomal assayB
Figure 4S3: The effect of the siRNA knock-down of HR and NHEJ proteins on HR
and NHEJ-mediated plasmid DSB repair. Cells left untreated (mock), transfected with
control (siNeg) or recombination protein-targeting siRNAs as for Fig.4S1, and re-transfected
with A) the HR reporter plasmid, or B) the NHEJ reporter plasmid. Percent of GFP-positive
cells was normalized to the percent of dsRed-positive cells. Bars represent mean fold change
over mock control. Mean of 3 experiments, error bars show s.e.m. Asterisks show significant
differences between siRNA-treated samples and untreated (mock) control. Statistical signicance
determined by unpaired Student’s t-test with Benjamini-Hochberg correction; signicance level
p<0.05 (*) and p<0.01 (**).
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Figure 4S4: FISH analysis and karyotype of CHO-K1 cells. FISH on two CHO-K1
clones: A) BS01, and B) BS03. FISH was performed using probes targetting the vectors used to
generate each clone. Chromosomes were counterstained with DAPI. Arrows point to the location
of the transgene integration sites. A commercial analysis of the BS01 clone was also performed
(200 nuclei analyzed; data not shown) giving a similar result. C) Quantification of integration
site loci in analyzed chromosomal spreads. D) The karyotype of the CHO-K1 cells with total of
20 chromosomes (D. Martinet , Cytogenetics Lab , University Hospital, Lausanne ). Metaphase
chromosome spreads were stained with Giemsa. The normal hamster chromosomes are on top,
followed by the Z group, derivative (der), and marker chromosomes (mar).
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Figure 4S5: Example of a plasmid-to-genome junction and underlying SD-MMEJ
mechanism. P1/P2– primer repeats, mh1/mh2 – microhomology repeats. Adapted from [372].
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...CTGTCTCTACTAAAAATACAAAAATTAGCCAGGTGTGTCGAATGGACAACCCGAGAATAACTATAAGACGACGCC	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Figure 4S6: Example of a plasmid-to-genome junction and SD-MMEJ mechanism
requiring a templated insertion. A) A scheme showing the mechanism of plasmid (dark
green) joining with the genome (blue). Another fragment of the plasmid (light green) serves as
an adaptor providing microhomlogies required for joining and becomes incorporated into the
junction as a templated insert. B) Sequences of plasmid and genome fragments shown in A.
P1/P2 and P3/P4 – primer repeats, mh1/mh2 and mh3/mh4 – microhomology repeats.
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Figure 4S7: Analysis of plasmid integration loci in cells transfected with vectors
containing or not a MAR. A) Plot of distances between the integration loci and the nearest
CHO gene. Black lines indicate the median values. ‘Sample’ indicates sequenced genomic
intergation sites in the samples, and ‘Control’ the control dataset of integration sites inserted at
similar positions into randomly chosen scaffold of similar length. B) The relationship between the
distance from the nearest gene and p-value was determined by an exact binomial test between
each sample set and the corresponding control set. Samples represent integration loci from a
polyclonal population of CHO cells transfected with the GFP plasmid without the MAR (GFP)
or with the MAR (MAR), and stable high expressing CHO clones transfected with plasmids with
the MAR (MAR clones). Asterisks indicate significant differences; p≤0.05 (*), p≤0.01 (**).
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Figure 4S8: The expression of CHO genes in the proximity of transgene integration
loci. The level of CHO gene expression, represented as reads per kilobase per million of mapped
reads (RPKM), was assessed based on transcriptome sequencing of the parental CHO cells. Black
lines indicate the median values. GFP: polyclonal cells transfected with the GFP plasmid without
the MAR, MAR: polyclonal cells transfected with the MAR-containing plasmid, MAR clones:
highly expressing selected CHO clones transfected with a MAR-containing plasmid.
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Table 4S1: List of HR and NHEJ targets for siRNA knock-down.
Pathway Target References
NHEJ Ku70/Ku80 [343]
DNA-PKcs [4, 84, 300]
LigIV [63]
Xrcc4 [63, 185]
53BP1 [361]
HR MDC1 [202, 309, 361, 379]
Rad51 [9, 19, 22, 341]
Rad51B, Rad51C,
Rad51D, Xrcc2, Xrcc3
[44, 192, 196, 217,
261, 315, 320]
Rad52 [336, 337, 92]
Rad54 [88, 126]
Brca1 [61, 368]
Bard1 [358]
Brca2 [68, 92, 194, 233, 368]
MRN (MRX in yeast) [308]
CtIP [285, 370, 373]
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Table 4S2: List of MMEJ targets for siRNA knock-down.
Target References
MRN (MRX in yeast) [73, 83, 184, 204, 380]
CtIP [347, 374]
PARP1 [12]
Ercc1/Xpf (Rad1/Rad10 in
yeast) [184, 204]
Ligase I [62, 187, 248, 254]
Ligase III (absent in yeast) [12, 73, 187, 248, 254]
Xrcc1 (absent in yeast) [73]
POLD3 (POL32 in yeast) [60, 184]
Polymerase theta (POLQ)
(absent in yeast) [168, 372, 160]
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Table 4S3: Sequences of plasmid-to-plasmid junctions.
original 
vector 
CGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
Junction 
#1 
CGGCAACTACAAGACCCGCGCCGAG---------------------------GTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
original 
vector 
TCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAG
TAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCA 
Junction 
#2 
TCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAG---------------------------------------------------
----------------------------------------------------------GCATCGAGCTGAAGGGCATCGACTTCA 
original 
vector 
CGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACT 
TCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAG
TAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCA 
Junction 
#3 
TCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAG---------------------------------------------------
----------------------CCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCA 
original 
vector 
TCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTAC
CCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGA
CGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
Junction 
#4 
CGGCAACTACAAGACCCGCGCCG------------------------------------------------------TGAACCGCA 
original 
vector 
CAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCG
AGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATTCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATC
ATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGGGGACGGCAGCGTGCAGCTCGCCGACCA
CTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTACCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAG
ACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAG 
Junction 
#5 
CAACTACAAGACCCGCG---------------------ATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCG 
original 
vector 
CAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGC
AGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACC
ATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGA 
Junction 
#6 
ATCTTCTTCAAGGACG------------------------------------------------------TGAAGTTCGAGGGCGA 
original 
vector 
CGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
Junction 
#7 
CGGCAACTACAAGACCCGCGCCGAGT-----------------CGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
original 
vector 
TGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTAC
AAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA
GGGCATCGACTTCAAGGAGGACGGCAACATTCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCG
ACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAG 
Junction 
#8 
TGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAA------------------------------------------------
---------------------------------CGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA 
original 
vector 
CCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGC 
Junction 
#9 
CCCGC-----------------------------------------------------CCTGGTGAACCGCATCGAGCTGAAGGGC 
original 
vector 
GACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCG 
AAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGC
GCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGG 
Junction 
#10 
AAGGCTACGTCCAGGAGCGCACCATCTT----------------------------------------------------------
-----------------------------------------------------------CTTCAAGGAGGACGGCAACATCCTGGG 
original 
vector 
CCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCA
ACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAG
CTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCAT 
Junction 
#11 
CCACATGAAGCAGCACGACTTCTTCAAGTCCGCCAT--------------------------------------------------
-----------------------------------------GCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAG 
original 
vector 
CCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGA
AGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTG
GAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAA
CATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACC
ACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCC 
Junction 
#12 
CCAGGAGCG----------------------------------------------------------------CGCGCCGAGGTGA 
Note: The I-Sce1 cleavage site and microhomology (mh) sequences of the original vector are indicated by red and blue
letters, respectively. The microhomologies of the SD-MMEJ model are underlined in the experimental junctions and
original vector. The "–" signs indicate deleted bases at the junctions.
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Table 4S5: Analysis of plasmid integration sites in cells transfected with vectors
with or without the MAR element.
Sample1 Integrationwithin genes2
Integration near
genes3
Expressed
genes4
Polyclonal population
without MAR 7/14 (*)
5 8/14 8/8
Polyclonal population
with MAR 6/14 10/14 (*) 5/10
High expressing clones
with MAR 6/10 (**) 8/10 7/8
1 Polyclonal populations of CHO cells transfected with GFP or MAR-GFP plasmids were sequenced by high-throughput
sequencing (Pacific Biosciences) and plasmid-to-genome junctions were predicted using bioinformatics tools. Integration
sites in high expressing CHO clones transfected with MAR-containing plasmids were PCR-amplified and sequenced using
Sanger sequencing.
2 integration locus inside or within 5kb from a gene
3 integration locus within 35kb from a gene
4 number of expressed genes in the neighborhood (within 35kb) of the integration locus
5 Statistical significance calculated between each sample set and the corresponding control set using an exact binomial
test. Significance levels p≤0.05 (*), p≤0.01 (**).
98
Chapter 5
Polymerase θ stimulates DSB repair by a MMEJ
mechanism involving long DNA end resection
This chapter is based on a manuscript in preparation entitled "Polymerase θ stimulates
DSB repair by a MMEJ mechanism involving long DNA end resection" by Kostyrko, K.,
Mermod, N.
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5.1 Abstract
DNA double stranded breaks (DSBs) are one of the most deleterious type of DNA lesions.
The main pathways responsible for repairing these breaks in eukaryotic cells are homologous
recombination (HR) and non-homologous end-joining (NHEJ). However, it is becoming
increasingly clear that a third group of still poorly characterized DSB repair pathways also
exists in cells. These mechanisms are collectively termed microhomology-mediated end
joining (MMEJ), highlighting their main feature, i.e. the use of short homologies in the
end-joining process. Here, I constructed GFP reporter assays to characterize two variants
of these alternative pathways – simple MMEJ and synthesis-dependent (SD)-MMEJ. The
use of these assays in Chinese hamster ovary (CHO) cells demonstrated that while MMEJ
is able to mediate relatively efficient DSB repair if longer (9 bp) microhomologies are
present, the majority of DSBs are repaired using the highly error-prone SD-MMEJ pathway.
I also performed siRNA knock-down of different genes proposed to play a role in MMEJ.
The depletion of most of these factors did not influence the relative efficiencies of the
different end joining pathways. However, the knock-down of polymerase θ inhibited DNA
end resection and repair through simple MMEJ in favor of other end-joining pathways.
This suggested that this enzyme may be important for MMEJ, while DNA synthesis in
SD-MMEJ may be mediated by a different low fidelity polymerase.
100
5.2 Introduction
During their lifetime cells constantly face DNA damage caused by byproducts of normal
metabolic processes or exogenous factors, such as chemical agents or ionizing radiation
(IR). One of the most deleterious types of DNA damage are double-stranded breaks
(DSBs), which can cause problems during replication and transcription, or lead to the
loss of chromosome fragments. Eukaryotic cells possess many mechanisms to sense and
repair these types of breaks. The two major pathways responsible for DSB repair are
non-homologous end-joining (NHEJ) and homologous recombination (HR) [212]. These
two mechanisms compete for broken DNA ends in the cell, and the choice between them
is made depending on the type of the DSB and the phase of the cell cycle. NHEJ, the
main pathway used in higher eukaryotes, is active throughout the cell cycle. It is a fast
process, which very efficiently repairs easily ligatable DSBs. In contrast, HR is a much
more complex mechanism, active mainly in the late S and G2 phase of the cell cycle. HR is
considered an error-free pathway as it can repair very complicated DSBs with high fidelity.
However, it requires extensive DNA end processing and a homologous DNA molecule as a
template.
In recent years it became apparent that a third mechanism of DSB repair also exists
in eukaryotic cells [21, 346]. This pathway, in normal cells masked by the main repair
processes, has many names: alternative end-joining (alt-EJ), alternative or backup NHEJ
(alt-NHEJ, a-NHEJ, B-NHEJ), or microhomology mediated end-joining (MMEJ) [12, 28,
73, 108, 254, 346]. It is still unclear whether it comprises one or more different mechanisms.
There seems to be no unanimous view on the subject, as reflected by the ambiguous
nomenclature. Here I will refer to these pathways collectively as MMEJ, to underline their
common feature, i.e. the use of very short 2-25 nt homologies in the alignment of the
broken ends before joining.
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Many fundamental findings on the functioning of the DSB repair pathways have been
made using in vivo plasmid end-joining assays. These assays are most commonly based on
the reconstitution of a functional reporter gene by one of the DSB repair mechanisms after
the induction of a break in a nonfunctional substrate. Many such assays were constructed to
investigate NHEJ and HR in various types of cells [18, 122, 171, 212, 266, 279, 290, 291, 380],
and recently also MMEJ [248, 328, 347]. However, with a growing number of new studies
reporting mechanistically distinct MMEJ pathways, the need arises for new, more specific
assays to distinguish between these pathways.
Here, I sought to design a GFP-reconstitution assay to measure synthesis-dependent
(SD)-MMEJ, one of the MMEJ variants, recently proposed by Yu and McVey [372]. Both
MMEJ and SD-MMEJ start with the 5’ to 3’ end resection [328, 372], similarly to HR, but
diverge in later steps. Repair is carried out by MMEJ if the resulting ssDNA overhangs
contain short regions of homology, which can pair together to mediate alignment of the two
sides of the DSB. However, if the extensive resection fails to expose any microhomologies,
the MMEJ machinery may be unable to re-join the two ends. Moreover, the presence of
long ssDNA overhangs precludes the use of the NHEJ pathway, which cannot process these
types of substrates [234, 383]. The SD-MMEJ model offers a solution in such situations.
In this mechanism, a non-processive DNA polymerase copies a sequence from up- or
downstream of the break, which subsequently serves to align the two sides of the break
enabling the continuation of the MMEJ pathway.
Here, I attempted to construct an SD-MMEJ assay and compared it with a previously
published reporter designed to measure simple MMEJ, where the rejoining of a functional
GFP sequence by either mechanism can be followed by flow cytometry [347]. While MMEJ
seemed to be more efficient in reconstituting the GFP sequence, sequencing analysis
revealed that the repaired DNA junctions extracted from GFP-positive cells resulted from
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both types of mechanisms, although SD-MMEJ was more frequently used than simple
MMEJ. This suggests that SD-MMEJ, while error-prone, is a very robust mechanism able
to repair difficult, incompatible DSBs without any need for pre-existing homology. When
combining the MMEJ assay with siRNA knock-down of genes involved in alternative end-
joining pathways, I observed that the depletion of polymerase θ decreased the efficiency of
MMEJ in favor of NHEJ and SD-MMEJ. These results are in contrast with previous reports
implicating this polymerase in the SD-MMEJ pathway, indicating that the SD-MMEJ
mechanism may rely on the activity of more than one DNA polymerase.
5.3 Materials and Methods
Cell culture
Adherent CHO DG44 cells [333] were cultivated in DMEM/F12+GlutaMAXTM sup-
plemented with 1x HT and 10% fetal bovine serum (Gibco, Invitrogen), and with the
antibiotic-antimycotic solution (Sigma-Aldrich, #A5955).
Construction of the recombination assays
The MMEJ and SD-MMEJ reporter cassettes were constructed by interrupting the GFP
coding sequence present in the pSV40-GFP plasmid (described previously [116]) with
restriction sites. The MMEJ vector was based on a previously described reporter [347].
Briefly, a naturally occurring 9b sequence (CGCGCCGAG) was duplicated and an 18bp
I-SceI recognition site was inserted in between the two copies of the sequence. Two in
frame stop codons present in the inserted sequence prevent the expression of a functional
GFP from the intact vector. Digestion with I-SceI linearizes the vector and creates a DSB
with 3’ overhangs.
Two SD-MMEJ reporter cassettes were designed using microhomologies already present
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in the GFP sequence. In the first assay (SD-MMEJ-1) the two 5bp microhomologies
(CGAGG) are 7bp apart. In the second assay (SD-MMEJ-2) the two 7bp microhomologies
(CCACCCT) are 5bp apart. To enable the formation of DSBs with 5’ incompatible
overhangs and prevent re-ligation upon digestion, two restriction sites (separated by 3
bp) were introduced into each vector inside one of the microhomologies. SpeI and AflII
recognition sites were used in SD-MMEJ-1, and AflII and EcoRI in SD-MMEJ-2. In
both cases, in-frame stop codons are present inside the restriction sites to prevent GFP
expression from the intact vectors.
Transfection and FACS analysis
MMEJ and SD-MMEJ plasmids were digested with the appropriate restriction enzymes
(New England Biolabs) for 5h and purified by ethanol precipitation. Aliquots were ana-
lyzed by gel electrophoresis to confirm complete digestion. CHO cells were transfected
with the linearized plasmids, and with the pGL3-CMV-dsRed plasmid, to normalize for
transfection efficiency, using Fugene 6 according to manufacturer’s instructions (Promega).
The pSV40-GFP vector (pGFP) was transfected in parallel as a positive control of GFP
expression. Expression of GFP and DsRed was monitored by fluorescence microscopy
(Carl Zeiss Microscope Axio Observer.A1) and flow cytometry. For flow cytometry cells
were harvested 24h following transfection and resuspended in 0.5 ml of PBS with 2% FBS
(Gibco, Invitrogen). Data was acquired using the CyAn analyzer (Beckman Coulter) and
analyzed using the FlowJo software (Tree Star). GFP repair efficiency was calculated as a
ratio of GFP-positive cells over the number of dsRed-positive cells.
Junction sequence analysis
For the analysis of junction sequences, CHO cells were transfected with the MMEJ and
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SD-MMEJ vectors but without the pGL3-CMV-dsRed plasmid, using Fugene 6 according
to manufacturer’s instructions (Promega). After 24h cells were harvested and GFP-positive
cells were sorted by FACS (MoFlo Astrios Cell Sorter, Beckman Coulter). Total DNA was
isolated using the DNeasy Blood & Tissue Kit (Qiagen). GFP sequences were amplified
by PCR using primers GFP-NcoI-F1 (ATTCCGGTACTGTTGGTAAAGCCACCA) and
GFPp2-Rev (TGTATCTTATCATGTCTGCT). PCR products were cloned into the NcoI
and XbaI-cleaved pSV40 vector. Ligation mixtures were transformed into recombination
deficient E. coli cells (XL10-Gold Ultracompetent Cells, Stratagene) and plated on LB and
ampicillin plates. Colonies were picked and analyzed by colony PCR for the presence of the
insert using primers GFP-NcoI-F1 and SV40_lateR (TCCAAACTCATCAATGTATC).
Plasmids isolated from positive clones were sequenced by Sanger sequencing.
siRNA and transfections
Small interfering RNA duplexes were specifically designed to target the Chinese hamster
homologs of DNA-PKcs, Ku70, Ligase I, Ligase III, polymerase θ and Pold3. The siRNAs
were designed and provided by Microsynth AG (Balgach, Switzerland). Three RNA
duplexes were designed per mRNA to increase the probability of successful knock-down.
Three negative (non-targeting) siRNAs were also designed as controls. For siRNA-mediated
knock-down, CHO-DG44 cells were transfected with equimolar amounts of three targeting
or non-targeting siRNA duplexes at a final concentration of 50nM using Lipofectamine
RNAiMAX, according to the manufacturer’s instructions (Invitrogen). After two days, the
siRNA-treated cells were re-transfected with the pre-digested MMEJ vector using Fugene
6 (Promega). GFP-positive cells were sorted and junctions amplified and sequenced as
described above.
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5.4 Results
5.4.1 CHO cells restore GFP expression more efficiently from
the MMEJ than the SD-MMEJ reporters
To measure the efficiency of extrachromosomal MMEJ and SD-MMEJ in mammalian cells,
I constructed GFP reporter assays aimed at specifically detecting these pathways. The
MMEJ repair substrate contains two 9bp microhomologies flanking the I-SceI restriction
site (Fig.5.1A). After I-SceI digestion and end-resection, annealing at these microhomolo-
gies should enable the restoration of a functional GFP coding sequence (Fig.5S1). Two
versions of the SD-MMEJ reporter were constructed, differing in size of microhomologies
and distance between them. They contain a GFP sequence interrupted by two tandem re-
striction sites, which serve to create a DSB with non-complementary 5’ overhangs (Fig.5.1B,
5S2, 5S3). Since there are no extended microhomologies in the sequence surrounding the
break, they should be amplified from another fragment of the vector by a DNA polymerase,
as illustrated in the SD-MMEJ mechanism shown on Fig.4S5. In the two substrates the
potential ’primer’ sequences (P1 and P2), as well as the microhomology (µ1), which needs
to be amplified to properly align the two broken ends, are located on one side of the DSB.
The use of these direct repeats should enable the restoration of a functional GFP sequence.
The linearized vectors were transiently transfected into CHO cells and the appearance
of GFP-positive cells was analyzed by flow cytometry. Over 50% of cells transfected
with the MMEJ reporter were able to reconstitute a functional GFP coding sequence
(Fig.5.2). In contrast, only approx. 9% of the cells transfected with one of the SD-MMEJ
assays (SD-MMEJ-1) successfully repaired the GFP gene. The second SD-MMEJ reporter
(SD-MMEJ-2) yielded only a few GFP-positive cells (approx. 0.5%). The difference
in efficiency between the two SD-MMEJ constructs could result from the choice of the
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microhomology repeats
primer repeats
promoter
restriction site
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μμSV40
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SpeI / AII
p2SV40 μ1 μ2p1
μ1 μ2
AII / EcoRI
p1 p2
Figure 5.1: GFP-reconstitution reporter cassettes for detection of simple MMEJ
and SD-MMEJ. A) MMEJ reporter, B) SD-MMEJ reporter. Description and abbreviations in
text.
restriction enzymes used to generate the break or from the two ’primer’ sequences not
being spaced far enough in the second assay (Fig.5S2, 5S3).
These results suggested that the MMEJ mechanism is more efficient than SD-MMEJ
pathway, possibly because of the presence of pre-existing, relatively long (9bp) microho-
mologies, which may provide a greater chance of successful GFP reconstitution. In contrast,
the lack of homology in the SD-MMEJ assays may force the repair machinery to copy the
microhomology from a more distant region of the plasmid, which may not necessarily lead
to the reconstitution of a functional GFP. To ultimately verify if all the reporter cassettes
were repaired as expected in CHO cells, and to unambiguously identify the mechanisms
used, I sequenced the reconstituted plasmids isolated from the GFP-positive cells.
5.4.2 MMEJ and SD-MMEJ reporters are more frequently re-
paired by the SD-MMEJ pathway
The sequences of 12 junctions were obtained from cells transfected with the MMEJ vector
and 5 and 4 junctions from cells transfected with either the SD-MMEJ-1 or the SD-MMEJ-2
vector, respectively. The sequences were then analyzed for the presence of microhomologies,
deletions and potential primer/microhomology pairs in the vicinity of the junction. The
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Figure 5.2: Frequency of GFP reconstitution from the MMEJ and SD-MMEJ assays
in CHO cells. Cells were transfected with a control GFP plasmid (GFP), non-digested (circ) or
linearized MMEJ or SD-MMEJ reporters (lin). Percentages of GFP-positive cells are shown with
respect to cells transfected with the control plasmid (shown as 100%). Mean of 3 experiments,
s.e.m. error bars.
presence of limited sequence loss (0-6bp) and a lack of microhomology was interpreted as
the result of the NHEJ mechanism. Junctions showing evidence of long end-resection (>6
bp), with at least 2 bp of pre-existing microhomology, were classified as simple MMEJ
products. If these short homologous sequences were absent, I searched for ≥ 2bp + ≥ 2bp
direct or inverted repeats up- or downstream of the junction, as well as for the presence of
templated inserts, which are hallmarks of the SD-MMEJ pathway.
Analysis of all the sequenced repair products revealed that the majority (60-75%) of
the junctions from cells transfected with both types of assays must have resulted from the
SD-MMEJ mechanism (Table 5.1, 5S1). The MMEJ mechanism seemed to account for only
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25-40% of all the junctions analyzed, despite the presence of the 9 bp microhomology region
in the vicinity of the cleavage site. Surprisingly, I did not observe any repair products that
could be unambiguously attributed to the NHEJ pathway. These results indicate that
not only the SD-MMEJ pathway is more efficient than simple MMEJ, but also that the
appearance of GFP fluorescence in these kind of reporter assays cannot be used as a sole
determinant of repair efficiency. Therefore, sequencing of the repaired junctions should
always be used to reliably estimate the true efficiency of end-joining mechanisms in the
cells.
Table 5.1: Analysis of the sequenced repair products.
Reporter Repair mechanism
number of
junctions (%)
Deletion size1 [bp] Pre-existing
microhomology
size [bp] (number
of junctions)
Primer repeat [bp]
+ microhomology
[bp] (number of
junctions)
MMEJ SD-MMEJ
MMEJ 3 (25%) 9 (75%) 17, 21, 27, 53, 54,
54, 64, 73, 81, 91,
109, 117
9 (2), 3 (1) 2+2 (2), 3+2 (2),
2+3 (3), 3+3 (1),
2+4 (1)
SD-MMEJ-1 2 (40%) 3 (60%) 10, 20, 30, 71, 103 9 (1), 4 (1) 2+3 (2), 4+2 (1)
SD-MMEJ-2 1 (25%) 3 (75%) 24, 48, 52, 76 3 (1) 3+2 (1), 2+4 (1),
3+4 (1)
1 Size of the sequence missing from the reporter construct after repair. Deletions are ordered from smallest to largest.
A deletion of 27bp would be expected from the MMEJ mechanism using the 9bp microhomology on its cognate assay
plasmid.
Out of the 6 MMEJ-type junctions obtained from all assays, half occurred at 9 bp
microhomologies (Table 5S1). In the 3 remaining cases, 3 bp and 4 bp of homology
were used for alignment. This indicated that the MMEJ mechanism shows a preference
for longer microhomologies. Interestingly, out of all the sequences obtained from cells
transfected with the MMEJ reporter, only one contained a GFP sequence successfully
reconstituted using the preset 9 bp microhomology (Table 5S1, junction #4). This may
suggest that precise, error-free repair events of the most proximal microhomology domains
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correspond to a very low percentage of all events.
In contrast, none of the SD-MMEJ constructs was repaired using the designed mi-
crohomologies, even though the SD-MMEJ mechanism often relied on 5bp (2 + 3 bp)
microhomology sequences (8/15 of SD-MMEJ-like junctions), as in the SD-MMEJ-1 assay
(Table 5.1, Tables 5S1 and 5S2). In most cases (9/15) the ’primer’ sequence was 2 bp
long and the amplified microhomology used for bridging the breaks was 2 bp (6/15) or
3 bp (6/15) long. This suggested that even very short sequences can serve as starters
for the SD-MMEJ DNA polymerase, making this process very robust in repairing breaks
completely devoid of extended microhomology. This, however, likely entails poor repair
fidelity, consistent with the low frequency of successful GFP reconstitution events from
the SD-MMEJ reporters.
Interestingly, the repair of the MMEJ cassette was accompanied by larger deletions
than the SD-MMEJ assays (Table 5.1, Fig.5.3). The deletions in the MMEJ reporter
plasmid were on average 16 and 13 bp longer than in the SD-MMEJ-1 and SD-MMEJ-2
plasmids, respectively. This difference almost exactly reflects the difference between the
5’ protruding ends in the SD-MMEJ vectors and recessive 5’ ends in the MMEJ vector
(∆=16 bp), suggesting that the extent of the 5’ to 3’ end resection was similar for all three
constructs. I concluded that all the reporter constructs can be used to study both types
of repair mechanisms.
Taken together, these results indicate that, while the simple MMEJ pathway is poten-
tially more precise if larger homologies are present, the SD-MMEJ pathway seems to be
much more frequently used. I hypothesize that the SD-MMEJ mechanism plays a role of
a salvage repair pathway when other mechanisms have failed.
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Figure 5.3: The distribution of deletion sizes in junctions from cells transfected
with the MMEJ, SD-MMEJ-1 and SD-MMEJ-2 reporters. Black lines represent mean
deletion sizes.
5.4.3 Depletion of polymerase θ inhibits DNA end resection and
repair through MMEJ in favor of other end-joining path-
ways
I next used the above described strategy to assess the relative efficiency of MMEJ and
SD-MMEJ pathways in cells depleted of factors thought to be implicated in these processes.
I therefore used short interfering RNA (siRNA) to knock-down Ligase I, Ligase III, DNA
polymerase θ and DNA polymerase δ subunit 3 (Pold3), all of which were previously
reported to play a role in alternative DSB repair pathways [47, 60, 184, 187, 248, 254, 371].
I also used siRNAs against two NHEJ genes – Ku70 and DNA-PKcs, and a non-targeting
control siRNA. The decrease in the target mRNA levels upon siRNA treatment was verified
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by real-time PCR (Fig.5S4). Since the reporter vectors did not seem to significantly differ
in the relative frequency of the MMEJ and SD-MMEJ mechanisms, I applied only the
MMEJ reporter, as it allows for higher recovery of GFP-positive cells.
Surprisingly, in cells transfected with the control siRNA, the frequency of MMEJ-
attributed repair (60%) was higher than that of SD-MMEJ (30%) (Fig.5.4A, Table 5S2),
which contrasted with the results obtained in untreated cells. This suggested that the
siRNA transfection alone could alter the frequency with which the two pathways are used.
I also observed some junctions that could only be attributed to the NHEJ mechanism
(10%). Similar repair patterns were observed in cells depleted in Ku70, DNA-PKcs,
Ligase I and Pold3, indicating that these factors may not be essential for the repair of
extrachromosomal DSBs. However, it should be noted that the knock-down of DNA-PKcs
and Ku70 increased the number of GFP-positive cells about 2-fold (data not shown), in
line with the view that alternative end-joining pathways are more active when NHEJ
is disabled [28, 72, 152, 186]. Moreover, DNA-PKcs-depletion slightly increased the
number of junctions repaired with the MMEJ mechanism. Interestingly, the knock-down
of polymerase θ significantly decreased the frequency of simple MMEJ (to 20%), in favor
of NHEJ (to 30%) and SD-MMEJ (to 50%), suggesting that it plays an important role in
the first pathway. This may also indicate that another low fidelity DNA polymerase is
used in SD-MMEJ when polymerase θ is absent. An increase in SD-MMEJ repair was
also noted in cells depleted of Ligase III, although in this case the frequency of MMEJ did
not change.
The analysis of deletion sizes in the recovered junctions demonstrated that loss of
polymerase θ led to a decrease in medium-sized deletions in favor of very short ones
(Fig.5.4B, Fig.5S5), consistent with the increased usage of the NHEJ pathway. This
potentially indicates that the lack of this polymerase may limit DNA end resection. The
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number of large deletions was decreased in favor of medium-sized deletions in the absence
of Ligase I and III, suggesting that lack of these ligases may also lead to the repair processes
that limit resection, but to a lesser extent.
In summary, it seems that polymerase θ mediates DSB repair by a MMEJ mechanism
involving long DNA end resection process, as the depletion of this enzyme seems to result
in an increased usage of the other end-joining pathways, i.e. NHEJ and SD-MMEJ. I
hypothesize that polymerase θ-independent SD-MMEJ may rely on a different low fidelity
enzyme.
5.5 Discussion
DSBs are potentially genotoxic DNA lesions, which need to be efficiently repaired by the
cells to prevent chromosomal aberrations or serious DNA damage, leading to carcinogenesis
or even cell death. The two major pathways responsible for DSB repair in eukaryotes are
HR and NHEJ. However, in recent years it became apparent that these mechanisms are
assisted by a family of alternative DSB repair pathways, collectively termed MMEJ. These
mechanisms are thought to come into play when the main repair pathways are insufficient
to repair all the breaks that arise in cells. This is often the case in cancer cells, which
suffer from high levels of oxidative stress [193, 318]. Indeed, many reports show that such
alternative MMEJ-like DSB repair pathways are more active in tumor cells [23, 323].
Studies of these alternative repair mechanisms advanced largely due to the development
of plasmid recombination assays, which allow to measure the efficiency of end-joining in
the cells. These assays are often based on transiently transfected or genome-integrated
reporter substrates, in which DSBs are induced by restriction enzymes. Restoration of
reporter gene expression serves to assess the efficiency of DSB repair. In addition the
structure of the repaired products is often verified by sequencing.
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Figure 5.4: The frequency of DSB repair mechanisms and deletion sizes in cells
transfected with MMEJ and SD-MMEJ reporters. A) The frequency of DSB repair
with NHEJ, MMEJ and SD-MMEJ mechanisms in cells depleted in NHEJ or MMEJ genes.
Statistical significance was calculated using the exact binomial test. Asterisks indicate significant
differences between the siRNA treated sample and control treated with a non-targeting siRNA
(siNeg), significance level p<0.05. B) The sizes of junctional deletions in siRNA-transfected cells.
Deletions in the sequenced MMEJ reporter junctions were classified as short (0-6bp), medium
(7-27bp) or large (>27bp).
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Here, I constructed two GFP reporter substrates to study a recently proposed subpath-
way of MMEJ, termed SD-MMEJ. I also compared my two constructs with a previously
described MMEJ reporter cassette. These experiments demonstrated that the MMEJ
reporter, transiently transfected in CHO cells, yielded higher numbers of GFP-positive cells
than the two SD-MMEJ reporters, likely due to the presence of longer microhomologies.
However, sequencing of the repaired junctions revealed that while evidently less accurate
and less likely to yield a functional GFP coding sequence, the SD-MMEJ mechanism is
more frequently used by the cells. Therefore, I hypothesize that the availability of homology
at the break site determines the pathway used for repair. If the DSB contains blunt or
compatible cohesive ends, an apparently rare situation, they can be easily ligated by the
NHEJ machinery (Fig.5.5). However, if the breaks are not compatible, extended 5’-3’ end
resection creates long ssDNA overhangs, which can anneal at pre-existing microhomologies,
enabling repair by MMEJ. In the absence of homology at the break site, the SD-MMEJ
mechanism can amplify the microhomology needed for alignment from another part of
the repaired molecule. In conclusion, the SD-MMEJ pathway seems to be a very robust
mechanism able to repair incompatible DSBs when other end-joining pathways fail.
I also analyzed the frequency of different DNA end-joining pathways in CHO cells
depleted in important NHEJ and MMEJ factors. Out of the siRNAs tested, only the
knock-down of polymerase θ significantly affected DNA end-joining in this transient assay.
Interestingly, depletion of this enzyme resulted in decrease of MMEJ repair in favor of
NHEJ and SD-MMEJ, indicating that polymerase θ may be especially important for this
former pathway. These results are in line with the proposed role of this polymerase in
MMEJ [45, 160, 168, 218]. While the increase in SD-MMEJ is inconsistent with previous
reports assigning polymerase θ to this pathway [47, 372], it may be explained by the
participation of other DNA polymerases in this process, e.g. translesion synthesis (TLS)
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Figure 5.5: The model of DSB end-joining repair.The proposed model of DNA end-
joining pathways in eukaryotic cells. The structure of the break and the availability of homology
determine the repair mechanism.
or replication enzymes. Indeed, yeast homologs of TLS polymerases η and ζ (Rad30 and
Rev3) as well as Pold3 (Pol32) were also reported to play a role in alternative DSB repair
pathways [184] .
In the present work, I describe the construction of reporter assays designed to specifically
detect repair events mediated by a sup-pathway of MMEJ – SD-MMEJ. The construction
of such assay proved to be more challenging than initially anticipated. However, I was able
to demonstrate that a combination of GFP fluorescence analysis and sequencing can be
used to successfully measure the contribution of the different end-joining pathways to the
repair of extrachromosomal DSBs. Here, due to the lack of time, I did not attempt to use
the assays in the integrated form, nor to analyze more junctions, which may have enabled
to obtain more statistically significant results. While this strategy would enable to study
the repair of chromosomal DSBs, the transient assays are significantly less time consuming.
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Moreover, they are a much better model to study the recombination of free DNA in a
cellular environment, such as plasmids delivered to the cells during transfection. Finally,
the efficiency of the intrachromosomal assays is often negatively influenced by the low
efficiency of in vivo digestion at a single locus by the restriction enzyme. Nevertheless, the
use of only transient assays may not be sufficient to draw universal conclusions concerning
DSB repair in eukaryotic cells, as it was demonstrated that extrachromosomal DNA breaks
are treated differently than genomic breaks [288, 354]. Therefore, to reliably assess the
contribution of the different pathways to DSB repair, both methods should be used in
parallel.
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5.6 Supplementary materials
…CAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCG… 
…GTTCAGGGCGCGGCTCATCCCTATTGTCCCATTAGCGCGGCTCCACTTCAAGC… 
…CAAGACCCGCGCCGAGTAGGGATAA 
…GTTCAGGGCGCGGCTCATCCC     CAGGGTAATCGCGCCGAGGTGAAGTTCG… 
TATTGTCCCATTAGCGCGGCTCCACTTCAAGC… 
…CAAGACCCGCGCCGAGTAGGGATAA 
…GTTC                          AAGTTCG… 
TATTGTCCCATTAGCGCGGCTCCACTTCAAGC… 
…CAAGACCCGCGCCGAGGTGAAGTTCG… 
…GTTCAGGGCGCGGCTCCACTTCAAGC… 
I-SceI µ (9bp) µ (9bp) 
non-functional GFP 
I-SceI digestion 
5’ to 3’ resection 
Annealing of 
microhomologies, 
flap removal and 
fill-in synthesis 
functional GFP 
            AAGTTCG… 
GCGCGGCTCCACTTCAAGC… 
…CAAGACCCGCGCCGAG
…GTTC 
Figure 5S1: The mechanism of action of the simple MMEJ reporter assay. Stop
codons are underlined. Red arrows indicate the direction of the 5’-3’ resection. Green arrows
indiate the direction of DNA synthesis. Adapted from [347].
118
…ACCCGCGCCGAGGTGAAGTTCGACTAGTAAACTTAAGGGCGACACC… 
…TGGGCGCGGCTCCACTTCAAGCTGATCATTAGAATTCCCGCTGTGG… 
…ACCCGCGCCGAGGTGAAGTTCGA 
…TGGGCGCGGCTCCACTTCAAGCTGATC 
TTAAGGGCGACACC… 
    CCCGCTGTGG… 
SpeI Afl II 
…ACCCG   CGAGGTGAA 
…TGGGCGCGGCTCCACTT 
GGT 
C
G
C
C
G
A
 G
A
A
G
T
T
 
…ACCCGCGCCGAGGTGAAGTTCGA 
…TGGGCGCGGCTCCACTT 
        GACACC… 
    CCCGCTGTGG… 
        GACACC… 
    CCCGCTGTGG… 
…ACCCGCGCCGAGGTGAAGTTCGAGG 
…TGGGCGCGGCTCCACTT 
       GACACC… 
    CCCGCTGTGG… 
…ACCCGCGCCGAGGTGAAGTTCGAGGCCGACACC… 
…TGGGCGCGGCTCCACTTCAAGCTCCCGCTGTGG… 
functional GFP 
Polymerization 
5’ to 3’ resection 
Annealing of 
microhomologies, 
flap removal and 
fill-in synthesis 
P1 µ1 P2 µ2 
Figure 5S2: Proposed mechanism of repair for the SD-MMEJ-1 reporter. Stop
codons are underlined. Red arrows indicate the direction of the 5’-3’ resection. Green arrows
indiate the direction of DNA synthesis. P1/P2– primer repeats, µ1/µ2 – microhomology repeats.
Adapted from [372].
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…CCCTGGCCCACCCTCGTGACCACTTAAGAATGAATTCCTGACCTAC… 
…GGGACCGGGTGGGAGCACTGGTGAATTCTTACTTAAGGACTGGATG… 
…CCCTGGCCCACCCTCGTGACCAC 
…GGGACCGGGTGGGAGCACTGGTGAATT 
AATTCCTGACCTAC… 
    GGACTGGATG… 
Afl II     EcoRI  
…CCCTGGCCCACCCTCGTGACCAC 
…GGGACCGGGTGGGAGCACTG 
         CCTAC… 
    GGACTGGATG… 
…CCCT   CCACCCTCGTGAC 
…GGGACCGGGTGGGAGCACTG 
CCC 
G
G
C
C
C
A
 T
C
G
T
G
A
 
         CCTAC… 
    GGACTGGATG… 
…CCCTGGCCCACCCTCGTGACCACCCT 
…GGGACCGGGTGGGAGCACTG 
        CCTAC… 
   GGACTGGATG… 
…CCCTGGCCCACCCTCGTGACCACCCTGACCTAC… 
…GGGACCGGGTGGGAGCACTGGTGGGACTGGATG… 
functional GFP 
Polymerization 
5’ to 3’ resection 
Annealing of 
microhomologies, 
flap removal and 
fill-in synthesis 
P1 µ1 P2 µ2 
Figure 5S3: Proposed mechanism of repair for the SD-MMEJ-2 reporter. Stop
codons are underlined. Red arrows indicate the direction of the 5’-3’ resection. Green arrows
indiate the direction of DNA synthesis. P1/P2– primer repeats, µ1/µ2 – microhomology repeats.
Adapted from [372].
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Figure 5S4: The effect of siRNA knock-down on target mRNA level. Total mRNA
was extracted from CHO cells transfected with three negative control siRNAs (siNeg) or with
specific siRNAs targeting the indicated gene. The mRNA level of the target was quantified by
qPCR. Values were normalized to the target mRNA levels in cells transfected with the control
siRNAs.
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Figure 5S5: The distribution of deletion sizes in cells depleted in MMEJ and NHEJ
genes. Black lines represent mean deletion sizes. The dotted line represents the expected
deletion size from a MMEJ mechanism relying on the preset 9 bp microhomology.
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Table 5S1: Sequenced repair products from cells transfected with the MMEJ and
SD-MMEJ assays. A) MMEJ assay, B) SD-MMEJ-1 assay, C) SD-MMEJ-2 assay.
A 
 
    microhomology                I-SceI                microhomology 
5’…CAAGACCCGCGCCGAGTAGGGATAA  CAGGGTAATCGCGCCGAGGTGAAGTTCG…3’ 
3’…GTTCAGGGCGCGGCTCATCCC  TATTGTCCCATTAGCGCGGCTCCACTTCAAGC…5’ 
 
 
MMEJ #1 junction 
original 
vector 
TCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAG
TAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCA 
junction TCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAG---------------------------------------------------
----------------------------------------------------------GCATCGAGCTGAAGGGCATCGACTTCA 
 
MMEJ #2 junction 
original 
vector 
CGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACT 
TCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAG
TAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCA 
junction TCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAG---------------------------------------------------
----------------------CCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCA 
 
MMEJ #3 junction 
original 
vector 
TCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTAC
CCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGA
CGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
junction CGGCAACTACAAGACCCGCGCCG------------------------------------------------------TGAACCGCA 
 
MMEJ #4 junction 
original 
vector 
CGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
junction CGGCAACTACAAGACCCGCGCCGAG---------------------------GTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
 
MMEJ #5 junction 
original 
vector 
CAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCG
AGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATTCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATC
ATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGGGGACGGCAGCGTGCAGCTCGCCGACCA
CTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTACCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAG
ACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAG 
junction CAACTACAAGACCCGCG---------------------ATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCG 
 
MMEJ #6 junction 
original 
vector 
CAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGC
AGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACC
ATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGA 
junction ATCTTCTTCAAGGACG------------------------------------------------------TGAAGTTCGAGGGCGA 
 
MMEJ #7 junction 
original 
vector 
CGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
junction CGGCAACTACAAGACCCGCGCCGAGT-----------------CGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCA 
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Table 5S1: Sequenced repair products from cells transfected with the MMEJ and
SD-MMEJ assays (continued).
 
 
MMEJ #8 junction 
original 
vector 
TGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTAC
AAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA
GGGCATCGACTTCAAGGAGGACGGCAACATTCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCG
ACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAG 
junction TGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAA------------------------------------------------
---------------------------------CGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA 
 
MMEJ #9 junction 
original 
vector 
CCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGC 
junction CCCGC-----------------------------------------------------CCTGGTGAACCGCATCGAGCTGAAGGGC 
 
MMEJ #10 junction 
original 
vector 
GACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCG 
AAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGC
GCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGG 
junction AAGGCTACGTCCAGGAGCGCACCATCTT----------------------------------------------------------
-----------------------------------------------------------CTTCAAGGAGGACGGCAACATCCTGGG 
 
MMEJ #11 junction 
original 
vector 
CCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCA
ACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAG
CTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCAT 
junction CCACATGAAGCAGCACGACTTCTTCAAGTCCGCCAT--------------------------------------------------
-----------------------------------------GCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAG 
 
MMEJ #12 junction 
original 
vector 
CCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGTAGGGATAACAGGGTAATCGCGCCGAGGTGA
AGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTG
GAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAA
CATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACC
ACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCC 
junction CCAGGAGCG----------------------------------------------------------------CGCGCCGAGGTGA 
 
 
 
B 
 
SpeI           AflII cut 
…ACCCGCGCCGAGGTGAAGTTCGA         TTAAGGGCGACACC… 
…TGGGCGCGGCTCCACTTCAAGCTGATC         CCCGCTGTGG… 
 
 
micro6 #1 
original vector TACAAGACCCGCGCCGAGGTGAAGTTCGACTAGTAAACTTAAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA 
junction TACAAGACCCGCGCCGAGGTGAAGTTCGAC----------AAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA 
 
micro6 #2 
original vector TACAAGACCCGCGCCGAGGTGAAGTTCGACTAGTAAACTTAAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA 
junction TACAAGACCCGCG------------------------------GGCGACACCCTGGTGAACCGCATCGAGCTGAA 
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Table 5S1: Sequenced repair products from cells transfected with the MMEJ and
SD-MMEJ assays (continued).
 
 
micro6 #3 
original vector CCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAC
TAGTAAACTTAAGGGCGACACCCTGGTGAACCGCATCGAGCTGAA… 
junction CCGAAGGCTACGTCCAGGAGCGCACCA-----------------------------------------------------
------------------CACCCTGGTGAACCGCATCGAGCTGAA… 
 
micro6 #4 
original vector CCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAC
TAGTAAACTTAAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGG
GGCACAAGCTGGAG… 
junction CCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAAC-----------------------------
ATCCTGGGGCACAAGCTGGAG… 
  
micro6 #5 
original vector TACAAGACCCGCGCCGAGGTGAAGTTCGACTAGTAAACTTAAG GGCGACACCCTGGTGAACCGCATCGAGCTGAA 
junction TACAAGACCCGCGCCGAGGTGAAGTTCGAC--------------------ACCCTGGTGAACCGCATCGAGCTGAA 
 
 
C 
 
 AflII          EcoRI 
…CCCTGGCCCACCCTCGTGACCAC         AATTCCTGACCTAC… 
…GGGACCGGGTGGGAGCACTGGTGAATT         GGACTGGATG… 
 
 
micro16 #1 
original 
vector 
GTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACTTAAGAATGAATTCCTGACCTACGGCGTGCA 
GTGCTTCAGCCGCTACCCCGACCACATG 
junction GTTCATCTGCACTAC----------------------------------------------------CCTGACCTACGGCGTGCA 
GTGCTTCAGCCGCTACCCCGACCACATG… 
 
micro16 #2 
original 
vector 
CACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACTTAAGAATGAATTCCTGACCTACGGCGTGCAGTGCTTC 
 
junction CACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGT------------------------CCTACGGCGTGCAGTGCTTC 
 
micro16 #3 
original 
vector 
CACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACTTAAGAATGAATTCCTGACCTACGGCGTGCAGTGCTTC 
AGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTT 
 
junction CACCACCGGCAAGCTG----------------------------------------------------------------------
------CCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTT 
 
micro16 #4 
original 
vector 
AAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACTTAAGAATGAATTCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCC 
 
junction AAGCTGCCCGTGCCCTGGCCCACCCTCG------------------------------------------------CGCTACCCC 
 
 
 Note: The microhomologies of the SD-MMEJ model are underlined with a double line, the microhomologies of the MMEJ
model are underlined with a single line. The "-" signs indicate deleted bases.
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siRNA junction # Mechanism Length of microhomology Deletion/insertion (bp)
Neg 1 MMEJ 9bp (Wang): CGCGCCGAG -27bp
2 SD-MMEJ 4bp: CG/GG (IR, 3bp upstream of junction) -74bp
7bp: CGCC/GGG (DR, 297bp downstream of 
junction)
3 SD-MMEJ
5bp: CTT/GG (DR, 326 bp upstream of 
junction) 
-84bp
4 SD-MMEJ
5bp: CGC/GG (IR, 388bp downstream of 
junction)
-90bp
5 MMEJ 9bp: GACGGCAAC -117bp
6 MMEJ 9bp (Wang): CGCGCCGAG -27bp
7 MMEJ 9bp (Wang): CGCGCCGAG -27bp
8 MMEJ 9bp (Wang): CGCGCCGAG -27bp
9 MMEJ 9bp (Wang): CGCGCCGAG -27bp
10 NHEJ blunt join -4bp
SD-MMEJ
6bp: GGG/CAG (IR, 173bp upstream from 
junction)
Ku70 1 MMEJ 9bp (Wang): CGCGCCGAG -27bp
2 MMEJ 9bp: CTTCAAGGA -117bp
3 SD-MMEJ
1) 5bp: CC/GCT (DR, 69bp upstream from 
junction)
-51bp                           
SD-MMEJ
2) 4bp: CG/CA (DR, 46bp downstream from 
junction)
38bp templated insert from GFP 
(215bp downstream)
4 MMEJ 9bp (Wang): CGCGCCGAG -27bp
5 SD-MMEJ
5bp: CG/GCG (DR, 127bp upstream from 
junction)
-21bp
6 NHEJ blunt join -4bp
SD-MMEJ
6bp: GGG/CAG (IR, 173bp upstream from 
junction)
7 MMEJ 9bp (Wang): CGCGCCGAG -27bp
8 NHEJ blunt join -6bp
SD-MMEJ GGG/GG (IR, 236 bp downstream of junction)
9 SD-MMEJ
5bp: GG/GGC (DR, 62bp downstream from 
junction)
-34bp
10 MMEJ 9bp (Wang): CGCGCCGAG -27bp
Table 5S2: Analysis of repair products from siRNA-treated cells transfected with
the MMEJ reporter.
  
 
 
 
 
 
siRNA junction # Mechanism Length of microhomology Deletion/insertion (bp)
LigI 1 MMEJ 9bp (Wang): CGCGCCGAG -27bp
2 NHEJ blunt join -23bp
3 SD-MMEJ
5bp: GCA/GT (DR, 102bp upstream of 
junction)
-52bp
4 MMEJ 9bp (Wang): CGCGCCGAG -27bp
5 SD-MMEJ
5bp: AG/CGC (DR, 46bp upstream from 
junction)
-17bp
6 SD-MMEJ
7bp: GC/TGAAG (DR, 32bp downstream from 
the junction)
-34bp
7 MMEJ 9bp (Wang): CGCGCCGAG -27bp
8 MMEJ 9bp (Wang): CGCGCCGAG -27bp
9 NHEJ 1bp join -5bp
10 MMEJ 9bp (Wang): CGCGCCGAG -27bp
LigIII 1 MMEJ 2bp: AC -74bp
SD-MMEJ
7bp: GAC/CCTG (DR, 171bp upstream from 
junction)
2 MMEJ 9bp (Wang): CGCGCCGAG -27bp
3 SD-MMEJ
5bp: AG/AAT (IR, 81bp downstream from 
junction)
-12bp
4 SD-MMEJ
7bp: CCGA/AGG (DR, 56p upstream from 
junction)
-11bp
5 MMEJ 9bp (Wang): CGCGCCGAG -27bp
6 SD-MMEJ
GTAG/CAG (IR, 261 bp downstream from 
junction)
-6bp
AG/CAG (DR, 94 bp upstream from the 
junction)
7 MMEJ 9bp: CTTCAAGGA -117bp
8 MMEJ 9bp (Wang): CGCGCCGAG -27bp
9 SD-MMEJ
5bp: AG/CCG (DR, 113bp upstream from 
junction)
-22bp
10 SD-MMEJ
5bp: GC/GGT (IR, 40 bp downstream from 
junction)
-16bp
Table 5S2: Analysis of repair products from siRNA-treated cells transfected with
the MMEJ reporter (2).
  
 
 
siRNA junction # Mechanism Length of microhomology Deletion/insertion (bp)
Pol theta 1 SD-MMEJ
5bp: CA/CCG (DR, 166bp upstream of 
junction)
-70bp
2 MMEJ 9bp (Wang): CGCGCCGAG -27bp
3 NHEJ blunt join -4bp
SD-MMEJ
6bp: GGG/CAG (IR, 173bp upstream from 
junction)
4 SD-MMEJ
1) 6bp: CA/CGCC (IR, 56bp upstream from the 
junction)
-99bp
SD-MMEJ
2) 4bp: CG/TG (on the insert, DR, 2bp 
upstream from the junction)
31bp templated insert from GFP 
(168bp downstream)
5 MMEJ 4bp: AGGG -9bp
6 NHEJ 1bp join -5bp
7 SD-MMEJ
4bp: CG/TA (IR, 49 bp upstream from 
junction)
-125bp
8 NHEJ 1bp join -5bp
9 SD-MMEJ
6bp: CCC/TAA (DR, 497bp upstream from 
junction)
-22bp
10 SD-MMEJ
6bp: AGC/AGG (IR, 277bp downstream from 
junction)
-117bp
Pold3 1 MMEJ 2bp: GG -10bp
2 MMEJ 4bp: AGGG -9bp
3 SD-MMEJ
7bp: CC/CGACA (DR, 233bp downstream from 
the junction)
-149bp
4 MMEJ 3bp: AGG -90bp
SD-MMEJ
5bp: TCC/AG (IR, 75bp downstream from 
junction)
5 SD-MMEJ
5bp: AG/CAG (DR, 91bp upstream from the 
junction)
-9bp
6 MMEJ 9bp (Wang): CGCGCCGAG -27bp
7 MMEJ 9bp (Wang): CGCGCCGAG -27bp
8 NHEJ blunt join -4bp
SD-MMEJ
6bp: GGG/CAG (IR, 173bp upstream from 
junction)
9 SD-MMEJ
5bp: CG/TGA (DR, 124bp upstream of 
junction)
-75bp
10 MMEJ 9bp: GACGGCAAC -117bp
Table 5S2: Analysis of repair products from siRNA-treated cells transfected with
the MMEJ reporter (3).
  
Note: ‘9 bp (Wang)’ indicates repair with the MMEJ mechanism relying on the preset 9 bp 
microhomology. 
siRNA junction # Mechanism Length of microhomology Deletion/insertion (bp)
DNA-PKcs 1 MMEJ 9bp: GACGGCAAC -117bp
2 SD-MMEJ
5bp: AGA/AT (IR, 81bp downstream from 
junction)
-27bp
3 MMEJ 9bp (Wang): CGCGCCGAG -27bp
4 MMEJ 9bp (Wang): CGCGCCGAG -27bp
5 MMEJ 3bp: CGC -66bp
6 MMEJ 9bp (Wang): CGCGCCGAG -27bp
7 SD-MMEJ
5bp: GCG/TG (DR, 121bp upstream from 
junction)
-57bp
8 MMEJ 9bp (Wang): CGCGCCGAG -27bp
9 NHEJ blunt join -4bp
SD-MMEJ
6bp: GGG/CAG (IR, 173bp upstream from 
junction)
10 MMEJ 4bp: CATC -117bp
Table 5S2: Analysis of repair products from siRNA-treated cells transfected with
the MMEJ reporter (4).
Chapter 6
A role for homologous recombination proteins in cell
cycle regulation
This chapter is based on a manuscript submitted for publication entitled "A role for
homologous recombination proteins in cell cycle regulation" by Kostyrko, K., Bosshard,
S., Urban, Z., Mermod, N.
This chapter contains data obtained together with Zuzanna Urban, during her Sum-
mer Undergraduate Program internship project, and Sandra Bosshard, during her Master
thesis project.
Zuzanna Urban participated in the characterization of the CHO Fucci cells (Fig.6S1,
6S2, 6S5). Sandra Bosshard performed siRNA knock-down experiments (Fig.6.2, 6.3, 6.4,
6S3A, 6S4, 6S6, 6S7). I generated and characterized the CHO Fucci cells, performed part
of the siRNA knock-down experiments and supervised all the work.
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6.1 Abstract
Eukaryotic cells respond to DNA breaks, especially double-stranded (DSBs), by activating
the DNA damage response (DDR), which encompasses DNA repair and cell cycle checkpoint
signaling. The DNA damage signal is transmitted to the checkpoint machinery by a network
of specialized DNA damage-recognizing and signal-transducing molecules. However, recent
evidence suggests that DNA repair proteins themselves may also directly contribute to
the checkpoint control. Here, we investigated the role of homologous recombination (HR)
proteins in normal cell cycle regulation in the absence of exogenous DNA damage. For
this purpose, we used Chinese Hamster Ovary (CHO) cells expressing the Fluorescent
ubiquitination-based cell cycle indicator (Fucci). Systematic siRNA-mediated knockdown
of HR genes in these cells demonstrated that the absence of several of these factors alters
cell cycle distribution, albeit differentially. The knock-down of MDC1, Rad51 and Brca1
caused the cells to arrest in the G2 phase, suggesting that they may be required for the
G2/M transition. In contrast, inhibition of the other HR factors, including several Rad51
paralogs and Rad50, led to the arrest in the G1/G0 phase. Moreover, the absence of
Rad51B, Rad51C, CtIP and Rad50 seemed to induce entry into the quiescent G0 phase.
In conclusion, the lack of many HR factors may lead to cell cycle checkpoint deficiency,
even in the absence of exogenous DNA damage, indicating that these proteins may play
an essential role both in DNA repair and checkpoint signaling.
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6.2 Introduction
DNA double strand breaks (DSBs), one of the most deleterious types of DNA lesions,
can result from ionizing radiation or chemical agents, or from natural cellular processes
such as DNA replication or maturation of the immune system genes. If left unrepaired,
they constitute a major threat to genetic integrity and stability, leading to cell death or
carcinogenesis [295]. In response to DSBs, cells activate a network of DNA repair and
signaling pathways, collectively termed the DNA damage response (DDR) [129, 145, 200].
To allow time for DNA repair, the DDR machinery activates cell cycle checkpoints that
arrest cell cycle progression until genome integrity is restored. The DDR-activated check-
points include the G1/S, the intra-S and the G2/M transitions. The G1/S checkpoint, the
most sensitive to DNA damage, is defective in most human cancers [178, 198].
The Mre11/Rad50/Nbs1 (MRN) complex is among the first sensors of DSBs, subse-
quently activating Ataxia telangiectasia mutated (ATM) [183]. ATM, a key protein kinase
in the DDR network, is responsible for phosphorylation of many downstream DNA repair
and cell cycle factors, including tumor suppressor p53, mediator of DNA-damage check-
point 1 (MDC1), cell cycle checkpoint kinase 2 (Chk2), and breast cancer susceptibility
protein 1 (Brca1) [294, 296]. The activation of these factors results in signaling cascades
ultimately leading to cell cycle arrest. ATM-dependent phosphorylation of histone H2AX
(γH2AX) also induces global changes in the chromatin structure leading to the recruitment
of DNA repair proteins to the sites of damage.
Several specialized pathways exist in higher eukaryotic cells to repair DNA breaks.
One of the main pathways responsible for DSB repair is non-homologous end-joining
(NHEJ). NHEJ is a fast process, based on a simple ligation of the two broken DNA ends,
active throughout the entire cell cycle [253]. In the absence of functional NHEJ, cells were
shown to use a highly error-prone, backup mechanism termed microhomology mediated
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end joining (MMEJ) [137, 152]. The third pathway, considered to be the most precise of
all the DSB repair mechanisms, was termed homologous recombination (HR) [284]. HR
requires extensive homology for repair, and thus is primarily used in late S and G2 phases
of the cell cycle, when genetic material is already replicated and sister chromatids are
available as repair template.
A key role in eukaryotic HR is played by the Rad51 recombinase, which coats ssDNA
ends resulting from the initial processing of the DSB [19, 293]. The DNA-bound Rad51
then searches for sequence homology along the complementary DNA strand and mediates
pairing between the two strands. The Rad51 protein is essential for cell proliferation, as
targeted knock-out of this gene leads to embryonic lethality in mice [330]. Other proteins
involved in HR include CtIP, Brca2, Rad52, Rad54 and the five Rad51 paralogs: Rad51B,
Rad51C, Rad51D, Xrcc2, and Xrcc3 [92, 233, 285, 315, 317]. Rad51B, Rad51C, Rad51D
and Xrcc2 together form the BCDX2 complex, which was proposed to facilitate the for-
mation and stabilization of the Rad51 nucleofilament [217]. Rad51C also participates in
the formation of a second complex with Xrcc3, termed CX3 [197]. The CX3 dimer was
reported to play an essential role in the final resolution of recombination intermediates.
The MRN complex, MDC1, and Brca1, which are components of the DDR response, also
play a role in HR [146, 174, 379].
It has been recently proposed that HR proteins, in addition to their role in DNA
repair, could also directly contribute to cell cycle control [14, 276, 367]. The knock-down
of Rad51 was shown to induce G2/M arrest, suggesting that this protein is required for
the progression from the G2 phase to mitosis [180, 86, 297], and Brca1 was reported to
play a role in the regulation of the G2/M and intra-S checkpoints [355, 367]. Rad51C was
also proposed to contribute to cell cycle regulation, although there are conflicting reports
as to its exact role. Rodrigue and others observed that the knock-down of Rad51C in
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human cells leads to the arrest at the G2/M checkpoint [276]. This indicated that Rad51C,
similarly to Rad51, is needed for the progression through the G2 phase. In another study,
Rad51C knock-down caused the cells to escape the intra-S and G2/M checkpoints, thus
allowing them to enter mitosis [14]. This work suggested that Rad51C may play a role in
the activation of G2/M checkpoint in response to DNA damage. Several other DSB repair
proteins have also been proposed to participate in cell cycle progression [176, 363].
Here, to systematically asses the role of HR factors in cell cycle regulation in the
absence of exogenous DNA damage, we silenced several important HR genes in Chinese
Hamster Ovary (CHO) cells expressing the fluorescent ubiquitination-based cell cycle
indicator (Fucci) [280]. We showed that the knock-down of many HR factors, including
Rad51, MDC1, Brca1, several Rad51 paralogs, CtIP, and Rad50 significantly affected
cell cycle progression, albeit differentially. The knock-down of MDC1, Rad51 and Brca1
caused the cells to arrest at the G2/M checkpoint, suggesting that these factors may be
required for the transition through the G2 phase and entry into mitosis. In contrast, the
absence of the remaining HR proteins increased the proportion of G1/G0 phase cells,
indicating that their deficiency may cause the cells to escape the G2/M checkpoint, divide
and subsequently become arrested in the G1 phase. We also observed that knock-down of
Rad51B, Rad51C, CtIP and Rad50 increased the proportion of G0 cells, suggesting that
in the absence of these factors cells may enter a quiescent state. In conclusion, it seems
that many HR proteins are not only important for DSB repair, but possibly also play a
role in the regulation of cell cycle progression.
6.3 Materials and Methods
CHO cells expressing Fucci probes
Adherent CHO DG44 cells [333] were cultivated in DMEM/F12+GlutaMAXTM sup-
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plemented with 1x HT and 10% fetal bovine serum (FBS) (Gibco, Invitrogen), and
with antibiotic-antimycotic solution (Sigma-Aldrich, #A5955). CHO Fucci cells were con-
structed using lentiviral vectors carrying the red and green fluorescent ubiquitination-based
cell cycle indicator (Fucci) cassettes [280]. The red Fucci cassette contains a monomeric
version of Kusabira Orange 2 (mKO2) reporter gene fused to a truncated human Cdt1
(hCdt1, amino acids 30–120). The mKO2-hCdt1(30/120) protein is expressed in G1 phase
and degraded at the onset of the S phase. The green Fucci cassette contains the monomeric
version of Azami green (mAG) reporter gene fused to the 110 amino acid N-terminus of
human Geminin (hGem amino acids 1-110). The mKO2-hGem(1/110) protein accumulates
through S, G2 and M phases of the cell cycle and is degraded in the metaphase/anaphase
transition of mitosis. The lentiviral constructs were kindly provided by M. Lutolf (EPFL,
Lausanne, Switzerland). Briefly, the cells were transduced with a 1:1 ratio of mKO2 and
mAG vectors at MOI 50. Three weeks after transduction double positive (mKO2+mAG+)
clones were single-cell sorted by fluorescence-activated cell sorting (FACS) (FACSAria II
sorter, Becton-Dickinson). A single clone (#21) with similar levels of mKO2 and mAG
fluorescence intensity was selected for subsequent experiments.
Cell synchronization
For starvation synchronization CHO cells were grown for 72h in medium supplemented with
0.2% FBS (Gibco, Invitrogen). For synchronization through contact inhibition cells were
grown for 3-5 days until complete confluency. Both methods synchronize the cells in G1/G0
phase. To reinitiate cell cycle progression cells were replated at lower density in complete
medium. For early S phase synchronization 10 000 double positive (mAG+mKO2+) cells
were sorted by FACS (FACSAria II sorter, Becton-Dickinson) into each well of a 12-well
plate.
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siRNA transfection
Small interfering RNA duplexes were specifically designed to target the Chinese hamster
homologs of HR genes. The siRNAs were designed and provided by Microsynth AG
(Balgach, Switzerland). Three RNA duplexes were designed per gene to increase the
probability of successful knock-down. Three negative (non-targeting) siRNAs were also
designed as controls. For siRNA-mediated knock-down, CHO-Fucci cells were transfected
with equimolar amounts of three siRNA duplexes at a final concentration of 50nM using
Lipofectamine RNAiMAX, according to the manufacturer’s instructions (Invitrogen). After
72h cells were analyzed by microscopy (Carl Zeiss Microscope Axio Observer.A1).
Flow cytometry
For flow cytometry cells were harvested 72h following siRNA transfection, resuspended in
0.5 ml of PBS with 2% FBS (Gibco, Invitrogen), and analyzed using the CyAn analyzer
(Beckman Coulter). Acquired data was analyzed using the FlowJo software (Tree Star).
For the time point experiment cells were harvested every 4h at 40, 44, 48, 64, 68 and 72h
post transfection, fixed in PBS with 4% PFA (1:2 v/v) and analyzed by flow cytometry.
6.4 Results
6.4.1 Characterization of CHO Fucci cells
The fluorescent ubiquitination-based cell cycle indicator (Fucci) system enables the si-
multaneous observation of multiple cell cycle phases in living cells [280]. The system
is based on the expression and ubiquitination of cell cycle-dependent human proteins
Cdt1 and Geminin, fused to fluorescent markers monomeric Kusabira Orange 2 (mKO2)
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and monomeric Azami Green (mAG), respectively. Depending on the expression and
accumulation of the fluorophores four main cell subpopulations can be visualized – the early
G1 phase cells, G1/G0 cells, early S cells and late S, G2 and M phase cells (Fig.6.1). The
freshly divided early G1 phase cells are non-fluorescent, but as the cells progress through
the G1 phase they start expressing and accumulate the mKO2-hCdt1(30/120) chimeric
protein. In the early S phase, while the mKO2-hCdt1(30/120) becomes ubiquitinated and
degraded, the cells start producing the mAG-hGem(1/110) fusion protein, which makes
them appear yellow under the microscope. Expression of mAG-hGem(1/110) persists
through the S, G2 and M phases, causing the cells to emit only green fluorescence until
the end of the cell cycle.
A B C 
Figure 6.1: Characterization of CHO Fucci cells. A) Scheme of the Fucci cell cycle [280].
B) Typical uorescence image of CHO Fucci cells. Arrows point to cells in G1/G0 (top), late S,
G2, and M (middle) and early S phase cells (bottom). C) Flow cytometry analysis of CHO Fucci
cells with four subpopulations of cells: mKO2-positive G1/G0 cells (PE channel), mAG-positive
late S, G2 and M cells (FITC channel), double positive (mKO2+mAG+) early S cells, and a
double negative (mKO2- , mAG-) early G1 cells.
To confirm that the CHO Fucci cells express the fluorescent probes in a cell cycle
dependent manner, we synchronized the culture by serum deprivation, which induces a
cell cycle arrest in the G1/G0 phase, or by contact inhibition, which causes G1 arrest
[119, 277]. We observed that over 90% of serum-deprived cells displayed red fluorescence
indicative of the G1/G0 phase (Fig.6S1,6S2). In cells grown to confluence this number
was lower (50%), indicating that this method is less efficient in synchronizing cells than
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serum starvation (Fig.6S1B,6S2B). We subsequently released the cells from cycle arrest
and monitored the cell cycle distribution 16-24h and 40-48h following release. Within 20h
the starved cells progressed through the S phase into the G2 and M phases, as evidenced
by the accumulation of green fluorescent cells. Cells grown to confluence reached this phase
faster (within 16h), which is consistent with the fact that this synchronization method
does not induce the cells to enter the G0 phase, which therefore need less time to resume
the cycle. Most starved cells remained synchronized until 48h post release, whereas the
cells grown to confluence became desynchronized. In conclusion, the CHO Fucci cells
appeared to express the fluorescent probes in a cell cycle dependent manner and therefore
may serve as a model to study cell cycle regulation.
6.4.2 Knock-down of HR factors differentially influences cell cy-
cle distribution of CHO Fucci cells
To assess the role of HR factors in cell cycle regulation, we subsequently treated the
CHO Fucci cells with a panel of short interfering RNAs (siRNAs) directed against these
genes. The efficiency of siRNA knock-down was assessed by qPCR (Fig.6S3A). Rad51
and Rad51D knock-down was also confirmed by western blot (Fig.6S3B). A non-targeting
siRNA as well as an siRNA against Cyclin D1, which is required for the progression through
the G1/S checkpoint [16], were used as a negative and positive control, respectively.
The different siRNA treatments did not affect the number of freshly divided early G1
phase cells (Fig.6.2A). However, we noted a decrease in this sub-population, albeit not
significant, with Rad51C siRNA. The number of G1/G0 cells was significantly increased
upon treatment with the Cyclin D1 siRNA, as expected from the role of this cyclin in the
cell cycle (Fig.6.2B). Interestingly, the knock-down of three Rad51 paralogs - Rad51B,
-C, and -D, as well as Rad50, one of the MRN components, and to a lower extant CtIP,
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had a similar effect. The accumulation of G1/G0 cells upon the knock-down of these
factors suggests that the progression through the G1 phase may be perturbed in their
absence, possibly involving the G1/S checkpoint. This is surprising, as these proteins are
thought to operate primarily in the late S and G2 phases of the cell cycle, when HR is
most active. However, it is possible that these factors may be necessary for the G2/M
checkpoint activation in response to DNA damage. In this scenario, the absence of these
factors would cause the cells to circumvent arrest and enter mitosis despite the presence of
unrepaired breaks, which later on would activate the G1/S checkpoint.
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Figure 6.2: Knock-down of HR factors affects cell cycle distribution of CHO Fucci
cells. Results are shown as fold change over the data obtained from mock-treated cells (mock).
Mean of ≥3 experiments, error bars show s.e.m. Asterisks indicate significant differences between
siRNA-treated samples and mock control. Statistical signicance relative to mock was determined
by unpaired Student’s t-test with Benjamini-Hochberg correction; signicance level p<0.05 (*),
p<0.01 (**).
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As expected, the proportion of early S phase cells was significantly decreased in the
absence of Cyclin D1, due to the defective G1/S transition (Fig.6.2C). We also noted a
decrease in this subpopulation in the presence of Xrcc2 siRNA, which, however, did not
correlate with an increase in the number of G1/G0 phase cells.
The knock-down of MDC1, Rad51 and Brca1 resulted in a significant accumulation
of green-fluorescent late S, G2 or M phase cells (Fig.6.2D). This further supported the
view that these proteins are required for the progression through the G2/M checkpoint
[86, 202, 297, 326, 367]. The percentage of green fluorescent cells was also slightly increased
in the presence of Xrcc2 siRNA. In contrast, the silencing of Cyclin D1 as well as Rad51B,
-C, -D, Rad50 and CtIP, resulted in a significant decrease in this subpopulation, due to
the aforementioned accumulation of G1/G0 phase cells.
In conclusion, several HR proteins appear to be involved in cell cycle regulation, albeit
differentially. MDC1, Rad51 and Brca1 seem to be essential for the progression from S
and G2 phases into mitosis, while Rad51 paralogs, Rad51B, -C and -D, as well as the
DNA end resection enzymes, Rad50 and CtIP may be required for activating the G2/M
checkpoint in response to damage and/or progression through the G1/S checkpoint.
6.4.3 Knock-down of Rad51B, Rad51C, CtIP and Rad50 in-
duces entry into the G0 phase
In addition to increasing the number of mKO2-positive cells, we also observed that the
knock-down of Cyclin D1 and several HR factors increased the level of mKO2 fluorescence
(Fig.6S4). A detailed analysis of these cells revealed two sub-populations with different
fluorescence intensities (Fig.6.3A). A recently published report identified these low- and
high mKO2-expressing cells as cycling G1 and quiescent G0 cells, respectively [325]. In
line with this, we observed an increase in the number of bright red fluorescent cells upon
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serum starvation (Fig.6S5), further supporting the view that this sub-population represents
non-cycling G0 cells.
We therefore set out to quantify the G1 and G0 sub-populations in cells transfected
with HR siRNAs. In controls, as well as in most siRNA-treated samples, the G0 phase
cells constituted only approx. 5-10% of the population (Fig.6.3B). However, treatment
with Cyclin D1 siRNA increased the number of quiescent cells to 30%. This is consistent
with previous studies showing that Cyclin D1 deficiency causes the cells to enter the G0
phase [133]. Interestingly, we also observed a very significant increase in the number of G0
cells upon the knock-down of Rad51B, Rad51C, CtIP, and Rad50. This was especially
striking in the presence of Rad51B and Rad51C siRNAs, where G0 cells comprised up
to 40% of the entire population. This implied that the absence of these HR factors may
constitute a signal to enter the quiescent state.
6.4.4 Rad51 and Rad51C depletion leads to cell cycle arrest
We next sought to investigate whether the aberrant cell cycle distribution upon siRNA
knock-down of HR factors results from a cell cycle arrest or a delayed cycle progression.
We focused our attention on Rad51 and Rad51C, the two HR proteins with pronounced,
but distinct effects on the cell cycle. We synchronized siRNA-treated cells in early S phase
by sorting double positive mKO2+mAG+ cells and analyzed their cell cycle distribution
1 and 2 days after sorting (Fig.6S6A). Since the normal doubling time of CHO DG44
cells is approx. 12-14h [116, 119], we estimated that in the 18h between sorting and the
first measurements, the cells should have completed the cell cycle, divided and nearly
completed another cycle. According to these calculations the majority of cells would
be green fluorescent at the beginning of the analysis (40h post transfection). This was
indeed the case for untreated cells, and for cells transfected with the non-targeting siRNA
140
mock siNeg siRad51 
siCyclin D1 siRad51B siRad51C 
A 
m
o
ck
si
Ne
g
si
Cy
cl
in
D1
si
M
DC
1
si
Ra
d5
1
si
Ra
d5
1B
si
Ra
d5
1C
si
Ra
d5
1D
si
Xr
cc
2
si
Br
ca
1
si
Ra
d5
2
si
Ra
d5
4
si
Ct
IP
si
M
re
11
si
Ra
d5
0
si
Nb
s1
G1 phase
G0 phase
Pe
rc
en
ta
ge
 o
f a
ll 
ce
lls
0
10
20
30
40
50
**
**
**
* *
B
Figure 6.3: Knock-down of Cyclin D1, Rad51B, Rad51C, CtIP and Rad50 induces
senescence. A) FACS plots of siRNA-treated cells. B) Percentages of cells in G1 and G0 phases.
Mean of ≥3 experiments, error bars show s.e.m. Asterisks show significant differences between
siRNA-treated samples and untreated (mock) control. Statistical signicance relative to mock was
determined by unpaired Student’s t-test with Benjamini-Hochberg correction; signicance level
p<0.05 (*), p<0.01 (**).
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(Fig.6S6B,C; Fig.6S7A,B). Both populations also showed a similar cell cycle distribution
over time with two more divisions, one between 44h and 48h and another less than 64h
post transfection. The time between these divisions was also consistent with the normal
CHO cell cycle duration.
Cells treated with the Cyclin D1 siRNA initially displayed a similar cell cycle pattern
as the controls, with one division 44-48h post transfection (Fig.6S6D, Fig.6S7C). However,
the next division seemed delayed to 64-68h, and the accumulation of G1 and G0 phase
cells started to become apparent. In Rad51-depleted cells, already the first division was
delayed compared to the controls (48-64h), after which most cells appeared not to divide
anymore (Fig.6S6E, Fig.6S7D). A small portion of cells (approx. 20%) underwent a second
division at around 64-68h after transfection. The percentage of green fluorescent cells
stayed high throughout the experiment indicating that most cells were arrested in late S,
G2 or M phase. This could indicate that a strong Rad51 deficiency causes the cells to
arrest in the late phases of the cycle, likely at the G2/M checkpoint. Mild Rad51 depletion,
possibly due to lower knock-down efficiency, may result in delayed cell cycle progression.
Cells treated with Rad51C siRNA also divided later than the controls (between 48h and
64h) pointing to delay in the cell cycle (Fig.6S6F, Fig.6S7E). However, Rad51C-deficiency
resulted in a steadily elevated proportion of cells in G1 and G0 phases, resembling the effect
of Cyclin D1 knock-down. Indeed, cluster analysis demonstrated that Rad51C-depleted
cells grouped together with Cyclin D1 siRNA-treated cells (data not shown). However, the
majority of these red-fluorescent cells appeared to be quiescent, reaching 50% of the entire
population (Fig.6.4). This was more than observed in the presence of Cyclin D1 siRNA
(10-20%). After the delayed first cycle, most of the Rad51C-deficient cells underwent a
second division within a normal time of 12-14h, although some cells remained arrested
in the G1 or G0 phase. This indicated that out of all the cells initially arrested in a
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quiescent G0 phase, some were later released from the block and re-entered the cell cycle,
possibly due to the loss of the knock-down effect. At 64h post transfection most of the
cells reverted to a profile resembling untreated cells.
Overall, we concluded that Rad51 knock-down causes an arrest at the late phases of
the cell cycle, most probably due to the G2/M checkpoint, or delayed cell cycle progression
in cells circumventing the arrest. In contrast, Rad51C depletion causes entry into the
quiescent G0 phase, most likely due to the activation of the G1/S checkpoint.
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Figure 6.4: Effect of HR protein depletion on the percentages of quiescent cells in
CHO Fucci cells synchronized in early S phase. Numbers below the bars represent time
(in hours) post siRNA transfection. The siRNA targets are indicated below the plot. Mock –
cells treated with transfection reagent only.
6.5 Discussion
The DNA damage response encompasses many functionally interconnected pathways,
including cell cycle checkpoint signaling and DNA repair. Many proteins participating in
cell cycle regulation are also known to control DNA repair, whereas the converse was not
known to be true for DNA repair factors. However, recent evidence suggested that some
DSB repair proteins may also be implicated in cell cycle regulation. To further explore this
connection between DNA repair proteins and cell cycle machinery, we analyzed the effect
of HR protein depletion on the CHO cell cycle in the absence of induced DNA damage. We
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found that the knock-down of several HR factors altered cell cycle progression, suggesting
that they may play a role in cell cycle control. However, lack of these proteins affected the
cell cycle differentially, despite their being part of the same DNA repair pathway.
In the late S and G2 phases, the presence of unrepaired DNA breaks results in the
activation of the G2/M cell cycle checkpoint by specialized DNA damage sensing factors,
e.g. ATM, ATR, p53, and Chk1 [189, 321]. We anticipated that the absence of crucial
HR factors would lead to the accumulation of unrepaired DSBs, thereby stimulating the
DDR to arrest the cells before division. Surprisingly, the knock-down of the majority of
HR proteins, including three Rad51 paralogs, CtIP, and Rad50, failed to arrest the cells
at the G2/M checkpoint. Instead, the presence of these factors seemed to be necessary
for the progression from G1 to S phase. Only the loss of MDC1, Rad51 and Brca1 led
to an accumulation of late S, G2 and M cells, likely due to the activation of the intra-S
and/or G2/M checkpoints. This could indicate that the knock-down of these three genes,
important for the early steps of the HR pathway, leads to the accumulation of enough
endogenous DNA damage to trigger the G2/M checkpoint.
The absence of the remaining HR factors may potentially inhibit the repair process
incompletely, instead rendering it more error-prone. These cells would still enter mitosis,
but due to the accumulation of imprecisely repaired DSBs, they may become arrested
at the next G1/S checkpoint, explaining the accumulation of cells in the G1/G0 phase.
However, in a recent study, Shibata and co-workers estimated that only about 15% of
DSBs occurring in the G2 phase are repaired by the HR pathway, while the remaining
breaks are efficiently repaired by other mechanisms [292]. This, together with our results
obtained in the absence of induced DNA damage, may indicate that the effects of HR
protein knock-down described here are not merely due to the accumulation of unrepaired
DSBs. Instead, these HR proteins may play a more direct role in the cell cycle, for instance
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by interacting with cell cycle signaling factors, cyclins or cyclin-dependent kinases.
Our results obtained with Rad51B and -C siRNAs are in contrast with recently
published observations that the knock-down of these Rad51 paralogs in HeLa cells blocks
progression through the G/M checkpoint [276]. However, it is possible that the absence of
these proteins in human cells may have a different impact on HR and/or the cell cycle,
than it does in CHO cells, which divide two times faster than HeLa cells and display
different kinetics of DSB repair [154, 263].
In the present study, we observed that apart from a defect in the G1/S transition,
the knock-down of Rad51B, Rad51C, CtIP and Rad50 also caused entry into the non-
proliferative G0 phase, resembling Cyclin D1 knock-down. This suggests that the absence
of these proteins may constitute a signal for the cells to withdraw from the cell cycle. This
may partially explain the characteristic enhanced proliferation of cancer cells, in which
HR proteins are often overexpressed. Taken together, this work indicates that many HR
components may be necessary for the normal cell cycle progression, at least in CHO cells.
It will therefore be of interest to decipher how these proteins transmit the signals to the
cell cycle control machinery, and what are their putative targets, to further understand
their role in the cell cycle regulation network.
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6.6 Supplementary materials
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Figure 6S1: Cell cycle progression of synchronized CHO Fucci cells. Cells were
synchronized by A) serum starvation, or B) contact inhibition. Cell cycle distribution data is
represented as percentages of cells in a given cell cycle phase at the indicated time post release
from the cell cycle arrest. Flow cytometry measurements were taken on the day of release (D0),
and during the first and second mitotic cycle (D1 and D2).
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Figure 6S2: Microscope images of synchronized CHO Fucci cells. A) Serum starvation,
B) contact inhibition. Time post release from cell cycle arrest is indicated below each image. All
images were acquired using the same exposure time.
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Figure 6S3: The effect of siRNA knock-down on target mRNA and protein levels.
CHO cells transfected with three siRNAs targeting the indicated gene, with three non-targeting
siRNAs (siNeg) or left untreated (mock). A) The mRNA level of the target was quantified
by qPCR using specific primers. Values were normalized to the target mRNA levels in cells
transfected with the non-targeting siRNA. B) Western blotting for Rad51 (left) and Rad51D
(right) in total protein extracts isolated from CHO cells. GAPDH and Tubulin – loading controls.
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Figure 6S4: Microscope images of CHO Fucci transfected with siRNAs against HR
factors. Images acquired 72h after the indicated siRNA transfection, or with the transfection
reagent only (mock).
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Figure 6S5: Flow cytometry profiles of CHO Fucci cells grown in full medium and
with low serum content. The amount of fetal bovine serum (FBS) in the medium is indicated
on each plot. Cells grown in full medium (left), cells grown low serum medium (right).
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Figure 6S6: Effect of Rad51 and Rad51C knock-down on cell cycle progression of
CHO Fucci cells synchronized in early S phase. A) General outline of the procedure. B-F)
Percentages of cells in a given cell cycle phase at the indicated time post siRNA transfection
(day 3 and 4 –D3 and D4). Arrows indicate the estimated average time of cell division, dotted
arrow indicates a cell division of a subpopulation of cells.
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Figure 6S7: Phase contrast images of cells synchronized in early S phase. Images
were acquired at the indicated time post siRNA transfection. Arrows indicate the estimated time
of cell division, dotted arrow - a division of a cell subpopulation.
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Chapter 7
Conclusions
7.1 Plasmid integration in mammalian cells
Introduction of foreign DNA into the eukaryotic cells can lead to its incorporation into the
genome [94, 156, 275]. However, the enzymatic machinery responsible for this phenomenon
remains largely undefined. In lower eukaryotes, plasmids containing genome-derived
sequences were shown to preferentially recombine with the homologous region of the
host cell chromosome [127, 249], pointing to a HR-dependent mechanism of integration.
However, in mammalian cells, this process does not seem to rely on extensive homology
between the exogenous and cellular DNA [156]. Moreover, the integration loci do not
appear to be restricted to any specific chromosomes or chromosomal regions [275]. This
suggested a random and homology-independent mode of integration.
According to the most widely accepted integration mechanism, the exogenous DNA
fragments are joined with the cellular DNA during the repair of naturally occurring
genomic lesions [167, 359]. In this model, the free plasmid ends are treated by the cell
DNA repair machinery like chromosomal DSBs. In the attempt to ‘repair’ them, the
cellular enzymes connect them to any neighboring, plasmid or genomic, DNA ends. The
former case leads to the formation of long plasmid concatemers, the latter results in the
incorporation of the vector into the genome. Since NHEJ was shown to very efficiently
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join broken DNA ends in mammalian cells, this pathway was proposed to be responsible
for the integration process.
However, the use of sequencing techniques revealed the presence of rearrangements,
deletions, insertions, and microhomologies in the regions surrounding the integration sites
[136, 203, 225]. These findings seem inconsistent with NHEJ, since it is considered to be a
fairly conservative and precise process (reviewed in [25]). Indeed, in the past years many
groups reported the existence of an alternative, highly error-prone end-joining pathway
relying on a different set of enzymes than NHEJ and employing microhomologies in the
repair process. This pathway, termed alternative NHEJ or MMEJ, was also associated
with spontaneous genomic rearrangements, loss of chromosome fragments and duplications
in cancer cells [138, 244, 299, 381]. Therefore, it seems possible that this mechanism,
rather than classical NHEJ, may be primarily responsible for plasmid genomic integration.
In the present study we find that a specific subset of MMEJ, namely the SD-MMEJ
pathway, allows DNA transfected into CHO cells to integrate into the genome. Furthermore,
we propose the existence of two distinct SD-MMEJ subpathways, relying on different
subsets of enzymes. One of these mechanisms, dependent on base- and nucleotide-excision
repair factors and translesion synthesis polymerases, seems to be responsible for forming
plasmid concatemers. The other pathway, partially dependent on HR and/or DNA
replication enzymes, seems to mediate plasmid recombination with the genome.
7.2 The role of MAR elements in DNA recombination
Previous studies performed by our group suggested that matrix attachment regions may
mediate increased plasmid integration into the genome of CHO cells by stimulating DNA
recombination. In the present work, we demonstrated that MAR-mediated plasmid
integration results from the enhanced SD-MMEJ pathway of DSB repair. However,
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the precise molecular mechanism by which MARs promote this process remains to be
elucidated.
MARs are very AT-rich and possess a high potential to unwind and denature the DNA
double helix [29, 31, 90, 262]. They were also shown to contain multiple target sites of
topoisomerase II, enzyme responsible for removing DNA supercoils by inducing DSBs [57].
These properties may potentially make MAR-containing chromatin regions more prone
to breaking. Indeed, MARs were previously associated with hotspots of DNA cleavage
and illegitimate recombination [307]. Recently Myers and co-workers also reported the
identification of a consensus motif enriched in recombination hot spots in human cells
[235, 236]. Interestingly, the two human MAR elements used in our study also seem to
contain these short sequences. Finally, MARs were also shown to be present in so-called
fragile sites, chromosomal loci with high tendency to breakage [143, 267]. These sites
were associated with genomic rearrangements, including deletions, translocations and
inversions, suggesting that DSBs may frequently arise in these regions [81, 274]. Moreover,
plasmid DNA was shown to preferentially integrate inside these sites [270]. All this taken
together suggests that MAR elements may constitute recombination hotspots, making
them preferred sites for illegitimate integration of foreign DNA.
The MMEJ pathway was reported to be most active during the S phase [328], suggesting
that it may be one of the primary mechanisms responsible for repairing breaks arising at
replication forks. In fact, several MMEJ-like mechanisms, characterized by the occurrence
of genomic rearrangements and microhomology junctions, were proposed to repair these
one-ended DSBs [60, 182]. MAR elements were previously reported to participate in the
initiation of DNA replication in mammalian cells, suggesting that these elements may
recruit replication enzymes [71, 259]. Among the factors mediating replication several were
shown to play a role in MMEJ, including Ligase I and Pold3. This points to a potential
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link between DNA replication, MMEJ-mediated repair and MAR elements.
Finally, it is possible that MARs are able to directly recruit MMEJ factors. It has
already been proposed that MARs associate with NHEJ enzymes, including Ku, DNA-PKcs,
Xrcc4, Ligase IV, as well as PARP1, an enzyme implicated in MMEJ [100, 220]. However,
this was not assessed for other DSB repair factors. Therefore, additional experiments are
needed to fully elucidate the possible direct interaction between MARs and the MMEJ
machinery.
7.3 The problems associated with studying DNA recombination
The studies of DNA recombination mechanisms in mammalian cells encounter many
difficulties stemming from the considerable genome sizes as well as from the abundance
of DNA repair mechanisms operating in these cells. Much of the research on DSB repair
pathways, including this work, was done in immortalized cultured cells. These models
usually originate from cancer cells and likely encounter more DNA damage than normal
cells, due to potential mutations of DNA repair genes, oxidative stress and repeated
replication and division cycles. Therefore, it can be expected that these cells may possess
more efficient DSB repair mechanisms and that the relative participation of different
pathways in the repair process is distinct from normally growing cells. Indeed, studies show
that alternative DSB repair pathways are often upregulated in tumor cells [23, 323]. Many
cancers were also reported to possess a more active HR pathway [206, 360]. Therefore, the
conclusions derived from experiments performed in these cells should not be extrapolated
to all cell types.
Many DSB repair proteins were discovered and described by using mutant cell lines
sensitive to DNA damaging agents or ionizing radiation. However, most of these cell lines
were generated by chemical mutagenesis and many of them were never sequenced at the
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genomic level. Consequently, their underlying mutations remain largely unknown. In this
study we analyzed two CHO mutants reported to be deficient in the components of the
NHEJ and HR pathways. Full transcriptome sequencing of these cells revealed significant
differences in the expression of other DNA repair genes, calling into question the reliability
of these cell lines and their usefulness in the studies of DSB repair mechanisms.
Plasmid recombination assays are another tool frequently used to study DNA recombi-
nation in mammalian cells. These assays often rely on the reconstitution of an inactive
reporter gene by repairing an enzymatically induced DSB. While these assays certainly
contributed to our understanding of the DSB repair in mammalian cells, they are not
always very specific and often fail to detect all types of repair events. Unless junction
sequencing is performed this may falsify the true contribution of the studied pathway
to the DSB repair process. This proved to be the case for the published reporter assays
used in this study. Moreover, these kind of assays only allow to study the repair of DSBs
generated by restriction enzyme digestion, which require little processing and can be
efficiently repaired by simple re-ligation. However, in vivo DSBs are often chemically
modified, possess incompatible DNA ends or lack terminal 3’-hydroxyl or 5’-phosphate
groups precluding ligation. Such ends require modification or resection prior to repair,
and may therefore be often repaired by other pathways.
The investigation of alternative DSB repair pathways is particularly complicated due
to the reported existence of many distinct sub-pathways. Moreover, the factors thought to
be implicated in MMEJ also participate in other DNA repair mechanisms and/or DNA
replication. This makes it very difficult to interpret the effects of their overexpression,
knock-down or knock-out, and is likely the reason why many conflicting reports have been
published on the subject. Interestingly, the results included in this work demonstrate that
particular HR proteins may also have pleiotropic effects, and that they may also contribute
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to one type of SD-MMEJ pathways. Furthermore, in addition to their roles in DNA repair,
they may also influence the cell cycle progression. In conclusion, all these factors should
be taken into account when studying the function of particular DSB repair pathways.
7.4 Final remarks
The drawback of random plasmid integration is the lack of control over the chromosomal
integration site. This can result in insertional mutagenesis, proto-oncogene activation
or silencing of the gene of interest. Gene targeting enables transgene integration at a
predefined genomic locus, allowing for safer generation of stably transfected cells. However,
this procedure is extremely inefficient in mammalian cells. Until now, the efforts to enhance
this process were aimed at inhibiting NHEJ. Many studies show that blocking the NHEJ
pathway enables to enhance HR. However, it only allows to increase targeted integration
2-30 fold, depending on the cell type [24, 136, 378]. This can be regarded as a moderate
improvement considering the fact that random integration events were estimated to occur
about 100-10000 times more frequently than targeted events (reviewed in [32, 301, 339]).
Moreover, while this strategy enables to increase HR-mediated integration, it results in
little or no decrease of random integration, likely due to very efficient alternative end-
joining pathways in the target cells [24, 136]. Here, we identify the SD-MMEJ pathway as
one of the primary mechanisms driving illegitimate integration in mammalian cells. This
knowledge should help to modify the DNA recombination potential of cultured mammalian
cells and increase the efficiency of gene targeting.
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ABSTRACT
Gene transfer and expression in eukaryotes is often
limited by a number of stably maintained gene copies
and by epigenetic silencing effects. Silencing may be
limited by the use of epigenetic regulatory se-
quences such as matrix attachment regions (MAR).
Here, we show that successive transfections of
MAR-containing vectors allow a synergistic increase
of transgene expression. This finding is partly ex-
plained by an increased entry into the cell nuclei
and genomic integration of the DNA, an effect that
requires both the MAR element and iterative trans-
fections. Fluorescence in situ hybridization analysis
often showed single integration events, indicating
that DNAs introduced in successive transfections
could recombine. High expression was also linked
to the cell division cycle, so that nuclear transport of
the DNA occurs when homologous recombination
is most active. Use of cells deficient in either non-
homologous end-joining or homologous recom-
bination suggested that efficient integration and
expression may require homologous recombination-
based genomic integration of MAR-containing
plasmids and the lack of epigenetic silencing events
associated with tandem gene copies. We conclude
that MAR elements may promote homologous
recombination, and that cells and vectors can
be engineered to take advantage of this property
to mediate highly efficient gene transfer and
expression.
INTRODUCTION
A major impediment to efﬁcient and stable transgene ex-
pression is the variability of expression noted in independ-
ently transformed mammalian cells and organisms, both
in experimental biology and for therapeutic applications.
The high degree of expression variability is thought to
depend on the number of transgene copies that integrate
within the host genome and on the site of transgene inte-
gration (1,2). Indeed, transgene expression may be inﬂu-
enced by the fortuitous presence of regulatory elements
at the random integration locus in the host genome. In
addition, transgene expression is thought to reﬂect the in-
ﬂuence of particular chromatin structure coming from
adjacent chromosomal domains (3–5). Finally, the co-
integration of multiple transgene copies at the same
genomic locus may lead to silencing, possibly because of
the formation of small inhibitory RNAs from antisense
transgene transcription (6).
To increase and stabilize transgene expression in mam-
malian cells, epigenetic regulators such as matrix attach-
ment regions (MAR) are increasingly used to protect
transgenes from silencing effects (7). MAR were ﬁrst dis-
covered two decades ago for their association with the
nuclear matrix or scaffold (8,9), a poorly characterized
structural network that may consist of various non-
histone nuclear proteins such as lamins, topoisomerases
and components of transcription machinery (10).
Eukaryotic chromosomes are organized in independent
loops of chromatin that may control DNA replication,
transcriptional regulation and chromosomal packaging
(11–15). MARs were proposed to be the speciﬁc DNA
sequences that anchor the chromosomes to the matrix
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and partition chromosomes into these 50–200 kb DNA
loop structures (16–18).
MARs are polymorphic 300–3000 bp-long DNA
elements composed essentially of non-coding AT-rich se-
quences, and they are estimated to be 50 000–100 000 in
the mammalian genomes (10). Their activity is thought
to relate to their structural properties rather than to
their primary sequence. Although no consensus MAR
sequence has been found, they often have AT-rich se-
quences (19) and they may adopt particular conform-
ations and physicochemical properties, such as a natural
curvature (20), a deep major groove and a narrow minor
groove (21), a high DNA strand unwinding and unpairing
susceptibility (12), and a high potential to double-helix
denaturation (22,23).
Besides providing a topological structure to the chro-
matin, MARs also contribute to regulate key genomic
functions (24), as they were involved in the control of
activities such as DNA replication and gene transcription
(25,26). For instance, several origins of replication have
been mapped within MARs in various eukaryotic
genomes (27). Moreover, MARs are able to recruit
endogenous replication factors and may allow sustained
episomal replication when placed within an active tran-
scription unit (28,29). Similarly, the ability of MARs to
inﬂuence gene expression has been associated to the
binding of protein factors in addition to the intrinsic
properties of their DNA sequence (8,30,31). MARs asso-
ciate with speciﬁc ubiquitous and tissue-speciﬁc transcrip-
tion factors such as special AT-rich binding protein1
[SATB-1; (32)], NMP4 (33) and CTCF (34), which may
in turn recruit regulatory proteins such as histone acetyl
transferases, topoisomerases and ATP-dependent chroma-
tin remodeling complexes to mediate a more expression-
permissive chromatin state (35,36), as well as components
of the transcription machinery and splicing factors (37,38).
Thus, in addition to deﬁning chromatin loop domains
and organizing chromosomal architecture, MARs may
contribute to control chromatin structure and gene
expression.
MAR elements were shown to increase transgene ex-
pression and to decrease the clonal variability in stable
transfections of mammalian cell lines and in transgenic
plants and animals (21,39–42). MARs were proposed to
act as insulators that protect transgenes from the repres-
sive effects of surrounding heterochromatic area of the
chromosomes and/or to relocate transgenes in an active
compartment of the nucleus (7). MAR were also incor-
porated into viral vectors to reduce their susceptibility to
silencing (43). A transgene ﬂanked with MAR elements
may thus constitute an autonomous chromatin domain
whose expression would remain independent of the
adjacent chromosomal environment.
MAR elements may also constitute targets of DNA re-
combination or rearrangement events, as exempliﬁed by
many MAR-related deletions and translocations involved
in leukaemia and breast cancer (44,45). Additionally, it
was shown that retroviral integration often occurs close
to or within MARs (46,47). MARs were shown to bind
DNA topoisomerase II (48), an enzyme that catalyzes
double-strand breaks, as may be required to initiate the
recombination pathways of DNA repair (49,50).
However, whether MARs might mediate or regulate
DNA recombination remains to be demonstrated.
In this study, we show that successive transfections of
MAR-containing expression vectors mediate an unexpect-
edly high increase in transgene expression when the DNA
reaches the nucleus at phases of the cell division cycle
when the homologous recombination (HR) pathway is
most active. This results in part from an increased trans-
port of the DNA in the nucleus and more efﬁcient
genomic integration. This effect is abrogated in cells deﬁ-
cient in HR as opposed to non-homologous end-joining.
This study thus allows to propose a new function of MAR
elements, which may be to promote homologous DNA
recombination. It also identiﬁes some of the limitations
to efﬁcient gene transfer and expression in eukaryotic
cells, and it provides new avenues for more efﬁcient and
more reliable gene expression, for instance to express
therapeutic proteins or for gene and cell therapies.
MATERIALS AND METHODS
Plasmids and constructs
pGEGFPcontrol contains the SV40 early promoter,
enhancer and vector backbone from pGL3 (Promega)
driving the expression of the eGFP gene from pEGFP-
N1 (Clontech). pPAG01SV40EGFP results from the in-
sertion of the chicken lysozyme MAR fragment upstream
of the SV40 early promoter of pGEGFPcontrol (51). The
human MAR 1–68 was identiﬁed by the SMARScan
program using DNA structural properties. It was cloned
from human bacterial artiﬁcial chromosomes in
pBluescript and then inserted into pGEGFPcontrol
upstream the SV40 early promoter, resulting in the
p1–68(NcoI ﬁlled)SV40EGFP plasmid (21).
pGL3-CMV-DsRed was created by inserting the DsRed
gene, under the control of the CMV promoter (including
the enhancer), from pCMV-DsRed (Clontech) in pGL3-
basic (Promega). pGL3-CMV-DsRed-kan was then
created by exchanging the ampicillin gene of pGL3-
CMV-DsRed for kanamycin resistance gene from
pCMV-DsRed (Clontech) by digestion of both plasmids
with BspHI. Then, the chicken lysozyme or the human 1–
68 MAR were inserted into the pGL3-CMV-DsRed-kan
plasmid. They were inserted as KpnI/BglII fragment con-
taining the chicken lysozyme fragment, or as KpnI/
BamHI human 1–68MAR fragment, upstream of the
CMV promoter in pGL3-CMV-DsRed-kan, resulting in
pPAG01GL3-CMV-DsRed and p1–68(NcoI) ﬁlledGL3-
CMV-DsRed, respectively.
Cell culture and transfection
The CHO DG44 cell line (52) was cultivated in DMEM:
F12 (Gibco) supplemented with HT (Gibco) and 10%
fetal bovine serum (FBS, Gibco). Parental CHO cells
AA8, NHEJ deﬁcient cells V3.3 (53) and HR deﬁcient
cells 51D1 (54) were kindly provided by Dr Fabrizio
Palitti (University of Tuscia, Italy) and were cultivated
in DMEM: F12 medium with 10% FBS and antibiotics.
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Transfections were performed using Lipofect-AMINE
2000, according to the manufacturer’s instructions
(Invitrogen). GFP or DsRed ﬂuorescence levels were ana-
lyzed using a ﬂuorescence-activated cell sorter (FACS), 1,
2 or 3 days post-transfection (transient transfections).
Stable pools of CHO-DG44 cells expressing GFP and/or
DsRed were obtained by cotransfection of the resistance
plasmid pSVpuro (Clontech). After two weeks of selection
with 5 mg/ml puromycin for CHO-DG44 (8 mg/ml puro-
mycin for AA8, V3.3 and 51D1), cells were analyzed by
FACS.
Cell subjected to multiple transfections were treated as
follows: after the ﬁrst transfection, the cells were trans-
fected a second time according to the protocole detailed
above, except that the resistance plasmid carried a differ-
ent resistance gene (pSV2 neo, Clontech). The two trans-
fections were at a 21 h interval, to be in phase with the cell
cycle progression, unless otherwise indicated in the text.
Twenty-four hours after the second transfection, cells were
passaged and selected with 250 mg/ml G418 and/or
2.5 mg/ml puromycin (250mg/ml G418 and 4 mg/ml puro-
mycin for AA8, V3.3 and 5A1D1). After 3 weeks of selec-
tion, GFP and/or DsRed expression was analyzed by
cytoﬂuorometry.
Fluorescence activated cell sorting
Transient expression of eGFP and DsRed proteins was
quantiﬁed at 24, 48 or 72 h after transfection using a
FACScalibur ﬂow cytometer (Becton Dickinson),
whereas expression of stable cell pools was determined
after at least 2 weeks of antibiotic selection. Cells were
washed with PBS, harvested in trypsin-EDTA, pooled,
and resuspended in serum-free synthetic ProCHO5
medium (Cambrex corporation). Fluorescence analyses
were acquired on the FACScalibur ﬂow cytometer
(Becton Dickinson) with the settings of 350V on the
GFP channel (FL-1) and 450V on the DsRed channel
(FL-3) for transient expression. Settings of 240V for
FL-1 and 380V for FL-3 were used to analyze stable ex-
pression. 100 000 events were acquired for stable trans-
fections and 10 000 for transient transfections. Data
processing was performed using theWinMDI 2.8 software.
Cell cycle analysis
At the indicated times, the cell cycle status was analyzed
by ﬂow cytometry after staining the nuclear DNA with
propidium iodide (PI). Cells were ﬁrst washed with a
(PBS), trypsinized and harvested in 1ml of growth
media by centrifugation for 5min at 1500 rpm (250 g) in
a microcentrifuge. After an additional PBS wash, cells
were resuspended in 1ml of PBS before ﬁxing with
ethanol by the addition of 500ml of cold 70% ethanol
dropwise to the cell suspension under agitation in a
vortex. Samples were incubated for 30min at 20C and
cells were centrifuged as before. The resulting cell pellet
was resuspended in 500 ml of cold PBS, supplemented with
50 mg/ml of RNaseA and the DNA was stained with 40 mg/
ml of PI for 30min in the dark. Cells were then washed
with PBS, centrifuged and resuspended in 500 ml of
ProCHO5 medium (Cambrex corporation) before
analysis in a FACScalibur ﬂow cytometer (FL-3
channel; Becton Dickinson). Ten thousand events were
acquired for each sample.
Fluorescent in situ hybridization
Fluorescent in situ hybridization (FISH) were performed
as previously described in Derouazi et al. (55) and Girod
et al. (21). Brieﬂy, metaphase chromosomal spreads were
obtained from cells transfected with or without the 1–68
human MAR and treated with colchicine. FISH was per-
formed using hybridization probes prepared by the direct
nick translation of pSV40GEGFP plasmid without the
MAR.
Isolation of nuclei and DNA
Nuclei were isolated 1, 2 or 3 days after transient trans-
fection(s), from proliferating and conﬂuent CHO DG44
cells grown in 6-well plates. Cells (1 106) were washed
twice with cold PBS, resuspended in 2 volumes of cold
buffer A [10 mM HEPES (pH 7.5), 10mM KCl, 1.5mM
Mg(OAc)2, 2mM dithiothreitol] and allowed to swell on
ice for 10min. Cells were disrupted using a Dounce
Homogenizer. The homogenate was centrifuged for
2min at 2000 rpm (370 g) at 4C. The pellet of disrupted
cells was then resuspended in 150 ml of PBS and deposited
on a cushion of buffer B [30% sucrose, 50mM Tris–HCl
(pH 8.3), 5mM MgCl2, 0.1mM EDTA] and centrifuged
for 9min at 3500 rpm (1200 g). The pellets of nuclei were
resuspended in 200 ml of buffer C [40% glycerol, 50mM
Tris–HCl (pH 8.3), 5mM MgCl2, 0.1mM EDTA] and
stored frozen at 80C until use (56).
Total cell DNA was isolated from CHO DG44 stable
cell pools or from isolated cell nuclei using the DNeasy
Tissue Kit from Qiagen. For stable cell pools, 1 106 con-
ﬂuent CHO DG44 cells growing in 6-well plates were col-
lected. DNA extraction was performed according to the
manufacturer’s instruction for the isolation of total DNA
from cultured Animal cells. DNA isolation was performed
on frozen pellets of isolated cell nuclei, which were ﬁrst
thawed and centrifuged at 1700 rpm (300 g) for 5min to
remove buffer C before beginning DNA extraction follow-
ing the same protocol as for the isolation of DNA from
stable cell lines.
Transgene copy number determination and quantitative
PCR
To determin the copy number of transgenes integrated in
the genome, 6 ng of genomic DNA were analyzed by
quantitative PCR using the SYBR Green-Taq polymerase
kit from Eurogentec Inc and ABI Prism 7700 PCR
machine. The following primers were used to quantify
the GFP gene: GFP-For: ACATTATGCCGGACAAA
GCC and GFP-Rev: TTGTTTGGTAATGATCAGCAA
GTTG, while primers GAPDH-For: CGACCCCTTCAT-
TGACCTC and GAPDH-Rev: CTCCACGACATACTC
AGCACC were used to amplify the GAPDH gene. The
ratios of the GFP target gene copy number were cal-
culated relative to that of the GAPDH reference gene as
described previously (57). To determine import of the
transgene into nuclei following transfection, quantitative
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PCR was performed on DNA extracted from puriﬁed
nuclei using the same GFP and GAPDH primer pairs as
described above.
The number of GAPDH gene and pseudogene copies
used as reference was estimated for the mouse genome, as
the CHO genome sequence is not available as yet.
Alignment to the mouse genome of the DNA sequence
of the 190 bp amplicon generated by the GAPDH
primers was performed using NCBI BLAST software. A
number of 88 hits was found per haploid genome. As the
CHO DG44 are near-diploid cells (55), we estimated that
176 copies of the GAPDH genes and pseudogenes occur in
the genome of CHO DG44 cells. This number was used as
a normalization standard for the quantiﬁcation of the
GFP transgene copy number.
Confocal microscopy
pGEGFPcontrol and p1-68(NcoI ﬁlled)SV40EGFP
plasmids were labeled either with rhodamine by the
Label IT Tracker TH-Rhodamine Kit or with Cy5 by
the Label IT Tracker Cy 5 Kit (Mirus, Mirusbio) accord-
ing to the manufacturer’s protocol, and puriﬁed by ethanol
precipitation. For transfection, DNA transfection was
carried out with the Lipofectamine 2000 reagent
(Invitrogen) according to the supplier’s instructions. At
3, 6 and 21 h after transfection, the medium was removed
and the cells were ﬁxed with 4% paraformaldehyde at
room temperature for 15min. When indicated, cells were
treated for 30min with LysoTracker Red DND-99
(Molecular Probes, Invitrogen) at a ﬁnal concentration
of 75 nM before ﬁxation, to stain the acidic organelles
(e.g. endosomes and lysosomes) according to the manu-
facturer’s instructions. The ﬁxed cells were then washed
twice with PBS and mounted in a DAPI/Vectashied
solution to stain the nuclei.
Fluorescence and bright-ﬁeld images were captured
using a Carl Zeiss LSM 510 Meta inverted confocal
laser-scanning microscope, equipped with a 63 NA 1.4
planachromat objective. Z-series images were obtained
from the bottom of the coverslip to the top of the cells.
Each 8-bit TIFF image was transferred to the ImageJ
software to quantify the total brightness and pixel area
of each region of interest. For data analysis, the pixel
areas of each cluster in the cytosol si(cyt), nucleus si(nuc)
and lysosome si(lys) were separately summed in each XY
plane. Theses values [S0Z=j(cyt), S0Z=j(nuc) and
S0Z=j(lys), respectively] were further summed through
all of Z-series of images and denoted S(cyt), S(nuc) and
S(lys), respectively. The total pixel area for the clusters of
labeled pDNA in the cells, S(tot), was calculated as the
sum of S(cyt), S(nuc) and S(lys). The fraction of pDNA in
each compartment was calculated as F(k)=S(k)/S(tot),
where represents each subcellular compartment (nucleus,
cytosol or lysosome).
RESULTS
Effect of iterative transfection on transgene expression
Previous work has led to the screening of human MARs to
identify one, termed MAR 1–68, that was found to
potently increase and stabilize gene expression in cultured
cells and in mice when inserted upstream of the promoter/
enhancer sequences (21,39). Co-transfection of a GFP ex-
pression vector and an antibiotic resistance plasmid,
followed by antibiotic selection of cells having stably
integrated the transgenes in their genome, typically
yields a bimodal distribution of the ﬂuorescence in poly-
clonal cell populations when analyzed by ﬂow cytometry
(Figure 1A). A ﬁrst cell subpopulation, which overlaps the
y-axis in this experimental setting, corresponds to cells
expressing GFP at undetectable levels, while another
subpopulation of cells expresses signiﬁcant GFP levels.
Inclusion of MAR 1–68 increased the level of expression
from ﬂuorescent cells and concomitantly reduced the pro-
portion of silent cells (15 versus 36%, Figure 1B). The
increase in expression did not depend on the use of the
viral SV40 promoter, as it was also obtained when ex-
pressing GFP from the the cellular glyceraldehyde
3-phosphate dehydrogenase (GAPDH) gene promoter
(Supplementary Figure S1).
We next tested whether two consecutive co-
transfections might further increase GFP expression
from the MAR-containing plasmids (Figure 1A). When
the same GFP expression vector was co-transfected
again 2 weeks later with a distinct antibiotic resistance
gene, a 2.4-fold increase of ﬂuorescence was observed on
average after selection for resistance to the second anti-
biotic, which is close to the expected 2-fold increase
(Figure 1A and C). In contrast, an unexpectedly higher
(4- to 5-fold) increase of GFP expression was observed
from two successive transfections performed on consecu-
tive days followed by selection with both antibiotics.
When averaging over all cells of the polyclonal popula-
tion, a 20-fold increase of expression was gained by suc-
cessive transfections of MAR-containing plasmids when
compared to a single transfection without a MAR
(Figure 1C). Furthermore, some of the cells displayed
very high levels of expression, and the occurrence of
silent cells was almost fully abrogated from the polyclonal
population (0.5%, Figure 1B). Consecutive transfections
without a MAR yielded modest GFP expression, resulting
in a 3.2-fold average increase of the overall ﬂuorescence
level when compared to a single transfection, and it did
not abrogate the occurrence of silent cells (Figure 1C and
data not shown). Thus, the presence of the MAR and the
iterative transfection act synergistically to mediate
elevated expression levels.
Overall, the expression levels obtained from the two
consecutive transfections of MAR-containing plasmids
were so high that the GFP ﬂuorescence could be readily
seen from the cell culture monolayers in the daylight, with-
out excitation with UV light (Supplementary Figure S2A).
This effect was not limited to the human MAR 1–68, as
both the relatively less potent chicken lysozyme MAR
(cLysMAR) and MAR X-29, a potent MAR isolated
from human chromosome X (21), yielded an increase in
expression when comparing double to single transfections
(Supplementary Figure S3). This indicated that the
elevated expression upon successive transfections may be
a general property of MAR elements. However, the
cLysMAR element yielded relatively lower transgene
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activation after a single transfection, and the increase in
expression observed after the successive transfections was
comparably lower. The converse was true of MAR X-29,
indicating that MARs ability to mediate each of these
effects may vary similarly.
The effect of the double transfection of MAR-
containing plasmids was not dependent either on the
GFP transgene or on the SV40 promoter used to express
GFP, as similar results were obtained when a CMV
promoter was used to express the DsRed reporter gene
or the immunoglobulin light and heavy chains
(Supplementary Figure S2B and data not shown).
Interestingly, the very high levels of immunoglobulins
expressed by monoclonal CHO cell clones often corre-
lated with an increased cell division time. This indi-
cates that the cells were likely reaching their
physiological limits in terms of protein synthesis. This
may be expected, as cells synthesizing similar amounts of
the recombinant protein as compared to their own cellular
proteins (100 pg per cell) should double the energetic
input required for each cell division. Nevertheless,
a large proportion of clones were found to express the
heterologous protein at very high levels without
interfering with their own metabolism, as they did not
slow down cell division signiﬁcantly (Supplementary
Figure S2B).
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Figure 1. Analysis of the effect of MARs and successive stable transfections on gene transfer and expression. CHO DG44 cells were co-transfected
with the GFP expression vector devoid of MAR element (GFP, dark line), or with the vector containing MAR 1–68 (MAR1–68GFP, red line), and
with the pSVpuro plasmid mediating resistance to puromycin. Some of these cells were submitted to a second transfection with the same GFP
expression vector but with a selection plasmid mediating neomycin resistance, either on the day following the ﬁrst transfection (blue line) or after 2
weeks of selection for puromycin resistance (green line). After 2 weeks of selection for puromycin (single transfections), or 3 weeks of selection for
both puromycin and neomycin resistance (double transfections at 1 day interval), or 2 weeks of selection for puromycin followed by the second
transfection and two weeks of neomycin resistance selection (double transfections at 2 weeks interval), eGFP ﬂuorescence was quantiﬁed by
cytoﬂuorometry. (A) Fluorescence distribution in polyclonal populations of GFP-expressing cells. The cell ﬂuorescence proﬁles shown are represen-
tative of four independent experiments. (B) Histogram showing the percentage of total cells corresponding to non/low-expressors that display <10
relative light units (RLU), or cells that display medium and high (>100 RLU) or very-high (>1000 RLU) GFP ﬂuorescence, as determined from the
analysis of stable cell pools as shown in panel A. (C) The mean GFP ﬂuorescence of each stable polyclonal cell pool was normalized to that obtained
from the transfection of MARGFP and the average and standard deviation of four independent transfections is shown as a fold increase over the
ﬂuorescence obtained by one transfection without a MAR. Asterisks indicate signiﬁcant differences in GFP expression (Student’s t-test, P< 0.05).
(D) FISH analysis of eGFP transgene chromosomal integration sites in cells singly or doubly transfected with or without the human MAR.
Metaphase chromosomes spreads of stable cell pools were hybridized with the GFP plasmid without MAR, and representative illustrations of
the results are shown. (E) Enlargements of chromosomes are shown to illustrate differences in ﬂuorescence intensities.
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Cointegration of transgenes upon iterative transfections
An important parameter driving high expression upon it-
erative transfection was found to be the time interval
between the two transfections. The synergistic effect on
expression was not observed when re-transfecting cells
after 2 weeks. Rather, the two transfections behaved as
two independent and thus additive events (Figure 1C).
This suggested that the plasmid DNAs from each trans-
fection may have to interact as episomes within the
nucleus and potentially form mixed concatemers before
co-integrating into the cell genome. This possibility was
assessed by FISH analysis of metaphase chromosomal
spreads from stable polyclonal populations. Eighty indi-
vidual metaphases of cells transfected once either with or
without the MAR element were hybridized with a probe
consisting of the GFP plasmid without a MAR. A single
integration site was observed, but higher ﬂuorescence
intensities were observed from cells transfected with the
MAR (Figure 1D and E). Fluorescence intensity was
further increased by the double transfection process, sug-
gesting that a higher number of transgene copies had
integrated. Unique integration sites were noted in all
cases after single or two consecutive transfections.
However, double integration events were observed in ap-
proximately half of the cells transfected twice at an
interval of 1 week, when little episomal DNA should
remain from the ﬁrst transfection. This indicates that in-
dependent integration events may occur if DNA integra-
tion from the ﬁrst transfection has been completed before
the second transfection is performed. Double transfec-
tions did not lead to apparently increased aneuploidies
nor to detectable chromosomal rearrangements, and
they did not detectably lead to insertions at a preferred
chromosomal locus, as none of the analyzed cells had an
identical integration site. Thus, transgene integration
upon two transfections does not appear to be targeted to
any speciﬁc chromosomes or chromosomal sites, as re-
ported earlier for single transfections of MAR-containing
plasmids (21).
High transgene expression requires phasing of the cell
cycle and transfections
As timing between transfections seemed to play a role in
high transgene expression, we analyzed the effect of sys-
tematic variations of the time interval. The highest GFP
expression level was observed when the second transfec-
tion was performed 21 h after the ﬁrst one, yielding con-
sistently a 5-fold increase of ﬂuorescence as compared to a
single transfection. When the second transfection was per-
formed after 18, 24 and 27 h, a 3- to 3.5-fold increase of
expression was obtained as compared to a single transfec-
tion, but these were signiﬁcantly lower than those
obtained after 21 h (Figure 2A). As this timing is close
to the duration of the ﬁrst cell division cycle after cell
passaging (Supplementary Figure S4), this suggested that
high transgene expression upon consecutive transfections
might be linked to particular phases of the cell division
cycle.
The distribution of the cells along the division cycle was
determined by PI staining of the DNA. This analysis
indicated an over-representation of cells at the G1 phase
18 h after cell passaging, and this was found to correspond
to the timing that yields the highest expression from a single
transfection (Figure 2B, Supplementary Figure S4A and B
and data not shown). A similar pattern and over-
representation of G1 cells was obtained 21 h after the
ﬁrst transfection, which again corresponds to the timing
that yields the highest expression levels upon a second
transfection (Figure 2B). If expression is indeed linked
to cell cycle phasing, another optimum for transgene ex-
pression should be observed if a second transfection was
performed at an interval corresponding to two cell div-
isions. After 42 h, the synergistic effect of the two trans-
fections was lost, as expression was similar to that
obtained for one transfection. However, a second, albeit
lower, synergistic increase of transgene expression was
observed after 48 h. The higher levels of expression
observed from a ﬁrst transfection at 18 h and for a
second transfection performed with a 21 or 48 h interval
imply that optimal DNA transfer and/or expression may
occur at speciﬁc cell division stages.
Effect of MAR and consecutive transfections on cellular
DNA uptake
FISH analysis suggested that elevated expression upon
successive transfections may result in part from the inte-
gration of a higher number of the transgene copies in the
genome (Figure 1D). Consecutive transfections at an
interval of one day might lead to an increase of the con-
centration of plasmid episomes in the nucleus, thereby
augmenting the probability of transgene integration
within the cell genome. To assess the amount of transgene
entering nuclei at each transfection, we performed transi-
ent single or double transfections followed by plasmid ex-
traction from nuclei isolated 1 or 2 days after the second
transfection and quantiﬁcation of the transgenes by real-
time quantitative PCR (qPCR). Cells doubly transfected
with MAR-GFP exhibited 3.8-fold more GFP transgene
copies in their nuclei than cells transfected just once with
MAR-GFP (Figure 3A). When comparing cells trans-
fected with these different plasmids expressing either
GFP or DsRed, we observed that the nuclear delivery re-
sulting from the second transfection of MAR-GFP was
4.2-fold higher than the one observed from a single trans-
fection of this plasmid. However, the nuclear transport of
the ﬁrstly transfected GFP plasmid was not increased sig-
niﬁcantly by performing a second transfection. We
concluded that DNA transport to the nucleus from the
second transfection is favored by performing a prior ﬁrst
transfection.
These conclusions were strengthened by confocal
imaging of DNA transport, where plasmids used for the
ﬁrst transfection were labeled with rhodamine while the
secondly transfected plasmids were labeled with Cy5 (red
and white labels, respectively, Figure 4A). Similar
numbers of rhodamine-labeled plasmid clusters were
observed in cell nuclei after a ﬁrst transfection with or
without a MAR, which correlates well with the lack of
effect of the MAR on DNA transport as assessed by
qPCR (Figures 3A and 4A). Nuclear plasmid clusters
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were observed in essentially all the cells after two trans-
fections. However only few cells expressed GFP, in agree-
ment with previous observations that only a minority of
cells are able to express transiently transfected genes (58).
The transport of transfected plasmid DNA in CHO
cells, which is known to consist of cellular uptake, lyso-
somal escape and nuclear import, is limited by endosomal/
lysosomal degradation (58). Thus, we next assessed the
intracellular trafﬁcking of transfected plasmid DNA by
quantifying its distribution in cellular organelles and in
the cytosol after each transfection, after speciﬁc staining
of the endosomal/lysosomal and nuclear compartments to
distinguish them from the cytosol. Results summarized in
Figure 4B show a similar subcellular distribution of
plasmid DNA with or without MAR 21 h after a ﬁrst
transfection, although nuclear transport of
MAR-containing plasmids seemed somewhat faster at
the earlier time points. Performing a second transfection
of the MAR-devoid plasmid did not yield an improved
nuclear transport. However, plasmids bearing a MAR
element escaped lysosomal retention and entered nuclei
much more efﬁciently, as 80% of the total Cy5-labeled
pDNA was located in the nuclei in presence of the
MAR 21h after the second transfection, as compared to
<40% of the plasmid devoid of MAR (Figure 4B).
Rather, most of the MAR-devoid plasmid ended up in
the lysosomal/endosomal compartment, as found also
for the ﬁrst transfection. The unexpected ﬁnding of a co-
operative effect of the MAR and of the iterative gene
transfer on lysosomal escape thus provides an explanation
for the increased concentration of plasmids in isolated
nuclei (Figures 3A and 4B). The reason for this phenom-
enon is unclear at present, but it might result in part from
the saturation of the cellular degradation compartments
by the DNA of ﬁrst transfection, thus allowing plasmids
of the second transfection to remain in the cytoplasm
where the MAR may promote plasmid transport into
the nucleus.
MAR elements increase the copy number of genome-
integrated transgenes
Next, we examined whether the increased transport of
plasmid DNA elicited by the MAR and the consecutive
transfections may increase transgene integration into the
genome of CHO cells. Stable polyclonal cell populations
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were selected as for Figure 1, and the average numbers of
stably integrated GFP transgene copies per genome were
determined on total cell DNA using qPCR. Inclusion of a
MAR element in transfected plasmids signiﬁcantly
increased the number of transgenes integrating in the
genome of stable cell pools (Figure 3B). Because the
MAR does not act to increase nuclear transport after
single transfections (Figure 3A), we concluded that the
MAR may increase genomic integration of the plasmid
per se. This ﬁnding supports previous indications that
the use of MARs may increase the number of transgene
copies that integrate in the genome of recipient cells
(51,59).
Successive transfections also mediated a 4-fold increase
of plasmid integration, which is commensurate to the
increase in free episomes noted in transient transfections
(Figure 3A and B). We estimated that 48 GFP plasmid
copies had integrated on average when transfecting once
without a MAR, while 163 copies and 676 copies on
average were obtained from one or two successive trans-
fections with the MAR, respectively. Overall, the incr-
eased nuclear transport synergistically elicited by both
the MAR and the successive transfections yielded a
>10-fold increase in transgene copy number when com-
bined to the MAR-driven increase of plasmid integration.
Note, however, that the double transfection of MAR-
containing plasmids yielded yet an even higher increase
in transgene expression (20-fold, Figure 3C). This
indicated that increased expression did not result solely
from increased transgene copy number, but that it must
also stem from a MAR-mediated increase of expression
per integrated transgene copy, as expected from the pre-
viously observed antisilencing and transcription activation
effects of this MAR element (39).
When assessing GFP expression and transgene copy
number in individual cell clones isolated from the poly-
clonal populations, a correlation was found between
transgene expression and copy number, in that higher
levels of integration and of expression were observed
from single or multiple transfections of MAR-containing
plasmids (Supplementary Figure S5A). Furthermore, no
signiﬁcant decrease of expression could be detected from
MAR-containing clones having co-integrated very high
numbers of transgene copies and MARs (Supplementary
Figure S5B), and stable elevated expression was main-
tained upon adaptation of several of these clones to
growth in suspension and further culturing (data not
shown). These results indicated that the MAR was able
to prevent inhibitory effects that may result from the re-
petitive nature of the co-integrated plasmids and/or from
antisense transcription, an effect that can be attributed to
the potent anti-silencing properties of this MAR element
(39). However, the average levels of expression did not
match perfectly with copy number, as noted when
analyzing individual cell clones (Supplementary Figure
S5A), or when comparing GFP expression from the
ﬁrstly or secondly transfected DNA, in co-transfection ex-
periments with the dsRED vector (Figure 3B and C). We
therefore conclude that the enhanced transgene expres-
sion observed after two successive transfections of
MAR-containing plasmids can be explained in part by
the improved nuclear import and genomic integration of
the plasmid DNA, which results in increased transgene
copy number, as well as by the lack of silencing and
higher transgene transcription. However, other effects
may also inﬂuence transgene expression in individual
clones depending on the transfection history and condi-
tions, clonal ﬁtness heterogeneity and/or possible effects
pertaining to the genomic integration locus.
Effects of DNA homology on plasmid integration and
expression
As the high GFP ﬂuorescence observed from successive
transfections of MAR-containing plasmids results in
part from the increased transgene integration at a single
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chromosomal locus, we next examined the molecular basis
of this effect. A possibility is that the integration of a
MAR-containing plasmid during the ﬁrst transfection
might promote secondary integration at the same
genomic locus during the second transfection. This may
be expected from the ability of the MAR to maintain
chromatin in an accessible state and thus to provide
proper targets for HR. Alternatively, the high number of
integrated transgenes may result from a more efﬁcient
concatemerization of the plasmids introduced during
both transfections, as may be mediated by the high con-
centration of episomes found in the nucleus. Indeed, HR
was proposed to mediate the formation of large
concatemers of transfected plasmids (60), which may
lead to the co-integration of multiple plasmid copies
upon recombination with the genomic DNA. In the
latter model, HR may occur between similar DNA se-
quences on the plasmids used during the ﬁrst and second
transfections, and thus the efﬁcacy of transgene integra-
tion and expression should critically depend on DNA
sequence homologies.
This latter possibility was ﬁrst assessed by analyzing
the effect of plasmid homology on transgene expression
by performing successive transfections with different
combinations of transgenes (GFP or DsRed), plasmid
backbones (ampicillin or kanamycin baterial resistance)
and/or MARs (chicken lysozyme MAR or the human
MAR 1–68). Transfection of distinct MARs, trans-
genes, or bacterial resistance all decreased the high expres-
sion normally observed with successive transfections
(Figure 5A). The double transfection effect was almost
fully abolished when using different MARs, trans-
genes and vector elements (MAR1-GFP+MAR2-RED
constructs), suggesting that plasmid homology is
required to achieve high expression from successive
transfections.
HR is often elicited as a DNA repair mechanism
of double-stranded breaks (DSB), in a process that
was termed homologous recombination repair (61,62).
Thus, we tested whether plasmid linearization prior to
transfection mediates the high expression obtained from
successive transfections. A more than additive increase
of transgene expression was also observed with circu-
lar plasmids, however, the overall expression was lower
than that obtained using linear plasmids (Supplementary
Figure S6). This is consistent with the increased
recombinogenic properties of linear DNA in HR
processes (63).
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Figure 4. Subcellular distribution of transfected DNA. (A) Confocal microscopy analysis of DNA intracellular trafﬁcking. Transient single or double
transfections were performed in CHO cells using plasmids bearing or not a MAR labeled with Rhodamine and Cy5 ﬂuorophores, as indicated.
Transfected cells were ﬁxed and stained with DAPI (blue) 3, 6, 21 h post-transfections. Cells expressing GFP appear in green on the pictures. (B)
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escence were used to estimate the amount of plasmid DNA in 120 cells.
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HR mediates increased expression
The requirement of plasmid homology and double-strand
breaks to achieve the higher expression levels upon the
double transfection implied that HR may be involved.
Transgenes were proposed to integrate into the cell genome
using two families of antagonistic pathways, termed non-
homologous end-joining (NHEJ) or HR. These pathways
are more active during speciﬁc phases of the cell cycle, as
exempliﬁed by HR, which is used to repair DNA damages
during or after DNA replication in the S and G2/M
phases of the cell cycle (64). Cells lacking classical
NHEJ genes show a double-stranded break repair biased
in favor of HR, suggesting that these two major pathways
normally compete to repair these DNA lesions (65). Thus,
one way to activate HR is to suppress or genetically
inactivate NHEJ, as seen in yeast and mammalian cells
(65–68). A possible implication of HR-related mechanisms
in the increased transgene expression that results from the
MAR and/or successive transfections was thus directly
assessed using CHO cell lines mutated in a key component
of either pathways, and which are thus only competent for
either HR or NHEJ.
The 51D1 CHO mutant derivative lacks the RAD51
strand transferase and is thus deﬁcient in HR, while
V3.3 CHO cells lack the catalytic activity of the DNA-
dependent protein kinase (DNA-PK) that plays an essen-
tial role to initiate the NHEJ pathway (13,54,69). In the
wild-type parental cell lines (AA8), the MAR mediated a
3-fold increase of the overall GFP ﬂuorescence in the poly-
clonal population (Figure 5B). However, few stably trans-
fected colonies survived after selection for antibiotic
resistance in the 51D1 cell line and GFP expression re-
mained very low. In contrast, an exacerbated MAR-
driven activation of transgene expression was observed
in NHEJ-deﬁcient cells, resulting in a >6-fold increase of
transgene expression when compared to cells transfected
once with the GFP expression vector without MAR.
Similar trends were noted for successive transfections,
in that GFP expression from V3.3 cells was increased in
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Figure 5. The MAR, plasmid homology and homologous recombination mediate high transgene expression. (A) Stable polyclonal cell pools were
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t-test, P< 0.05). No stably transfected cells were obtained form the double transfection of 51D1 cells.
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the presence of the MAR as compared to the parental
AA8 cells (Figure 5B, note the different scales of the top
and bottom panels). Inactivation of the NHEJ pathway
had little effect on the expression of the MAR-devoid
plasmid but it further exacerbated the expression
increase elicited by the MAR, indicating that presence of
the MAR and high HR activity are both necessary to
obtain very high transgene expression. Cells deﬁcient in
HR did not yield stable colonies from the double trans-
fection, demonstrating the requirement of the HR
pathway in the efﬁcient integration and maintenance of
transgenes in the successive gene transfer process.
Analysis of the number of integrated transgene copies
revealed a 25-fold higher number of integrated transgene
copies upon the double transfection of MARGFP in
NHEJ-deﬁcient V3.3 cells (Supplementary Figure S7).
However, a relatively larger (over 35-fold, Figure 5B)
increase in expression was obtained from two consecutive
transfections of the V3.3 cells with the MAR. Again, this
indicated that the observed MAR-mediated increase in
expression results both from an increase in transgene
genomic integration and in an augmentation of the expres-
sion per transgene copy.
DISCUSSION
The variability in gene expression among independently
transformed cells or organisms is well documented.
Inconsistent expression levels have been associated to
the variable number of genes that have stably integrate
in the host cell genome, to properties of the sites of inte-
gration, and/or to the gene transfer procedures. Non-viral
gene transfer remains characterized by variable expression
efﬁciencies and by an uncertain outcome in terms of ex-
pression levels and stabilities. Gene ampliﬁcation has been
used to augment the copy number and hence expression
of the exogenous genes (70), however this often leads to
unstable expression when the selection reagent is removed
(71). An alternative has been to optimize expression vec-
tors by inserting synthetic or natural regulatory sequences
that increase and/or stabilize expression, such as MAR
elements (39). However, even in the most favorable con-
ditions, transfections have lead to the occurrence of cells
that integrate the transgene in their genome but express it
at low levels. Hence, the identiﬁcation of stable cell lines is
usually associated with the tedious isolation and charac-
terization of many clones to identify one with the desired
expression properties. Here, we show that very high levels
of transgene expression can be consistently obtained in
nearly all cells of a polyclonal cell population after succes-
sive transfections of MAR-containing constructs. Our
results further indicate that efﬁcient gene transfer and ex-
pression of MAR-driven vectors require a functional HR
or repair pathway.
In this study, we show that MAR elements can act in
part to increase the number of copies of exogenous genes
that integrate in the genome, substantiating previous
non-quantitative observations (21,59). However, the intu-
ition that a high copy number always supports stronger
expression is often non-valid, as the presence of multiple
gene copies co-integrated at one or a few loci of the host
genome has been reported to favor silencing. The propen-
sity of repeated elements to pair and assemble in hetero-
chromatin or to generate double-stranded and/or small
interfering RNAs from antisens transcription of adjacent
transgenes is a frequent cause of gene silencing (6,72).
Here, the copy number of integrated transgenes and cell
ﬂuorescence levels were shown to correlate well when
comparing single or double transfections performed in
the presence of the MAR. We ﬁnd also that the MAR-
mediated increase in transgene expression results in part
from the integration of more transgene copies in the host
cell genome. However, we also ﬁnd that the relative
increase of transgene expression is higher than the increase
of transgene copy number upon inclusion of the MAR.
This indicates that MAR 1-68 acts both to increase trans-
gene integration and to increase expression per transgene
copy. Overall, we estimate that increased integration
mediates 70% of the observed effect on the increase of
expression, while the augmentation of transgene transcrip-
tion per se, as shown to occur in presence of MAR 1-68
(39), accounts for the remaining 30% of the increase of
expression observed upon successive transfections. Thus,
both effects concur to mediate the very high expression
levels observed after successive transfections of MAR-
containing plasmids.
We also ﬁnd that transgene genomic integration is syn-
ergistically increased by successive gene transfers and by
the MAR. Successive transfections of MAR-containing
plasmids result in improved plasmid transport to the
nucleus, as explained by the decreased targeting of the
second DNA load to the degradation compartment.
While the greater amounts of episomal plasmids in the
nucleus may readily explain the increased co-integration
of independent DNA loads in successive transfections
(Supplementary Figure S8), we ﬁnd that the MAR-
mediated increase in transgene integration does not result
from an increased plasmid targeting or transport to the
nucleus. This indicated that the MAR may directly
promote the recombination of the exogenous DNA with
the host cell genome.
In vertebrates, HR and NHEJ differentially contribute
to repairing abnormal DNA structures such as
double-stranded breaks, depending on the nature of the
DNA damage and the phase of the cell cycle (64). This
study shows that plasmid integration critically depend on
a functional HR pathway, as inactivation of Rad51, a key
initiator of HR (73), nearly abolishes transgene integra-
tion and expression. Conversely, inactivation of the antag-
onistic NHEJ pathway, which is associated to increased
HR, concomitantly increases the integration and expres-
sion of MAR-containing plasmids, but not of the
MAR-devoid control. In addition, increased integration
and expression upon successive MAR transfections
require the plasmids to have homologous DNA sequences.
Furthermore, the cells must be in the G1 cell cycle phase at
the time of transfection, and we ﬁnd that DNA transport
to the nucleus is nearly completed within 6 h after DNA
transfer, at which time cells have progressed to exit S and
enter G2 (see Supplementary Data), at which time HR is
most active. Taken together, these ﬁndings provide strong
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support for the involvement of HR in the increased inte-
gration, and, consequently, the higher expression observed
in presence of the MAR and/or upon double transfections.
They also suggest that plasmid integration by a HR repair
pathway may be increased in the presence of a MAR
element on the DNA. However, a direct demonstration
of the role of MAR elements in activating HR will
require further experimentations.
Mammalian cells contain the enzymatic machinery
required to mediate recombination between newly
introduced plasmid DNA molecules, and HR between
co-injected plasmid molecules is an efﬁcient process in
cultured mammalian cell lines, approaching 100% of the
molecules (60). Plasmid concatemers thereby formed may
integrate at one or a few sites in the host chromosome, the
integration site being different in independently trans-
formed cells (74). The orientation of the copies within
the concatemer is not random, but usually organized as
tandem head-to-tail arrays, as generated by the HR of
independent plasmid copies in the cell (75). HR between
the newly introduced DNA and its homologous chromo-
somal sequence has been reported to occur infrequently in
the absence of MAR element, at a frequency of 1:1000
cells receiving DNA (76). However, estimations based on
transgene expression, such as antibiotic selection, may sig-
niﬁcantly underestimate the true frequency of integration.
Whether plasmid concatemers may be able to undergo HR
with previously integrated transgene copies, or whether a
single integration event of a large plasmid concatemer
occurs, remains difﬁcult to assess experimentally. In any
case, the contribution of MAR elements to promote HR
proposed in this study readily provides an explanation to
the previously observed MAR-mediated increase in the
occurrence of cells that stably integrate the transfected
genes, and thus in the number of antibiotic-resistant
colonies (21).
The requirement of a functional HR pathway to
mediate efﬁcient integration of MAR-containing con-
structs implies that these DNA elements might be
preferred sites of homologous pairing and DNA recom-
bination. A number of molecular mechanisms have been
proposed to explain the mode of action of MARs. For
instance, they may reduce the occurrence of
lowly-expressing cells by protecting transgenes from
silencing effects linked to integration at heterochromatic
loci (7). MARs may recruit regulatory proteins that
modify chromatin to adopt a more transcriptionally per-
missive state by mediating histone hyperacetylation, they
may change subnuclear localization of the transgene, or
they may facilitate the association of transcription factors
that activate gene transcription (2,8,36,39). Although not
mutually exclusive, our results indicate that a signiﬁcant
part of the effect of MAR elements on transgene expres-
sion might in fact be attributed to increased transgene in-
tegration into the host cell genome by HR.
The proposed role of MARs as HR-promoting genomic
signals might result from their action on chromatin and/or
on DNA accessibility, thereby providing an access to
DNA binding proteins such as topoisomerases (48). As
reported in this study and by prior reports, all cells
take-up the transgene during a transfection although few
express it at a detectable level. This effect remains poorly
understood, but it may result from the slow or inefﬁcient
unpacking of the DNA from complexes generated by the
transfection reagents (77). Thus, the MAR might poten-
tially act in part by facilitating the release of the DNA
from complexes with the transfection agent and/or with
repressive protein structures. However, speciﬁc DNA
structures may also act to promote recombination. For
instance, endonuclease-mediated double-stranded DNA
breaks mediate improved rates of HR in eukaryotes,
bacteria and archae (78–82). Thus, an involvement of
the unwinding and DNA strand unpairing potential of
MARs might directly or indirectly promote the associ-
ation of recombination-initiating proteins (22,23,83,84).
Finally, MAR elements have been associated with the pro-
motion of DNA replication of episomally maintained
vectors (28,29). However, this latter effect requires a
promoter mediating transcription of the MAR, which is
not the case in this study. Furthermore, the MAR
sequence used in this study did not lead to increased epi-
somal DNA, and transgene maintenance was clearly asso-
ciated to chromosomal integration. Thus, if a direct role
for DNA replication appears unlikely in the settings used
in this study, the requirement of proteins such as replica-
tion promoting activity in both replication and HR would
be consistent with a role of MARs in promoting both
activities.
Overall, our ﬁndings imply that successive transfections
and the MAR may mediate very efﬁcient expression by
promoting HR between individual plasmid molecules,
thereby favoring the chromosomal integration of larger
concatemers, and by maintaining a permissive chromatin
structure after genomic integration. An interesting but
as yet unexplored possibility might be that the MAR
and HR-mediated events may lead to transgene integra-
tion at regions of homologies with the cellular genome.
One tantalizing possibility might even be that genomic
integration might occur at the endogenous cellular MAR
elements, as may result from the fact that MARs share
similar AT-rich and highly repetitive sequences across spe-
cies. Thus, the transgenes would be expected to integrate
at more accessible or privileged regions of the genome,
explaining the efﬁcient and stable expression. It will be
interesting to evaluate whether MAR elements may con-
tribute to regulating HR in a chromosomal context and
whether this can be exploited to facilitate gene replace-
ment strategies.
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